<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Dialogues Clin Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">Dialogues Clin Neurosci</journal-id><journal-id journal-id-type="pmc">Dialogues Clin Neurosci</journal-id><journal-title-group><journal-title>Dialogues in Clinical Neuroscience</journal-title></journal-title-group><issn pub-type="ppub">1294-8322</issn><issn pub-type="epub">1958-5969</issn><publisher><publisher-name>Les Laboratoires Servier</publisher-name><publisher-loc>France</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4140516</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research</subject></subj-group></article-categories><title-group><article-title>Patient-reported outcomes in obsessive-compulsive disorder</article-title><trans-title-group xml:lang="es"><trans-title>Resultados percibidos por el paciente en el trastorno obsesivo compulsivo</trans-title></trans-title-group><trans-title-group xml:lang="fr"><trans-title>R&#x000e9;sultats rapport&#x000e9;s par les patients dans les troubles obsessionnels compulsifs</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Subramaniam</surname><given-names>Mythily</given-names></name><degrees>MHSM</degrees><xref ref-type="corresp" rid="COR1">*</xref><aff>Research Division, Institute of Mental Health, Singapore</aff></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Soh</surname><given-names>Pauline</given-names></name><degrees>BA</degrees><aff>Research Division, Institute of Mental Health, Singapore</aff></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Ong</surname><given-names>Clarissa</given-names></name><degrees>BA</degrees><aff>Research Division, Institute of Mental Health, Singapore</aff></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Esmond Seow</surname><given-names>Lee Seng</given-names></name><degrees>BA</degrees><aff>Research Division, Institute of Mental Health, Singapore</aff></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Picco</surname><given-names>Louisa</given-names></name><degrees>MPH</degrees><aff>Research Division, Institute of Mental Health, Singapore</aff></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Vaingankar</surname><given-names>Janhavi Ajit</given-names></name><degrees>MSc</degrees><aff>Research Division, Institute of Mental Health, Singapore</aff></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Chong</surname><given-names>Siow Ann</given-names></name><degrees>MMed</degrees><aff>Research Division, Institute of Mental Health, Singapore</aff></contrib></contrib-group><author-notes><corresp id="COR1"><label>*</label>E-mail: <email>mythily@itnh.com.sg</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>6</month><year>2014</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>6</month><year>2014</year></pub-date><volume>16</volume><issue>2</issue><fpage>239</fpage><lpage>254</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2014 Institut la Conf&#x000e9;rence Hippocrate - Servier Research Group</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The purpose of the article was to provide an overview of patient-reported outcomes (PROs) and related measures that have been examined in the context of obsessive-compulsive disorder (OCD). The current review focused on patient-reported outcome measures (PROMs) that evaluated three broad outcome domains: functioning, health-related quality of life (HRQoL), and OCD-related symptoms. The present review ultimately included a total of 155 unique articles and 22 PROMs. An examination of the PROs revealed that OCD patients tend to suffer from significant functional disability, and report lower HRQoL than controls. OCD patients report greater symptom severity than patients with other mental disorders and evidence indicates that PROMs are sensitive to change and may be even better than clinician-rated measures at predicting treatment outcomes. Nonetheless, it should be noted that the measures reviewed lacked patient input in their development. Future research on PROMs must involve patient perspectives and include rigorous psychometric evaluation of these measures.</p></abstract><trans-abstract xml:lang="es"><p>El prop&#x000f3;sito de este art&#x000ed;culo fue proporcionar una panor&#x000e1;m&#x000ed;ca de los resultados perc&#x000ed;bidos por el paciente (PROs) y las mediciones relacionadas que se han efectuado en el trastorno obsesivo compulsivo (TOC). La revisi&#x000f3;n se centr&#x000f3; en las mediciones de los resultados perc&#x000ed;bidos por el paciente (PROMs) que evaluaron tres grandes &#x000e1;reas de resultados: func&#x000ed;onamiento, calidad de vida relacionada con la salud (CdVRS) y s&#x000ed;ntomas relacionados con el TOC. La presente revisi&#x000f3;n incluy&#x000f3; un total de 155 art&#x000ed;culos ind&#x000ed;viduales y 22 PROMs. Un an&#x000e1;l&#x000ed;sis de los PROs revel&#x000f3; que los pacientes con TOC tienden a sufrir de una marcada incapacidad funcional y refieren una CdVRS menor que los controles. Los pacientes con TOC muestran una mayor gravedad sintom&#x000e1;tica que los pacientes con otros trastornos mentales y la evidencia indica que las PROMs son sensibles a los cambios y en la predicci&#x000f3;n de los resultados terap&#x000e9;uticos pueden ser incluso mejores que las mediciones realizadas por los cl&#x000ed;nicos. Sin embargo, hay que tener en cuenta que las med&#x000ed;ciones revisadas carec&#x000ed;an del aporte del paciente en su desarrollo. A futuro la investigaci&#x000f3;n de las PROMs debe inclu&#x000ed;r las perspectivas del paciente e &#x000ed;ncorporar rigurosas evaluac&#x000ed;ones ps&#x000ed;com&#x000e9;tr&#x000ed;cas de estas mediciones.</p></trans-abstract><trans-abstract xml:lang="fr"><p>Cet article &#x000e9;tudie les r&#x000e9;sultats rapport&#x000e9;s par les patients (PRO, patient-reported outcome) et leurs mesures, analys&#x000e9;s dans le contexte des TOC (troubles obsessionnels compulsifs). Les mesures des r&#x000e9;sultats rapport&#x000e9;s par les patients (PROM, patient-reported outcome measures) &#x000e9;valuent ici trois grands domaines: le fonctionnement, la qualit&#x000e9; de vie li&#x000e9;e &#x000e0; la sant&#x000e9; (QdVLS) et les sympt&#x000f4;mes li&#x000e9;s aux TOC. La revue actuelle a finalement inclus un total de 155 articles originaux et 22 PROM. L'analyse des PRO montre que les patients atteints de TOC souffrent d'incapacit&#x000e9; fonctionnelle significative et rapportent une moins bonne QdVLS que les t&#x000e9;moins. Leurs sympt&#x000f4;mes rapport&#x000e9;s sont plus s&#x000e9;v&#x000e8;res que ceux des patients atteints d'autres troubles mentaux et des donn&#x000e9;es montrent que les PROM sont sensibles au changement et peuvent m&#x000ea;me mieux pr&#x000e9;dire les r&#x000e9;sultats th&#x000e9;rapeutiques que les mesures faites par les m&#x000e9;decins. Notons cependant que les mesures analys&#x000e9;es ne disposent pas, dans leur &#x000e9;volution, de la contribution des patients. La recherche future sur les PROM doit fate intervenir le point de vue des patients et inclure une &#x000e9;valuation psychom&#x000e9;trique rigoureuse de ces mesures.</p></trans-abstract><kwd-group><kwd><italic>patient-reported outcome</italic></kwd><kwd><italic>obsessive-compulsive disorder</italic></kwd><kwd><italic>functioning</italic></kwd><kwd><italic>health-related quality of life</italic></kwd><kwd><italic>symptom</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Obsessive-compulsive disorder (OCD) is a debilitating disorder characterized by two distinct phenomena: obsessions, which are recurrent and persistent intrusive thoughts, images, or urges (eg, pertaining to contamination, order/symmetry etc) that in most individuals cause marked anxiety or distress; and/or compulsions, which are repetitive covert or overt actions that are carried out to suppress or neutralize these distressing thoughts, images or urges (eg, checking, washing, or counting etc). More than 90% of patients with OCD have both obsessions and compulsions, although 30% suffer predominantly from obsessions and 20% predominantly with compulsions.<sup><xref rid="ref1" ref-type="bibr">1</xref></sup> OCD has been moved from the anxiety disorders category to the obsessive-compulsive and related disorders group in the most recent edition of the <italic>Diagnostic and Statistical Manual of Mental Disorders (DSM-5).</italic>
<sup><xref rid="ref2" ref-type="bibr">2</xref></sup> A diagnosis of OCD implies that the obsessions and compulsions are time-consuming, eg, take more than an hour a day and interfere significantly with daily, occupational, or social functioning.<sup><xref rid="ref2" ref-type="bibr">2</xref></sup>
</p><p>Epidemiological studies have estimated the lifetime prevalence of OCD as ranging from 2.3% to 3.8% in the general population,<sup><xref rid="ref3" ref-type="bibr">3</xref>,<xref rid="ref5" ref-type="bibr">5</xref></sup> with the average age of onset of the disorder to be around 20 years<sup><xref rid="ref3" ref-type="bibr">3</xref>,<xref rid="ref5" ref-type="bibr">5</xref></sup> and a treatment gap of about 60%. <sup><xref rid="ref6" ref-type="bibr">6</xref></sup> Although symptoms typically wax and wane, a chronic course is the norm in the absence of adequate treatment. Comorbidity with OCD is common and associated conditions include affective disorders and anxiety disorders.<sup><xref rid="ref5" ref-type="bibr">5</xref></sup>
</p><p>OCD also causes considerable disability. While the 1990 and 2000 Global Burden of Disease (GBD) studies included three specific anxiety disorders: post-traumatic stress disorder (PTSD), panic disorder (PD), and OCD, due to the high degree of comorbidity across anxiety disorders, the 2010 GBD assessed the burden of all anxiety disorders but chose not to provide estimates for specific anxiety disorders.<sup><xref rid="ref7" ref-type="bibr">7</xref></sup> In the GBD 2010 study, anxiety disorders were a major global cause of years lost to disability (YLD), contributing 3.5% of all YLD. The World Health Organization estimated OCD to be the 11th leading cause of nonfatal burden in the world in 1990, accounting for 2.2% of total YLD.<sup><xref rid="ref8" ref-type="bibr">8</xref></sup>
</p><p>A patient-reported outcome (PRO) is any report of the status of a patient's health condition that comes directly from the patient, without interpretation of the patient's response by a clinician or anyone else. The outcome can be measured in absolute terms (eg, severity of a symptom, sign, or state of a disease) or as a change from a previous state.<sup><xref rid="ref9" ref-type="bibr">9</xref></sup> A patient-reported outcome measure (PROM), eg, a questionnaire, log, or diary is a means to capture PRO data and can be used to measure symptom severity, functioning, treatment benefits, or side effects.</p><p>PROMs are important because objective measures of disease outcome are not always available, and they reflect what is most salient to patients about their condition and its treatment. PROMs are unique indicators of the impact of disease on patients, and can empower patients by giving them a voice and decision-making capacity in evaluating the efficacy of treatment, its side effects, and affordability. PROMs are especially important in the context of mental illnesses such as OCD because their symptoms may not always be perceptible to others. Indeed, the time taken up by obsessions or compulsions as well as the extent of distress experienced can only be reported by patients themselves. Similarly, treatment effectiveness is best reported by patients as improvements on clinician-rated measures may not correspond to how the patient functions or feels. Clinicians may overlook the negative side effects of treatment, which are often the reason for noncompliance.</p><p>A number of PROs have been reported among OCD patients. While some of the PROMs are generic and include questions designed to summarize perceived health in relation to broad life domains, others are condition-specific. Examples of generic instruments include the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36)<sup><xref rid="ref10" ref-type="bibr">10</xref></sup> and the World Health Organization Quality of Life BREF (WHOQOL-BREF),<sup><xref rid="ref11" ref-type="bibr">11</xref></sup> On the other hand, condition-specific instruments such as the Obsessive-Compulsive Inventory (OCI)<sup><xref rid="ref12" ref-type="bibr">12</xref></sup> mainly evaluate symptom domains directly associated with OCD.</p><p>The aim of this systematic review was to present an overview of PROs in the context of OCD. It includes the constructs, corresponding scales, and key findings related to PROs in OCD patients.</p></sec><sec sec-type="methods"><title>Methodology</title><p>Index terms for PROs differ between the major bibliographic databases. It has been suggested that review authors should not rely on a single index or subheading search term to identify studies addressing PROs.<sup><xref rid="ref13" ref-type="bibr">13</xref></sup> Multiple search terms are usually necessary. Furthermore, the search needs to combine index terms and free-text terms, and is likely to require several iterations.<sup><xref rid="ref13" ref-type="bibr">13</xref></sup> The present review was guided by the PRISMA statement and conducted in two phases. In the first phase, the authors (MS, CO, PS, and ES) identified various PROMs that were used in patients with OCD. They then conducted a systematic review using a search strategy using two keywords: (i) obsessive-compulsive disorder; AND (ii) specific instrument, and limited the search to abstract, title, and keywords. The databases used for the systematic review were PubMed, Science Direct, Medline, and Psyclnfo. In addition, reference lists of all included studies were hand searched. To ensure recency of articles, the search was restricted to the period between and inclusive of January 1995 to October 2013. Potentially relevant papers were examined by at least two authors who worked independently, with discrepancies of opinion resolved by meeting together as a group. Inclusion criteria included: (i) the study cohort comprised OCD patients where OCD was the primary diagnosis, diagnosed clinically or using <italic>DSM</italic> criteria; (ii) the study described outcomes among OCD patients using PROMs; (iii) the study was among adult populations; and (iv) the study focused on at least one of the three broad groups of outcomes&#x02014;symptoms primarily related to OCD, functioning, and health-related quality of life (HRQoL). Exclusion criteria included studies not reported in English, studies in the general population (ie, not a patient population), case reports, case series, studies conducted only for validation purposes and studies that did not report on outcomes per se.</p></sec><sec sec-type="results"><title>Results</title><sec><title>Search results</title><p>The searches returned a total of 1368 articles. This included 945 unique articles after the removal of 423 duplicates. Screening by abstracts removed a further 725 articles. Full texts of the remaining 220 manuscripts were then retrieved and a further 65 studies were excluded. A total of 155 studies met all criteria and were included in the paper.</p><p>A total of 22 PROMs were used across the included studies. An overview of each instrument's measurement properties and how it assesses and scores outcomes is shown in <italic>Table I.</italic> Details of the sample and the outcome measures used in each of the 155 studies are outlined in <italic>Table II</italic> (available in the online version of this article).</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table I</label><caption><title>Patient-reported outcome measures: assessing functioning, health-related quality of life, and symptoms.</title></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1">
<bold>Name of instrument (ref)</bold>
</td><td rowspan="1" colspan="1">
<bold>Main domain of assessment/Number of subscales</bold>
</td><td rowspan="1" colspan="1">
<bold>Number of items</bold>
</td><td rowspan="1" colspan="1">
<bold>Time for administration</bold>
</td><td rowspan="1" colspan="1">
<bold>Scoring</bold>
</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Functioning</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Sheehan's Disability Scale (SDS)<sup><xref rid="ref15" ref-type="bibr">15</xref></sup>
</td><td rowspan="1" colspan="1">Measure of functional impairment in three domains&#x02014;work, social life, and family/home responsibilities</td><td rowspan="1" colspan="1">3-item</td><td rowspan="1" colspan="1">1-2 minutes</td><td rowspan="1" colspan="1">A 0-10 visual analogue scale for each item. The three items may be summed into a single measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired).</td></tr><tr><td rowspan="1" colspan="1">Social Adjustment Scale&#x02014;Self Report (SAS-SR)<sup><xref rid="ref16" ref-type="bibr">16</xref></sup>
</td><td rowspan="1" colspan="1">Measures role performance in 6 major areas of functioning&#x02014;work, social/leisure activities, relationships with extended family, marital role as a spouse, parental role and role within the family unit.</td><td rowspan="1" colspan="1">54-item</td><td rowspan="1" colspan="1">15-20 minutes</td><td rowspan="1" colspan="1">0-5 for each domain and for the total score (all items are summed and divided by the number of items completed). Higher scores indicate poorer social functioning.</td></tr><tr><td rowspan="1" colspan="1">Work and Social Adjustment Scale (WSAS)<sup><xref rid="ref17" ref-type="bibr">17</xref></sup>
</td><td rowspan="1" colspan="1">Assesses level of functional impairment due to an identified problem across 5 domains. 1) ability to work, 2) home management, 3) social leisure activities, 4) private leisure activities and 5) ability to form and maintain close relationships with others.</td><td rowspan="1" colspan="1">5-item</td><td rowspan="1" colspan="1">1-5 minutes</td><td rowspan="1" colspan="1">A 9-point Likert scale from 0 = no impairment at all to 8 = very severe impairment. Item scores are summed to calculate total score. Higher scores indicate greater functional impairment.</td></tr><tr><td rowspan="1" colspan="1">
<bold>Health-related quality of life</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Illness Intrusiveness Rating Scale (IIRS)<sup><xref rid="ref46" ref-type="bibr">46</xref></sup>
</td><td rowspan="1" colspan="1">Measures three domains &#x0201c;Relationship and Personal Development&#x0201d;, &#x0201c;Intimacy&#x0201d;, and &#x0201c;Instrumental Life&#x0201d;</td><td rowspan="1" colspan="1">13-item</td><td rowspan="1" colspan="1">10 minutes</td><td rowspan="1" colspan="1">Each domain is rated for level of intrusiveness on a scale ranging from 1 (not very much) to 7 (very much).</td></tr><tr><td rowspan="1" colspan="1">Medical Outcomes Study 36-Item Short Form (SF-36)<sup><xref rid="ref10" ref-type="bibr">10</xref></sup>
</td><td rowspan="1" colspan="1">Measures well-being across 8 domains: physical functioning, limitations due to physical health problem, bodily pain, general health, vitality, social functioning, limitations due to emotional problems and mental health.</td><td rowspan="1" colspan="1">36-item</td><td rowspan="1" colspan="1">5-10 minutes</td><td rowspan="1" colspan="1">The number of response choices per item ranges for two to six. The SF-36 yields an eight-dimensional profile, with each scale having a range from 0 to 100. Higher scores indicate better quality of life status.</td></tr><tr><td rowspan="1" colspan="1">Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q)<sup><xref rid="ref44" ref-type="bibr">44</xref></sup>
</td><td rowspan="1" colspan="1">Measures quality of life across 8 summary scales: general activities, physical health, emotional well-being, household duties, leisure time activities, social relations, work, and school/course work.</td><td rowspan="1" colspan="1">93-item</td><td rowspan="1" colspan="1">40-45 minutes</td><td rowspan="1" colspan="1">Each domains is assessed on a 5-point scale from very poor to very good, and the domains are aggregated to produce an overall score.</td></tr><tr><td rowspan="1" colspan="1">Quality of Life Inventory (QOLI)<sup><xref rid="ref45" ref-type="bibr">45</xref></sup>
</td><td rowspan="1" colspan="1">Measures overall life satisfaction and importance within 16 domains: health, self-esteem, goals and values, money, work, play, learning, creativity, helping, love, friends, children, relatives, home, neighbourhood, and community.</td><td rowspan="1" colspan="1">32-item</td><td rowspan="1" colspan="1">5 minutes</td><td rowspan="1" colspan="1">Each domain is rated in terms of its importance to overall happiness (0-2) and in terms of respondent's satisfaction with the area (-3 to 3). Importance ratings are multiplied by their satisfaction ratings to produce a weighted satisfaction score for each area of life.</td></tr><tr><td rowspan="1" colspan="1">Quality of Life Scale (QOLS)<sup><xref rid="ref47" ref-type="bibr">47</xref></sup>
</td><td rowspan="1" colspan="1">Measures five conceptual domains of quality of life: material and physical well-being, relationships with other people, social, community and civic activities, personal development and fulfillment, and recreation. The instrument was later expanded to include Independence.</td><td rowspan="1" colspan="1">16-item</td><td rowspan="1" colspan="1">5 minutes</td><td rowspan="1" colspan="1">Seven-point scale anchored by &#x0201c;delighted&#x0201d;, &#x0201c;pleased&#x0201d;, &#x0201c;mostly satisfied&#x0201d;, &#x0201c;mixed&#x0201d;, &#x0201c;mostly dissatisfied&#x0201d;, &#x0201c;unhappy&#x0201d;, &#x0201c;terrible&#x0201d;. Scores can range from 16 to 112.</td></tr><tr><td rowspan="1" colspan="1">The Lancashire Quality of Life Profile (LQoLP)<sup><xref rid="ref48" ref-type="bibr">48</xref></sup>
</td><td rowspan="1" colspan="1">For the subjective aspect, LQoLP focusses on 9 specific domains - work and education, leisure and participation, religion, finance, living situation, legal and safety, family relations, social relations and health.</td><td rowspan="1" colspan="1">105-item</td><td rowspan="1" colspan="1">30 minutes</td><td rowspan="1" colspan="1">All items are rated on a 7-point scale (can't be worse to can't be better). The sum of the nine dimension scores is the 'perceived QoL score'.</td></tr><tr><td rowspan="1" colspan="1">World Health Organization Quality of Life Assessment (WHOQOL-BREF)<sup><xref rid="ref1" ref-type="bibr">1</xref></sup>
</td><td rowspan="1" colspan="1">Measures quality of life across four domains- physical health, psychological, social relationships and environment.</td><td rowspan="1" colspan="1">26-item</td><td rowspan="1" colspan="1">10-15 minutes</td><td rowspan="1" colspan="1">1-5 point Likert scale for each item. Higher overall scores indicate higher quality of life.</td></tr><tr><td rowspan="1" colspan="1">
<bold>Symptoms</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Clark-Beck Obsessive Compulsive Inventory (CBOCI)<sup><xref rid="ref88" ref-type="bibr">88</xref></sup>
</td><td rowspan="1" colspan="1">11 items that assess obsessive behaviors and 14 items that assess complusive behaviors.</td><td rowspan="1" colspan="1">25-item</td><td rowspan="1" colspan="1">10-20 minutes</td><td rowspan="1" colspan="1">Items scored on 4 point Likert scale ranging from 0 (absence of symptoms) to 3 (high difficulty with symptoms). Items are summed for a total score.</td></tr><tr><td rowspan="1" colspan="1">Dimensional Obsessive-Complusive Scale (DOCS)<sup><xref rid="ref89" ref-type="bibr">89</xref></sup>
</td><td rowspan="1" colspan="1">Measures the severity of the four most empirically supported OCD symptom dimensions: contamination, responsibility for harm and mistakes, symmetry/ordering, and unacceptable thoughts.</td><td rowspan="1" colspan="1">20-item</td><td rowspan="1" colspan="1">5-10 minutes</td><td rowspan="1" colspan="1">The responder first reads a description of the symptom dimension and following each description are five items (rated 0 to 4) that measure (a) time occupied by obsessions and rituals, (b) avoidance behavior, (c) distress, (d) functional interference, and (e) difficulty disregarding the obsessions and refraining from doing compulsions.</td></tr><tr><td rowspan="1" colspan="1">Hamburg Obsessive-Compulsive Inventory (HZI/HOCI)<sup><xref rid="ref90" ref-type="bibr">90</xref></sup>
</td><td rowspan="1" colspan="1">Measures obsessions and compulsions on six different subscales: checking behavior; washing and cleaning behavior; symmetry and ordering behavior; counting, touching, repetitive speaking: thoughts of words and pictures; aggressive impulses and fantasies towards oneself or others.</td><td rowspan="1" colspan="1">72-item</td><td rowspan="1" colspan="1">Approximately 23 minutes</td><td rowspan="1" colspan="1">Each subscale has 12 items and each item can be answered with &#x0201c;true&#x0201d; or &#x0201c;false&#x0201d;. The &#x0201c;true&#x0201d; answers are summed for the subscale scores.</td></tr><tr><td rowspan="1" colspan="1">Maudsley Obsessive-Compulsive Inventory (MOCI)<sup><xref rid="ref92" ref-type="bibr">92</xref></sup>
</td><td rowspan="1" colspan="1">Measures overt rituals and their related obsessions within 4 subscales: checking, washing/cleaning, slowness, and doubting.</td><td rowspan="1" colspan="1">30-item</td><td rowspan="1" colspan="1">Approximately 15 minutes</td><td rowspan="1" colspan="1">A dichotomous correct/incorrect format; &#x0201c;yes&#x0201d; answered are scored 1 point and &#x0201c;no&#x0201d; answers 0 point.</td></tr><tr><td rowspan="1" colspan="1">Obsessional Beliefs Questionnaire-44 (OBQ-44)<sup><xref rid="ref93" ref-type="bibr">93</xref></sup>
</td><td rowspan="1" colspan="1">OBQ-44, a shortened version of the original 87-item OBQ, consists of 3 factor- analytically derived subscales assessing domains of cognitive in: responsibility/threat estimation (16 items); perfectionism/certainty (12 items) and importance/control of thoughts (16 items).</td><td rowspan="1" colspan="1">44-item</td><td rowspan="1" colspan="1">10-20 minutes</td><td rowspan="1" colspan="1">Obsessional beliefs are rated on a 7-point scale from 1 (disagree very much) to 7 (agree very much). Higher scores indicate stronger beliefs.</td></tr><tr><td rowspan="1" colspan="1">Obsessive Compulsive Inventory, Revised (OCI-R)<sup><xref rid="ref12" ref-type="bibr">12</xref></sup>
</td><td rowspan="1" colspan="1">OCI-R or OCI-Short Version, a revised version to address the limitaitons of OCI, measures the frequency and distress experiences across 6 domains: washing, obsessing, hoarding, ordering, checking, and neutralizing.</td><td rowspan="1" colspan="1">18-item</td><td rowspan="1" colspan="1">Approximately 10 minutes</td><td rowspan="1" colspan="1">This instruments uses a 5-point Likert scale (from 0 = not at all, to 4 = extremely). The maximum score on the OCI-R is 72, with a score of 21 reflecting clinically significant levels of symptoms.</td></tr><tr><td rowspan="1" colspan="1">Padua Inventory, Revised (PI-R)<sup><xref rid="ref94" ref-type="bibr">94</xref></sup>
</td><td rowspan="1" colspan="1">Several revisions of the original PI have been published. Derived from a factor-analytic study, the most widely used PI-R is a 5- factor structure scale that assesses impulses, washing, checking, rumination and precision.</td><td rowspan="1" colspan="1">41-item</td><td rowspan="1" colspan="1">10-20 minutes</td><td rowspan="1" colspan="1">This instrument uses a 5-point Likert scale (from 0 = not at all, to 4 = very much). The maximum score is 164 and higher scores represent greater interference in routine daily functioning.</td></tr><tr><td rowspan="1" colspan="1">Structured Clinical Interview for Obsessive-Compulsive Spectrum <italic>Self-Report - Lifetime</italic> (SCI-OBS-SR)<sup><xref rid="ref95" ref-type="bibr">95</xref></sup>
</td><td rowspan="1" colspan="1">Measures seven domains: child-hood/adolescence experiences, doubt, hyper-control, attitude toward time, perfectionism, repetition and automation, and specific themes&#x02014;contamination, cleaning, sexuality, existential attitudes toward religion, aggressiveness, impulsiveness, and somatic themes.</td><td rowspan="1" colspan="1">183-item</td><td rowspan="1" colspan="1">40 minutes</td><td rowspan="1" colspan="1">Subjects answer either Yes or No to each item on the questionnaire according to the lifetime presence/absence of the described manifestation.</td></tr><tr><td rowspan="1" colspan="1">Symptom Checklist-90-Revised (SCL-90-R)<sup><xref rid="ref96" ref-type="bibr">96</xref></sup>
</td><td rowspan="1" colspan="1">9 primary symptom dimensions are measured: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, and a category of additional items.</td><td rowspan="1" colspan="1">90-items</td><td rowspan="1" colspan="1">12-15 minutes</td><td rowspan="1" colspan="1">Symptoms are rated on a 5-point scale ranging from 0 'not at all' to 4 'extremely' Items are summed for a total score.</td></tr><tr><td rowspan="1" colspan="1">Vancouver Obsessional-Compulsive Inventory (VOCI)<sup>97</sup>
</td><td rowspan="1" colspan="1">Measures a range of obsessions, compulsions, avoidance behaviour, and personality characteristics of known or theoretical importance in OCD: contamination, checking, obsessions, hoarding, just right experiences, and indecisiveness.</td><td rowspan="1" colspan="1">55-item</td><td rowspan="1" colspan="1">10-20 minutes</td><td rowspan="1" colspan="1">This instrument uses a 5-point Likert-type scale, with ratings being summed to provide scores on the six separate subscales.</td></tr><tr><td rowspan="1" colspan="1">Yale-Brown Obsessive-Compulsive Scale, <italic>Self-Report Version</italic> (Y-BOCS-SR)<sup><xref rid="ref98" ref-type="bibr">98</xref></sup>
</td><td rowspan="1" colspan="1">Measures the severity of OCD symptoms independently of the type of clinical obsessions and compulsions the individual experiences.</td><td rowspan="1" colspan="1">10-item (5 on obsessions and 5 on compulsions)</td><td rowspan="1" colspan="1">Approximately 10 minutes</td><td rowspan="1" colspan="1">Respondent indicates the presence or absence of obsessions/compulsions from a checklist of 58 symptoms and answers 10 questions indicating: time spent, interference, distress, resistance, and control. These responses are rated on a 5-point Likert type scale (0 = 'none', 4 = 'extreme'). The cutoff point for clinically significant symptoms is 16 or more.</td></tr></tbody></table></table-wrap></sec><sec><title>Patient-reported outcomes related to functioning</title><p>Patients with OCD suffer from considerable disability as obsessive-compulsive (OC) symptoms can disrupt social relationships and impair occupational functioning. Knowing the predictors of functional impairment in OCD can facilitate treatment of the disorder by directing clinicians to those aspects of the problem. Storch et al<sup><xref rid="ref14" ref-type="bibr">14</xref></sup> suggested that patients who do not respond to first-line interventions could instead be offered therapies aimed at reducing factors associated with disability, thereby reducing burden of illness. There is also an increasing focus on patient-reported functional outcomes in clinical trials where they are often used to supplement traditional clinician-assessed outcomes. Scales that have been used to assess functioning in OCD include Sheehan Disability Scale (SDS),<sup><xref rid="ref15" ref-type="bibr">15</xref></sup> Social Adjustment Scale-Self Report. (SAS-SR)<sup><xref rid="ref16" ref-type="bibr">16</xref></sup> and the Work and Social Adjustment Scale (WSAS),<sup><xref rid="ref17" ref-type="bibr">17</xref></sup>
<italic>Table I.</italic>
</p><p>Social functioning in OCD patients was found to be worse than community norms/controls.<sup><xref rid="ref18" ref-type="bibr">18</xref>,<xref rid="ref20" ref-type="bibr">20</xref></sup> Comparing across mental illnesses, Kennedy et al<sup><xref rid="ref20" ref-type="bibr">20</xref></sup> reported that those with OCD had the highest work disability scores among six common mental disorders. Social functioning of OCD patients was comparable to that of patients with depression and alcoholism.<sup><xref rid="ref19" ref-type="bibr">19</xref></sup> Those with OCD were less impaired in terms of social functioning compared to those with social anxiety disorder (SAD),<sup><xref rid="ref21" ref-type="bibr">21</xref></sup> but were significantly more impaired in extended family functioning than patients with PD. Starcevic et al<sup><xref rid="ref22" ref-type="bibr">22</xref></sup> found no difference in disability scores between OCD patients with and without obsessive-compulsive personality disorder.</p><p>A younger age of onset of OCD was found to have a negative impact on social functioning in the domains of work and family unit role.<sup><xref rid="ref19" ref-type="bibr">19</xref></sup> This could be because an early onset of illness is specifically burdensome for patients' academic and professional development.<sup><xref rid="ref19" ref-type="bibr">19</xref></sup> Depressive and anxiety symptoms have also been found to be significantly related to disability<sup><xref rid="ref14" ref-type="bibr">14</xref>,<xref rid="ref19" ref-type="bibr">19</xref>,<xref rid="ref23" ref-type="bibr">23</xref></sup> and depression was found to mediate the relationship between OCD-related distress and functional disability.<sup><xref rid="ref14" ref-type="bibr">14</xref></sup>
</p><p>Functional disability has been associated with OCD symptom severity. <sup><xref rid="ref14" ref-type="bibr">14</xref>,<xref rid="ref19" ref-type="bibr">19</xref>,<xref rid="ref23" ref-type="bibr">23</xref>,<xref rid="ref27" ref-type="bibr">27</xref></sup> Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) compulsion scores were significantly related to social functioning.<sup><xref rid="ref23" ref-type="bibr">23</xref></sup> Storch et al<sup><xref rid="ref14" ref-type="bibr">14</xref></sup> found that the extent to which an individual attempts to resist and is able to control his or her OCD symptoms mediates the relationship between OC symptoms and functional disability. Severity of sexual/religious obsessions and hoarding symptoms were associated with overall social adjustment.<sup><xref rid="ref19" ref-type="bibr">19</xref></sup> Disability was correlated with insight with regards to OCD,<sup><xref rid="ref28" ref-type="bibr">28</xref></sup> as was the degree of avoidance and pathological doubting.<sup><xref rid="ref29" ref-type="bibr">29</xref></sup> Occupational disability was also associated with poorer social functioning.<sup><xref rid="ref30" ref-type="bibr">30</xref></sup> The Social Adjustment Scale (SAS)-non family score (excludes marital and family functioning score) was significantly associated with hostility expressed by patient's relatives.<sup><xref rid="ref31" ref-type="bibr">31</xref></sup>
</p><p>Fontenelle et al<sup><xref rid="ref32" ref-type="bibr">32</xref></sup> found that among OCD patients, brain-derived neurotropic factor plasma levels correlated negatively on a trend level with total score on the SDS. The severity of disability was associated with the use of psychotropic agents<sup><xref rid="ref33" ref-type="bibr">33</xref></sup> as well as refusal of pharmacotherapy among OCD patients.<sup><xref rid="ref34" ref-type="bibr">34</xref></sup>
</p><p>Studies have found improved patient-reported functioning following treatment of OCD with pharmacotherapy and/or psychotherapy. Statistically significant improvements in the SDS subscales were reported in the active treatment arm compared with the placebo arm in two studies.<sup><xref rid="ref24" ref-type="bibr">24</xref>,<xref rid="ref35" ref-type="bibr">35</xref></sup> A prospective observational study conducted in a naturalistic primary care setting reported significant improvement in all three dimensions of SDS compared with baseline scores.<sup><xref rid="ref36" ref-type="bibr">36</xref></sup> T&#x000fc;kel et al<sup><xref rid="ref26" ref-type="bibr">26</xref></sup> found that baseline Y-BOCS and SDS subscale scores of nonresponders were significantly higher than those of responders, and baseline SDS-work scores were found to be significant predictors of nonresponse to selective serotonin reuptake inhibitors (SSRIs). Studies have also found significant improvements in functioning following cognitive behavioral therapy (CBT),<sup><xref rid="ref25" ref-type="bibr">25</xref></sup> group behavior therapy<sup><xref rid="ref37" ref-type="bibr">37</xref></sup> and Internet-administered CBT,<sup><xref rid="ref38" ref-type="bibr">38</xref></sup> as well as marginal improvement following multi-family behavior therapy.<sup><xref rid="ref37" ref-type="bibr">37</xref></sup> Improved functioning was also reported following computer-guided behavior therapy (BT STEPS). Those randomized to BT STEPS and clinician-guided behavior therapy improved significantly more than patients assigned to relaxation therapy.<sup><xref rid="ref39" ref-type="bibr">39</xref></sup> Another study on patients using BT STEPS found that improvement, as measured by the Work and Social Adjustment Scale (WSAS), was significantly greater in patients who received additional scheduled help-line support from a clinician than patients who were asked to request support when they needed it.<sup><xref rid="ref40" ref-type="bibr">40</xref></sup> Increased baseline work and social adjustment was found to be a positive predictor of intensive residential treatment (IRT) response.<sup><xref rid="ref41" ref-type="bibr">41</xref></sup> The authors hypothesized that this could be because those with better social skills established stronger peer support during treatment, benefitted more from peer modeling, and engaged more in the treatment process than those with poorer social functioning.<sup><xref rid="ref41" ref-type="bibr">41</xref></sup> Alternatively, poorer social functioning may indicate more treatment-resistant, debilitating OCD.<sup><xref rid="ref41" ref-type="bibr">41</xref></sup>
</p><p>(See <italic>Table IIa,</italic> available in the online version of this article, for summary of included studies).</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table IIa</label><caption><title>Summary of the sample, interventions, and outcome measures used in included studies that measured functioning using patient-reported outcome measures (PROMs).</title></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1">
<bold>Reference</bold>
</td><td rowspan="1" colspan="1">
<bold>Study sample (N, number of sites, country)</bold>
</td><td rowspan="1" colspan="1">
<bold>Study methodology</bold>
</td><td rowspan="1" colspan="1">
<bold>PROM(s) used</bold>
</td><td rowspan="1" colspan="1">
<bold>Major findings</bold>
</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">Brakoulias et al<sup><xref rid="ref33" ref-type="bibr">33</xref></sup>
</td><td rowspan="1" colspan="1">154 participants with a primary OCD diagnosis; several sites in NSW; Australia</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SDS</td><td rowspan="1" colspan="1">The use of psychotropic agents for treating OCD symptoms was associated with higher SDS work and social subscale scores.</td></tr><tr><td rowspan="1" colspan="1">Chambless &#x00026; Steketee<sup><xref rid="ref31" ref-type="bibr">31</xref></sup>
</td><td rowspan="1" colspan="1">60 patients with a primary OCD diagnosis, 41 patients with a primary PD with agoraphobia (PDA) diagnosis and relatives living with the patients; Washington, DC and Massachusetts; USA</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">SAS-SR</td><td rowspan="1" colspan="1">The effect of hostility at baseline on post-treatment functioning was moderated by relative type such that the negative relationship between hostility and functioning was only observed with non-spousal relatives.</td></tr><tr><td rowspan="1" colspan="1">Didie et al<sup><xref rid="ref18" ref-type="bibr">18</xref></sup>
</td><td rowspan="1" colspan="1">210 patients with a primary OCD diagnosis, 45 patients with a primary BDD diagnosis and 40 patients with comorbid BDD+OCD; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SAS-SR</td><td rowspan="1" colspan="1">All participants reported poorer overall social adjustment compared to community norms. BDD+OCD participants had significantly higher SAS-SR total scores than OCD participants. No difference in social functioning was found between OCD and BDD participants.</td></tr><tr><td rowspan="1" colspan="1">Diefenbach et al<sup><xref rid="ref25" ref-type="bibr">25</xref></sup>
</td><td rowspan="1" colspan="1">70 patients with a primary OCD diagnosis; Connecticut and Minnesota; USA</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">SDS</td><td rowspan="1" colspan="1">SDS baseline scores were significantly and positively correlated with OC and depressive symptoms. Participants showed significant improvement in their SDS scores from pre- to post-treatment, with greater improvement observed in family functioning than work and social functioning. There was also a subset of patients who experienced clinically significant improvement in OC symptoms without showing a corresponding improvement in functioning.</td></tr><tr><td rowspan="1" colspan="1">Farris et al<sup><xref rid="ref27" ref-type="bibr">27</xref></sup>
</td><td rowspan="1" colspan="1">288 participants with a primary OCD diagnosis; 2 sites: Pennsylvania and New York; USA</td><td rowspan="1" colspan="1">Meta-analysis of 4 RCTs</td><td rowspan="1" colspan="1">SAS-SR</td><td rowspan="1" colspan="1">Greater OCD symptom severity was moderately associated with poorer social functioning at post-treatment.</td></tr><tr><td rowspan="1" colspan="1">Fontenelle et al<sup><xref rid="ref32" ref-type="bibr">32</xref></sup>
</td><td rowspan="1" colspan="1">40 patients with a primary OCD diagnosis and 40 community controls; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SDS</td><td rowspan="1" colspan="1">BDNF plasma levels were marginally and positively correlated with overall functioning in the OCD group.</td></tr><tr><td rowspan="1" colspan="1">Fontenelle et al<sup><xref rid="ref28" ref-type="bibr">28</xref></sup>
</td><td rowspan="1" colspan="1">60 patients with a primary OCD diagnosis; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SDS</td><td rowspan="1" colspan="1">Composite insight was significantly and positively correlated with social disability.</td></tr><tr><td rowspan="1" colspan="1">G&#x000e9;rard et al<sup><xref rid="ref36" ref-type="bibr">36</xref></sup>
</td><td rowspan="1" colspan="1">373 patients with OCD, 6270 patients with MDD, 2848 patients with GAD, 1213 patients with SAD and 656 patients with PD; France</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">SDS</td><td rowspan="1" colspan="1">At baseline, even patients with low physician-rated illness severity reported significant disability. From pre-treatment to the 12-week follow-up visit, patients' SDS subscale scores improved significantly. Mean improvement in SDS subscale scores for all participants was moderately and positively correlated with physician-rated improvement.</td></tr><tr><td rowspan="1" colspan="1">Greist et al<sup><xref rid="ref39" ref-type="bibr">39</xref></sup>
</td><td rowspan="1" colspan="1">218 patients with a primary OCD diagnosis; 8 sites; Utah, Colorado, Florida, Texas, Ontario, North Carolina, Massachusetts, and Georgia; USA</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">WSAS,</td><td rowspan="1" colspan="1">Patients who underwent computer-guided exposure sessions (BT STEPS) or clinician-guided behavior therapy improved significantly more from baseline to endpoint on WSAS total score than patients in the placebo condition. There was no significant difference between BT STEPS and clinician-guided therapy.</td></tr><tr><td rowspan="1" colspan="1">Hollander et al<sup><xref rid="ref24" ref-type="bibr">24</xref></sup>
</td><td rowspan="1" colspan="1">466 patients with a primary OCD diagnosis; 1) 58 sites in 7 countries and 2) 62 sites in 14 countries</td><td rowspan="1" colspan="1">Retrospective analysis of data from 2 previous RCTs</td><td rowspan="1" colspan="1">SDS</td><td rowspan="1" colspan="1">Patients with more severe OCD symptoms had signsficantly higher SDS subscale scores at baseline. Patients receiving active treatment showed a significant reduction in dysfunction compared to the placebo group. In addition, responders reported significantly less functional impairment than nonresponders, and relapsed patients had significantly higher SDS scores than non-relapsed patients.</td></tr><tr><td rowspan="1" colspan="1">Huppert et al<sup><xref rid="ref23" ref-type="bibr">23</xref></sup>
</td><td rowspan="1" colspan="1">66 patients with OCD, 36 healthy controls (HCs); USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SAS-SR, SDS</td><td rowspan="1" colspan="1">SDS scores for HCs and patients in remission did not significantly differ, though both groups reported less disability than current OCD patients who, in turn, experienced less disability than comorbid OCD patients.</td></tr><tr><td rowspan="1" colspan="1">Kennedy et al<sup><xref rid="ref20" ref-type="bibr">20</xref></sup>
</td><td rowspan="1" colspan="1">14 participants with OCD, 77 participants with major depression, 21 participants with PD, 30 participants with social phobia, 21 participants with mixed anxiety disorder and 29 controls; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SDS</td><td rowspan="1" colspan="1">OCD participants had significantly greater work, social, and family disability than controls, but did not differ from the other clinical groups in work or social disability.</td></tr><tr><td rowspan="1" colspan="1">Kenwright et al<sup><xref rid="ref40" ref-type="bibr">40</xref></sup>
</td><td rowspan="1" colspan="1">44 patients with a primary OCD diagnosis; UK</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">WSAS</td><td rowspan="1" colspan="1">Improvement in WSAS total score was significantly greater among patients provided with scheduled help-line support than patients who were asked to request support when needed. However, all patients' WSAS scores improved significantly from pre- to post-treatment.</td></tr><tr><td rowspan="1" colspan="1">Lochner et al<sup><xref rid="ref21" ref-type="bibr">21</xref></sup>
</td><td rowspan="1" colspan="1">220 patients with OCD, 53 patients with PD and 64 patients with SAD; South Africa</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SDS</td><td rowspan="1" colspan="1">OCD patients reported greater current impairment in friendship, activities of daily living and extended family functioning than PD patients. However, they reported significantly less current impairment in social life and social functioning than SAD patients.</td></tr><tr><td rowspan="1" colspan="1">Mancebo et al<sup><xref rid="ref30" ref-type="bibr">30</xref></sup>
</td><td rowspan="1" colspan="1">238 participants with a primary OCD diagnosis; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SAS-SR</td><td rowspan="1" colspan="1">Participants with occupational disability reported greater impairment in their social and leisure, extended family and family unit functioning than those without occupational disability.</td></tr><tr><td rowspan="1" colspan="1">Montgomery et al<sup><xref rid="ref35" ref-type="bibr">35</xref></sup>
</td><td rowspan="1" colspan="1">401 patients with OCD; 53 sites in 12 countries</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">SDS</td><td rowspan="1" colspan="1">Improvement on SDS subscale scores was significantly greater in at least one treatment condition (the three treatment groups received varying doses of citalopram) compared to the placebo condition.</td></tr><tr><td rowspan="1" colspan="1">Rosa et al<sup><xref rid="ref19" ref-type="bibr">19</xref></sup>
</td><td rowspan="1" colspan="1">815 patients with a primary OCD diagnosis; 7 specialized outpatient clinics comprising the Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SAS-SR</td><td rowspan="1" colspan="1">Greater OC symptom severity, poorer quality of life as well as current comorbidity with depression, PTSD or eating disorders predicted greater overall social dysfunction. The SAS work, social/leisure, family unit, marital role and economic situation subscale scores were related to poorer quality of life.</td></tr><tr><td rowspan="1" colspan="1">Santana et al<sup><xref rid="ref34" ref-type="bibr">34</xref></sup>
</td><td rowspan="1" colspan="1">60 patients with OCD diagnosis; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SDS</td><td rowspan="1" colspan="1">Patients who reported at least one refusal of pharmacotherapy had higher levels of family disability.</td></tr><tr><td rowspan="1" colspan="1">Starcevic et al<sup><xref rid="ref22" ref-type="bibr">22</xref></sup>
</td><td rowspan="1" colspan="1">148 patients with OCD diagnosis; several sites in NSW, Australia</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SDS</td><td rowspan="1" colspan="1">No significant difference in SDS scores was found between participants with and without OCPD.</td></tr><tr><td rowspan="1" colspan="1">Stewart et al<sup><xref rid="ref41" ref-type="bibr">41</xref></sup>
</td><td rowspan="1" colspan="1">476 patients with OCD, USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">WSAS</td><td rowspan="1" colspan="1">The responder group had higher psychosocial functioning at baseline than the non-responder group, and better initial psychosocial adjustment was found to be a predictor of IRT response.</td></tr><tr><td rowspan="1" colspan="1">Storch et al<sup><xref rid="ref14" ref-type="bibr">14</xref></sup>
</td><td rowspan="1" colspan="1">87 treatment-seeking participants with a primary OCD diagnosis; 2 sites: Minnesota and Florida; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SDS</td><td rowspan="1" colspan="1">SDS total score was significantly and positively related to OCD symptom severity, anxiety, depression, and maladaptive interpretation of intrusions. Analyses revealed that the Y-BOCS Resistance/Control factor and depression fully mediated the relationship between OC symptoms and functional disability.</td></tr><tr><td rowspan="1" colspan="1">T&#x000fc;kel et al<sup><xref rid="ref26" ref-type="bibr">26</xref></sup>
</td><td rowspan="1" colspan="1">59 patients with a primary OCD diagnosis; Turkey</td><td rowspan="1" colspan="1">Randomised trial</td><td rowspan="1" colspan="1">SDS</td><td rowspan="1" colspan="1">Non-responders to the administered SSRI treatment scored significantly higher on the 3 SDS subscales than responders, even after adjusting for OCD symptom severity. The 3 subscales were positively correlated with OCD symptom severity. Greater work disability significantly predicted non-response to treatment.</td></tr><tr><td rowspan="1" colspan="1">Van Noppen et al<sup><xref rid="ref37" ref-type="bibr">37</xref></sup>
</td><td rowspan="1" colspan="1">36 patients with OCD; USA</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">SDS</td><td rowspan="1" colspan="1">Patients who received group behavior therapy (GBT) improved significantly in overall functioning from pre- to post-test as well as from pre-test to 1-year follow-up. However, patients who received multi-family behavior therapy (MFBT) did not show significant improvement in functioning from baseline to either post-test or follow-up.</td></tr></tbody></table></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table IIb</label><caption><title>Summary of the sample, intervention, and outcome measures used in included studies that measured health-related quality of life using patient-reported outcome measures (PROMS).</title></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1">
<bold>Reference</bold>
</td><td rowspan="1" colspan="1">
<bold>Study sample (N, number of sites, country)</bold>
</td><td rowspan="1" colspan="1">
<bold>Study methodology</bold>
</td><td rowspan="1" colspan="1">
<bold>PROM(s) used</bold>
</td><td rowspan="1" colspan="1">
<bold>Major findings</bold>
</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">Albert et al<sup><xref rid="ref52" ref-type="bibr">52</xref></sup>
</td><td rowspan="1" colspan="1">151 patients with OCD; Italy</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SF-36</td><td rowspan="1" colspan="1">Patients with OCD showed greater impairment in all domains of mental health-related quality of life, especially social functioning.</td></tr><tr><td rowspan="1" colspan="1">Andersson et al<sup><xref rid="ref82" ref-type="bibr">82</xref></sup>
</td><td rowspan="1" colspan="1">23 patients with OCD; Sweden</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">QOLI</td><td rowspan="1" colspan="1">At post-treatment, results indicated a non-significant trend on the EQ-5D with a small effect size of 0.24. The result for QOLI was non-significant.</td></tr><tr><td rowspan="1" colspan="1">Besiroglu et al<sup><xref rid="ref77" ref-type="bibr">77</xref></sup>
</td><td rowspan="1" colspan="1">25 health care-seekers with OCD and 23 non-health care-seekers with OCD; Turkey</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">WHO-QOL-103 TR</td><td rowspan="1" colspan="1">Individuals whose QOL is minimally impaired by OCD are less likely to seek health care compared to significantly affected patients.</td></tr><tr><td rowspan="1" colspan="1">Besiroglu et al<sup><xref rid="ref75" ref-type="bibr">75</xref></sup>
</td><td rowspan="1" colspan="1">43 patients with comorbid OCD and MDD and 67 patients with OCD only; Turkey</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">WHO-QOL-BREF-TR</td><td rowspan="1" colspan="1">The OCD-MDD group reported significantly lower physical and psychological health and social relationship domain scores compared with patients with OCD only.</td></tr><tr><td rowspan="1" colspan="1">Besiroglu et al<sup><xref rid="ref80" ref-type="bibr">80</xref></sup>
</td><td rowspan="1" colspan="1">53 patients with OCD; Turkey</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">WHO-QOL-BREF-TR</td><td rowspan="1" colspan="1">There was no significant difference between the pre and post-treatment quality of life domain scores. Social relationship scores at follow-up were associated with baseline compulsion severity.</td></tr><tr><td rowspan="1" colspan="1">Bobes et al<sup><xref rid="ref55" ref-type="bibr">55</xref></sup>
</td><td rowspan="1" colspan="1">36 patients with OCD; Spain</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SF-36</td><td rowspan="1" colspan="1">OCD patients reported significantly lower mean scores on all SF-36 scales as compared to Spanish norms, especially in social functioning, role, emotional and mental health.</td></tr><tr><td rowspan="1" colspan="1">Brown et al<sup><xref rid="ref86" ref-type="bibr">86</xref></sup>
</td><td rowspan="1" colspan="1">15 patients with OCD; USA</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">Q-LES-Q</td><td rowspan="1" colspan="1">Results showed a significant improvement in overall sense of well-being following participation in 12-week moderate-intensity exercise intervention.</td></tr><tr><td rowspan="1" colspan="1">Cordioli et al<sup><xref rid="ref81" ref-type="bibr">81</xref></sup>
</td><td rowspan="1" colspan="1">47 patients with OCD; Brazil</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">WHO-QOL-BREF</td><td rowspan="1" colspan="1">Significant improvement in the quality of life in the four domains of QOL after 12 weekly cognitive behavioral group therapy sessions.</td></tr><tr><td rowspan="1" colspan="1">Dehlin et al<sup><xref rid="ref85" ref-type="bibr">85</xref></sup>
</td><td rowspan="1" colspan="1">5 patients with scrupulosity-based OCD; USA</td><td rowspan="1" colspan="1">Multiple baseline across participants design</td><td rowspan="1" colspan="1">QOLS</td><td rowspan="1" colspan="1">Patients showed a 26% increase in QOLS scores after undergoing ACT.</td></tr><tr><td rowspan="1" colspan="1">Cassin et al<sup><xref rid="ref72" ref-type="bibr">72</xref></sup>
</td><td rowspan="1" colspan="1">28 outpatients with OCD and 28 outpatients with comorbid OCD and MDD; Canada</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">Q-LES-Q</td><td rowspan="1" colspan="1">Patients with comorbid OCD and MDD scored significantly lower on Q-LEQ-Q subjective feelings, overall well-being, social relations and general activities.</td></tr><tr><td rowspan="1" colspan="1">Didie et al<sup><xref rid="ref18" ref-type="bibr">18</xref></sup>
</td><td rowspan="1" colspan="1">210 patients with OCD, 45 patients with BDD and 40 patients with comorbid BDD and OCD; USA</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">SF-36, Q-LES-Q</td><td rowspan="1" colspan="1">OCD subjects and BDD subjects had poorer quality of life as compared with the US population norms.</td></tr><tr><td rowspan="1" colspan="1">Dougherty et al<sup><xref rid="ref79" ref-type="bibr">79</xref></sup>
</td><td rowspan="1" colspan="1">30 patients with OCD (only 23 completers); USA</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">Q-LES-Q</td><td rowspan="1" colspan="1">Pre-treatment and post-treatment analyses showed significant improvements in quality of life.</td></tr><tr><td rowspan="1" colspan="1">Eisen et al<sup><xref rid="ref49" ref-type="bibr">49</xref></sup>
</td><td rowspan="1" colspan="1">197 patients with OCD; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">Q-LES-Q</td><td rowspan="1" colspan="1">Marital status and symptom severity of obsessions and depression contributed to the degree of impairment in QOL. OCD patients showed marked impairment in domains such as the ability to work and perform household duties, subjective sense of well-being, social relationships and ability to enjoy leisure activities compared to community norms.</td></tr><tr><td rowspan="1" colspan="1">Farooqi &#x00026; Rasul<sup><xref rid="ref71" ref-type="bibr">71</xref></sup>
</td><td rowspan="1" colspan="1">60 patients with OCD; Pakistan</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">WHO-QOL-BREF</td><td rowspan="1" colspan="1">Female patients reported better overall QOL, especially in social and environmental domains as compared with male patients.</td></tr><tr><td rowspan="1" colspan="1">Fontenelle et al<sup><xref rid="ref51" ref-type="bibr">51</xref></sup>
</td><td rowspan="1" colspan="1">53 patients with OCD and 53 community members; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SF-36</td><td rowspan="1" colspan="1">Patients with OCD reported significantly lower levels of QOL in all domains except bodily pain. Hoarding and washing symptoms contributed significantly for the decline in the social quality of life in OCD hoarders.</td></tr><tr><td rowspan="1" colspan="1">Gezginc et al<sup><xref rid="ref63" ref-type="bibr">63</xref></sup>
</td><td rowspan="1" colspan="1">25 pregnant outpatients with OCD and 25 pregnant healthy controls; Turkey</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">WHO-QOL-BREF</td><td rowspan="1" colspan="1">OCD pregnant women scored lower subscores in all 4 domains as compared to health controls. Also, OCD duration was negatively correlated to the psychological health domain.</td></tr><tr><td rowspan="1" colspan="1">Gururaj et al<sup><xref rid="ref70" ref-type="bibr">70</xref></sup>
</td><td rowspan="1" colspan="1">35 patients with OCD and 35 patients with schizophrenia; India</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">WHO-QOL-BREF</td><td rowspan="1" colspan="1">Patients with OCD reported better QOL in the physical and environmental domains as compared to patients with schizophrenia. However, in terms of psychological and social domains, both groups reported similar QOL.</td></tr><tr><td rowspan="1" colspan="1">Hertenstein et al<sup><xref rid="ref66" ref-type="bibr">66</xref></sup>
</td><td rowspan="1" colspan="1">73 patients with OCD; Germany</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">WHO-QOL-BREF</td><td rowspan="1" colspan="1">At baseline, participants reported a significantly diminished psychological, social, physical, and global QOL compared to the German general population. The QOL was significantly improved after 12 months of treatment.</td></tr><tr><td rowspan="1" colspan="1">Hollander et al<sup><xref rid="ref24" ref-type="bibr">24</xref></sup>
</td><td rowspan="1" colspan="1">466 patients with OCD; USA</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">SF-36</td><td rowspan="1" colspan="1">Patients receiving escitalopram or paroxetine reported significant improvements on most SF-36 dimensions, but patients taking 20 mg/d escitalopram were seen to improve earlier in work-related functioning.</td></tr><tr><td rowspan="1" colspan="1">Hou et al<sup><xref rid="ref65" ref-type="bibr">65</xref></sup>
</td><td rowspan="1" colspan="1">57 outpatients with OCD and 106 healthy controls; Taiwan</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">WHO-QOL-BREF</td><td rowspan="1" colspan="1">OCD group reported lower QOL in the general, psychological and social relationship domains as compared to the control group. Also, severe obsession and compulsion symptoms and low social support were significantly correlated to poor QOL.</td></tr><tr><td rowspan="1" colspan="1">Huppert et al<sup><xref rid="ref23" ref-type="bibr">23</xref></sup>
</td><td rowspan="1" colspan="1">66 patients with OCD and 36 healthy controls; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">Q-LES-Q</td><td rowspan="1" colspan="1">Greater severity of OCD was correlated to worse QOL. Results suggested a linear relationship between the Q-LES-Q and OCD severity. Individuals with OCD and comorbid disorders were more impaired than individuals with only OCD.</td></tr><tr><td rowspan="1" colspan="1">Akdede et al<sup><xref rid="ref60" ref-type="bibr">60</xref></sup>
</td><td rowspan="1" colspan="1">23 patients with OCD and 22 healthy controls; Turkey</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">WHO-QOL-BREF-TR</td><td rowspan="1" colspan="1">OCD patients reported worse QOL in the psychological and social domains. There were significant correlations between attention, visual tracking and working memory and the psychological, social and environmental domains of QOL.</td></tr><tr><td rowspan="1" colspan="1">Koran et al<sup><xref rid="ref59" ref-type="bibr">59</xref></sup>
</td><td rowspan="1" colspan="1">60 outpatients with OCD and U.S. population published norms (2474); USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SF-36</td><td rowspan="1" colspan="1">Patients with OCD perceived the mental health domains of their quality of life as more impaired than the physical health domains. Severity of OCD was related to lower scores on the social functioning domain.</td></tr><tr><td rowspan="1" colspan="1">Koran et al<sup><xref rid="ref64" ref-type="bibr">64</xref></sup>
</td><td rowspan="1" colspan="1">147 patients with OCD, U.S. population published norms (2474); USA</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">SF-36</td><td rowspan="1" colspan="1">Both the active drug and placebo groups reported significant improvements in psychosocial domains of HRQOL. For subjects who went through 40 weeks of treatment with extended-release fluvoxamine, there were increased improvements in the psychosocial domains.</td></tr><tr><td rowspan="1" colspan="1">Kugler et al<sup><xref rid="ref68" ref-type="bibr">68</xref></sup>
</td><td rowspan="1" colspan="1">102 patients with OCD; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOS-36</td><td rowspan="1" colspan="1">Social functioning QOL was significantly worse and physical health QOL was significantly better in OCD patients as compared to persons with PD, MDD and schizophrenia. Resistance against obsessive-compulsive symptoms mediated the relationship between obsessive-compulsive symptom severity and social functioning QOL.</td></tr><tr><td rowspan="1" colspan="1">Kumar et al<sup><xref rid="ref58" ref-type="bibr">58</xref></sup>
</td><td rowspan="1" colspan="1">31 patients with OCD and 30 healthy controls; India</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">WHO-QOL-BREF</td><td rowspan="1" colspan="1">OCD patients reported worse QOL as compared with healthy controls. Also, there was a negative correlation between cognitive appraisals (thought control, importance of thoughts and inflated responsibility) and psychological domains.</td></tr><tr><td rowspan="1" colspan="1">Masellis et al<sup><xref rid="ref73" ref-type="bibr">73</xref></sup>
</td><td rowspan="1" colspan="1">43 patients with OCD; Canada</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">IIRS</td><td rowspan="1" colspan="1">QOL was particularly affected by obsessional severity compared to compulsion severity. Comorbid depression severity greatly predicted poor QOL, accounting for 54% of the variance.</td></tr><tr><td rowspan="1" colspan="1">Moritz et al<sup><xref rid="ref116" ref-type="bibr">116</xref></sup>
</td><td rowspan="1" colspan="1">79 patients with OCD and 32 healthy controls; Germany</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">SF-36</td><td rowspan="1" colspan="1">OCD patients reported significantly decreased mean QOL scores for every domain as compared to healthy controls. Correlations with QOL were most evident for depression severity and number of OCD symptoms.</td></tr><tr><td rowspan="1" colspan="1">Norberg et al<sup><xref rid="ref62" ref-type="bibr">62</xref></sup>
</td><td rowspan="1" colspan="1">188 patients with OCD; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">QOLI</td><td rowspan="1" colspan="1">OCD patient sample's total QOLI scores were at the 11th percentile in comparison to clinical norms.</td></tr><tr><td rowspan="1" colspan="1">Ooms et al<sup><xref rid="ref61" ref-type="bibr">61</xref></sup>
</td><td rowspan="1" colspan="1">16 patients with OCD; Netherlands</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">WHO-QOL-BREF</td><td rowspan="1" colspan="1">Baseline QOL scores of OCD patients were significantly lower in all domains as compared to a Dutch normative population. There were distinct improvements in the general score and in the physical, psychological and environmental domains following deep brain stimulation.</td></tr><tr><td rowspan="1" colspan="1">Rapaport et al<sup><xref rid="ref50" ref-type="bibr">50</xref></sup>
</td><td rowspan="1" colspan="1">521 patients with OCD, non-psychiatric community sample (67), MDD (366), chronic/double depression (576), PD (302), PTSD (139), dysthymia (315), SP (358), premenstrual dysphoric disorder (437), 11 multicenter trials; USA</td><td rowspan="1" colspan="1">Cross-sectional (retrospective data)</td><td rowspan="1" colspan="1">Q-LES-Q</td><td rowspan="1" colspan="1">OCD subjects showed greater impairment on the social relationship, family relationships, leisure, ability to function and vision items. Depression and anxiety comorbidity significantly predicted Q-LES-Q scores for OCD subjects.</td></tr><tr><td rowspan="1" colspan="1">Rodriguez-Salgado et al<sup><xref rid="ref53" ref-type="bibr">53</xref></sup>
</td><td rowspan="1" colspan="1">64 outpatients with OCD and 9151 respondents from the general population; Spain</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SF-36</td><td rowspan="1" colspan="1">OCD patients had significantly decreased mean QOL scores for all SF-36 subscales except those related to physical health and pain in comparison to the general population.</td></tr><tr><td rowspan="1" colspan="1">Simpson et al<sup><xref rid="ref83" ref-type="bibr">83</xref></sup>
</td><td rowspan="1" colspan="1">108 patients with OCD. Study conducted at two academic outpatient Clinics; USA</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">Q-LES-Q</td><td rowspan="1" colspan="1">No significant difference in the rate of change in quality of life between the two groups (augmentation of SRIs with ERP versus stress management training), post-hoc analyses however revealed modest but significantly superior quality of life at study completion (post-test).</td></tr><tr><td rowspan="1" colspan="1">Solanki et al<sup><xref rid="ref69" ref-type="bibr">69</xref></sup>
</td><td rowspan="1" colspan="1">50 outpatients with OCD and 50 patients with schizophrenia; India.</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">WHO-QOL-BREF</td><td rowspan="1" colspan="1">There was no statistically significant difference in the QOL between the OCD and schizophrenia group. Both groups scored the lowest on the social relationship domain.</td></tr><tr><td rowspan="1" colspan="1">Srivastava et al<sup><xref rid="ref56" ref-type="bibr">56</xref></sup>
</td><td rowspan="1" colspan="1">45 outpatients with OCD, 50 patients with MDD and 150 healthy controls; India</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">WHO-QOL-BREF</td><td rowspan="1" colspan="1">Compared with healthy controls, OCD patients reported a lower QOL in the physical well-being, psychological well-being, social and environmental domains. Compared to MDD patients, the QOL of patients with OCD was significantly higher in psychological well-being, social and environmental domains.</td></tr><tr><td rowspan="1" colspan="1">Stengler-Wenzke et al<sup><xref rid="ref57" ref-type="bibr">57</xref></sup>
</td><td rowspan="1" colspan="1">75 outpatients with OCD, 243 patients with schizophrenia and 315 respondents from the general population; Germany</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">WHO-QOL-BREF</td><td rowspan="1" colspan="1">Compared with general population, QOL of patients with OCD and schizophrenia was lower in all domains. OCD patients scored lower scores in the domains of psychological well-being and social relationship and overall QOL than patients with schizophrenia.</td></tr><tr><td rowspan="1" colspan="1">Stengler-Wenzke et al<sup><xref rid="ref74" ref-type="bibr">74</xref></sup>
</td><td rowspan="1" colspan="1">75 outpatients with OCD; Germany</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">WHO-QOL-BREF</td><td rowspan="1" colspan="1">Compulsions were found to be negatively associated with QOL. Depressive symptoms were also negatively associated with QOL.</td></tr><tr><td rowspan="1" colspan="1">Twohig et al<sup><xref rid="ref84" ref-type="bibr">84</xref></sup>
</td><td rowspan="1" colspan="1">79 patients with OCD; USA</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">QOLS</td><td rowspan="1" colspan="1">QOL improved in both conditions (ACT and progressive relaxation training) but was marginally in favor of ACT at post treatment.</td></tr><tr><td rowspan="1" colspan="1">Vikas et al<sup><xref rid="ref67" ref-type="bibr">67</xref></sup>
</td><td rowspan="1" colspan="1">32 patients with OCD and 30 patients with depression; India</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">WHO-QOL-BREF</td><td rowspan="1" colspan="1">OCD patients had the lowest scores in the psychological health domain whereas they had relatively high scores in the social relationship domains. OCD patients in comparison to depressed patients had significantly higher scores in QOL domains of physical and psychological health.</td></tr></tbody></table></table-wrap><table-wrap id="T4" orientation="portrait" position="float"><label>Table IIc</label><caption><title>Summary of the sample, interventions, and outcome measures used in included studies that measured symptoms using PROMs.</title></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1">
<bold>Reference</bold>
</td><td rowspan="1" colspan="1">
<bold>Study sample (N, number of sites, country)</bold>
</td><td rowspan="1" colspan="1">
<bold>Study methodology</bold>
</td><td rowspan="1" colspan="1">
<bold>PROM(s) used</bold>
</td><td rowspan="1" colspan="1">
<bold>Major findings</bold>
</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">Aardema et al<sup><xref rid="ref161" ref-type="bibr">161</xref></sup>
</td><td rowspan="1" colspan="1">85 OCD patients; Canada</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ, PI-R</td><td rowspan="1" colspan="1">The relationship between obsessive beliefs and OC symptoms decreased significantly when inferential confusion was controlled. Conversely, the relationship between inferential confusion and OC symptoms was not substantially affected when obsessive belief was controlled.</td></tr><tr><td rowspan="1" colspan="1">Abramowitz et al<sup><xref rid="ref171" ref-type="bibr">171</xref></sup>
</td><td rowspan="1" colspan="1">77 OCD patients; 2 sites; Minnesota &#x00026; Connecticut, USA</td><td rowspan="1" colspan="1">Cross-sequential</td><td rowspan="1" colspan="1">OCI-R</td><td rowspan="1" colspan="1">Analyses suggest that OCI-R is sensitive to treatment effects and that pre- to post-test change on this instrument reflects improvement in OCD and other symptoms following CBT.</td></tr><tr><td rowspan="1" colspan="1">Alonso et al<sup><xref rid="ref127" ref-type="bibr">127</xref></sup>
</td><td rowspan="1" colspan="1">50 OCD patients, 30 healthy controls; Spain</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ</td><td rowspan="1" colspan="1">A correlation between OBQ-44 domains and regional grey matter was not observed in OCD patients. Study also suggests a significant correlation between OC-related dysfunctional beliefs and morphometric variability in the anterior temporal lobe.</td></tr><tr><td rowspan="1" colspan="1">Alonso et al<sup><xref rid="ref169" ref-type="bibr">169</xref></sup>
</td><td rowspan="1" colspan="1">141 OCD patients; Spain</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ</td><td rowspan="1" colspan="1">Change in dysfunctional beliefs was not affected by the COMT and BDNF genotype in isolation. Their interaction, however, had an effect on the responsibility/overestimation of threat and over importance/need to control thoughts scores.</td></tr><tr><td rowspan="1" colspan="1">Aksaray et al<sup><xref rid="ref157" ref-type="bibr">157</xref></sup>
</td><td rowspan="1" colspan="1">23 OCD female &#x00026; 26 GAD female patients; Turkey</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">Women with OCD were more sexually nonsensual avoidant and anorgasmic than the women with GAD. The patients with fear of contamination obsessions on MOCI were more sexually nonsensual, and avoidant than obsessive compulsives with other types of fears.</td></tr><tr><td rowspan="1" colspan="1">Altemus et al<sup><xref rid="ref185" ref-type="bibr">185</xref></sup>
</td><td rowspan="1" colspan="1">8 OCD patients; USA</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">Subjects reported no significant improvements in OC symptoms on MOCI or Y-BOCS following 8 weeks open trial of flutamide. However, feelings of aggressiveness did fall.</td></tr><tr><td rowspan="1" colspan="1">Andersson et al<sup><xref rid="ref82" ref-type="bibr">82</xref></sup>
</td><td rowspan="1" colspan="1">23 OCD patients; Sweden</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">Y-BOCS-SR, OCI-R</td><td rowspan="1" colspan="1">Participants reported statistically significant improvements in self-rated OCD symptoms (Y-BOCS &#x00026; OCI-R) following a 15-weeks of internet-based CBT.</td></tr><tr><td rowspan="1" colspan="1">Anholt et al<sup><xref rid="ref139" ref-type="bibr">139</xref></sup>
</td><td rowspan="1" colspan="1">66 OCD, 20 panic &#x00026; or agoraphobia, 20 PG patients, 30 controls; Netherlands</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ, PI-R</td><td rowspan="1" colspan="1">OCD patients reported higher OBQ-87 scores than both panic patients and normal controls, but did not differ from the pathological gambling patients. Pathological gamblers however, reported no increase in OCD symptoms. The OC spectrum theory for pathological gambling is questionable.</td></tr><tr><td rowspan="1" colspan="1">Anholt et al<sup><xref rid="ref126" ref-type="bibr">126</xref></sup>
</td><td rowspan="1" colspan="1">50 tic-free OCD, 19 OCD +tic, 18 TS w/o OCD patients, 30 controls; Netherlands</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ, PI</td><td rowspan="1" colspan="1">Tic-free OCD patients scored higher OBQ-87 than TS patients while no differences were found between OCD with or without tic patients. Thus, dysfunctional beliefs have no discriminative power with respect to OCD with or without tic patients.</td></tr><tr><td rowspan="1" colspan="1">Anholt et al<sup><xref rid="ref190" ref-type="bibr">190</xref></sup>
</td><td rowspan="1" colspan="1">120 OCD patients; Netherlands</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">PI-R</td><td rowspan="1" colspan="1">Differences in neither the measurement between self- and clinician-administered measures nor the way severity is being calculated can account for the differences between the PI-R and the Y-BOCS Severity scale. Findings suggest that the two scales measure unrelated features of OCD.</td></tr><tr><td rowspan="1" colspan="1">Anholt et al<sup><xref rid="ref174" ref-type="bibr">174</xref></sup>
</td><td rowspan="1" colspan="1">104 OCD patients; Netherlands</td><td rowspan="1" colspan="1">Cross-sequential</td><td rowspan="1" colspan="1">OBQ, PI-R</td><td rowspan="1" colspan="1">OBQ-44 and OBQ-87 were compared for sensitivity to treatment change and other OCD measures. Results revealed identical medium effect size, the limitation of OBQ as a primary measure of treatment change and a lack of symptom dimension association to OBQ pre-post- treatment changes.</td></tr><tr><td rowspan="1" colspan="1">Arntz et al<sup><xref rid="ref104" ref-type="bibr">104</xref></sup>
</td><td rowspan="1" colspan="1">27 OCD, 37 non-OCD anxiety patients, 28 non patients; Netherlands</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">PI</td><td rowspan="1" colspan="1">Subjective OCD-like experience and checking behaviors were higher in OCD patients being exposed to a high responsibility classification task than in all other groups. Although the PI checking subscale correlated with their subjective ratings, it was not correlated with their checking behaviors, suggesting the causal role of responsibility in OCD.</td></tr><tr><td rowspan="1" colspan="1">Baptista et al<sup><xref rid="ref141" ref-type="bibr">141</xref></sup>
</td><td rowspan="1" colspan="1">24 OCD and 24 Medical Clinic(MC) patients for chronic diseases; 2 sites; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ</td><td rowspan="1" colspan="1">MC group scored higher than the OCD group in domains of OBQ-Tolerance for Uncertainty, Threat estimation, Responsibility and Perfectionism. The same findings occurred with DAS, which was significantly correlated with the OBQ.</td></tr><tr><td rowspan="1" colspan="1">Black et al<sup><xref rid="ref194" ref-type="bibr">194</xref></sup>
</td><td rowspan="1" colspan="1">38 non-depressed OCD patients; USA</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">MOCI, SCL-90-R</td><td rowspan="1" colspan="1">Respondents were less symptomatic on their MOCI doubting/conscientious and checking scores and marginally better on the SCL-90-R positive symptom distress index, given 12 weeks of treatment with paroxetine, placebo or CBT.</td></tr><tr><td rowspan="1" colspan="1">Bortoncello et al<sup><xref rid="ref177" ref-type="bibr">177</xref></sup>
</td><td rowspan="1" colspan="1">104 OCD patients; Brazil</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">OBQ</td><td rowspan="1" colspan="1">OBQ-44's sensitivity to treatment change following CBGT was good and all 3 belief domains declined significantly, hence proving the quality of this measure.</td></tr><tr><td rowspan="1" colspan="1">Brakoulias et al<sup><xref rid="ref33" ref-type="bibr">33</xref></sup>
</td><td rowspan="1" colspan="1">154 OCD patients; Australia</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ</td><td rowspan="1" colspan="1">The relationship between 5 Y-BOCS-derived OC symptom dimensions and the 3 OC cognitive Domains (OBQ) was examined. The symmetry/ordering dimension was associated with increased perfectionism/intolerance of uncertainty, the unacceptable/taboo thoughts dimension was associated with increased importance/control of thoughts and the doubt/checking dimension was associated with increased responsibility/threat estimation.</td></tr><tr><td rowspan="1" colspan="1">Brakoulias et al<sup><xref rid="ref148" ref-type="bibr">148</xref></sup>
</td><td rowspan="1" colspan="1">154 OCD patients; Australia</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">VOCI, SDS</td><td rowspan="1" colspan="1">VOCI obsessions were found to be correlated with higher usage rates of both psychotropic agent and antipsychotic agent.</td></tr><tr><td rowspan="1" colspan="1">Calamari et al<sup><xref rid="ref151" ref-type="bibr">151</xref></sup>
</td><td rowspan="1" colspan="1">367 OCD patients; USA &#x00026; Canada</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ, Y-BOCS-SR</td><td rowspan="1" colspan="1">Relations between belief and symptom -based subgroups were examined. Symmetry symptom subgroup membership was modestly associated with membership in the Perfectionism/Certainty beliefs subgroup.</td></tr><tr><td rowspan="1" colspan="1">Careau et al<sup><xref rid="ref160" ref-type="bibr">160</xref></sup>
</td><td rowspan="1" colspan="1">83 OCD patients, 213 student controls; Canada</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ</td><td rowspan="1" colspan="1">The relationship between 5 different childhood experiences to 5 conceptually matched OBQ belief domains was examined. Beliefs related to responsibility, threat perception, and perfectionism showed association to their theoretically related early experiences. Threat perception and sociotropy experiences were closely related to most OBQ belief domains.</td></tr><tr><td rowspan="1" colspan="1">Chik et al<sup><xref rid="ref99" ref-type="bibr">99</xref></sup>
</td><td rowspan="1" colspan="1">88 OCD, 44 OAD patients, 48 student controls; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ, OCI-R</td><td rowspan="1" colspan="1">OCD patients with high, OCD-H or low, OCD-L dysfunctional beliefs differed in their 1) metacognitive beliefs which correlated with the OC symptom measures in the OCD-H and 2) monitoring tendencies which correlated with the OC symptom measures in the OCD-L.</td></tr><tr><td rowspan="1" colspan="1">Choi et al<sup><xref rid="ref166" ref-type="bibr">166</xref></sup>
</td><td rowspan="1" colspan="1">22 OCD patients and 22 matched healthy controls; South Korea</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">Regional brain gray matter volumes were not correlated with the MOCI scores in patients with OCD despite significant volume reduction in bilateral planum polare.</td></tr><tr><td rowspan="1" colspan="1">Clark et al<sup><xref rid="ref88" ref-type="bibr">88</xref></sup>
</td><td rowspan="1" colspan="1">56 OCD patients, 38 non-obsessional psychiatric outpatients, 35 community adults and 403 undergraduate students; Canada, Australia, USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">CBOCI, PI-WSUR</td><td rowspan="1" colspan="1">A validation study of CBOCI. The OCD group scored significantly higher on the CBOCI total score than all other groups.</td></tr><tr><td rowspan="1" colspan="1">Dastgiri &#x00026; Nateghian<sup><xref rid="ref102" ref-type="bibr">102</xref></sup>
</td><td rowspan="1" colspan="1">25 OCD, 25 GAD patients and 25 normal subjects; Iran</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">PI</td><td rowspan="1" colspan="1">Results revealed a significant correlation between PI scores and worry. While is PI is able to differentiate OCD and GAD from normal subjects, PI is unable to differentiate OCD from GAD subjects unless worry score is being controlled.</td></tr><tr><td rowspan="1" colspan="1">de Berardis et al<sup><xref rid="ref146" ref-type="bibr">146</xref></sup>
</td><td rowspan="1" colspan="1">112 OCD patients; Italy</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">TAS-20 (measure for Alexithymia) total score and sub factors positively correlated with score for item #11 on the Y-BOCS, severity of OCD (as measured by MOCI) and MADRS scores (depression measure).</td></tr><tr><td rowspan="1" colspan="1">Dehlin et al<sup><xref rid="ref85" ref-type="bibr">85</xref></sup>
</td><td rowspan="1" colspan="1">5 scrupulosity-based OCD patients; USA</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">OCI-R</td><td rowspan="1" colspan="1">Treatment outcomes in 5 scrupulosity-based OCD patients following 8 sessions of ACT were assessed. Average daily compulsions and avoided valued activities decreased significantly.</td></tr><tr><td rowspan="1" colspan="1">Doyle et al<sup><xref rid="ref135" ref-type="bibr">135</xref></sup>
</td><td rowspan="1" colspan="1">62 patients with schizophrenia treated with clozapine, 35 OCD patients; Ireland</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OCI</td><td rowspan="1" colspan="1">The OCD group reported significantly more symptoms for all OCI subscales compared to the clozapine group. In terms of profile, the clozapine group scored highest on the Doubting scale, a cognitive symptom whereas the OCD group scored highest on Washing, a behavioral symptom. Both groups reported greater distress with cognitive rather than behavioral symptoms.</td></tr><tr><td rowspan="1" colspan="1">Einstein &#x00026; Menzies<sup><xref rid="ref149" ref-type="bibr">149</xref></sup>
</td><td rowspan="1" colspan="1">60 OCD patients; Australia</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">PI, OCI-SV</td><td rowspan="1" colspan="1">Magical ideation (Ml) was found to correlate highly with impaired control over mental activities, and urges and worries about losing control over motor behaviors in PI. It also attained positive correlations with the checking subscales on the PI and on the neutralising, obsessing, and hoarding scales of the OCI-SV. Neither the PI nor the OCI-SV contamination/washing scales were significantly correlated with MI.</td></tr><tr><td rowspan="1" colspan="1">Einstein &#x00026; Menzies<sup><xref rid="ref119" ref-type="bibr">119</xref></sup>
</td><td rowspan="1" colspan="1">11 cleaning &#x00026; 20 checking OCD patients, 19 PD patients, 21 controls; Australia</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI, OCI-SV</td><td rowspan="1" colspan="1">OCD group reported magical ideation scores higher than both the PD group and normal subjects. OCD washers obtained higher MI scores than OCD checkers but they did not differ on scores on MOCI and OCI-SV.</td></tr><tr><td rowspan="1" colspan="1">Einstein &#x00026; Menzies<sup><xref rid="ref170" ref-type="bibr">170</xref></sup>
</td><td rowspan="1" colspan="1">34 OCD outpatients; Australia</td><td rowspan="1" colspan="1">Cross-sequential</td><td rowspan="1" colspan="1">MOCI, OCI-SV, PI</td><td rowspan="1" colspan="1">OC symptoms decreased significantly following CBT. MI improvement was significantly correlated with improvement on both the PI and the OCI-SV.</td></tr><tr><td rowspan="1" colspan="1">Emmelkamp et al<sup><xref rid="ref108" ref-type="bibr">108</xref></sup>
</td><td rowspan="1" colspan="1">89 OCD, 45 neurotic patients &#x00026; 79 normal subjects; Netherlands</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">MOCI; LOI</td><td rowspan="1" colspan="1">The MOCI may be used to evaluate effects of treatment, but it less sensitive than target ratings of obsessional problems. It reliably discriminates between obsessional patients and normal, patients with anorexia nervosa and anxiety disorders; however, it failed to discriminate the obsessionals from depressives.</td></tr><tr><td rowspan="1" colspan="1">Enander et al<sup>195</sup>
</td><td rowspan="1" colspan="1">48 OCD patients; Sweden</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">DOCS, OCI-R</td><td rowspan="1" colspan="1">DOCS found to show fair sensitivity treatment effects following Internet-delivered CBT with intervention being exposure with response prevention.</td></tr><tr><td rowspan="1" colspan="1">Enright et al<sup><xref rid="ref164" ref-type="bibr">164</xref></sup>
</td><td rowspan="1" colspan="1">32 OCD patients and 32 with OAD; UK</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">A distinction between checkers and non-checkers in the OCD group was made using MOCI. Non-checkers displayed greater negative priming across all presentation speeds compared to checkers.</td></tr><tr><td rowspan="1" colspan="1">Ettelt et al<sup><xref rid="ref149" ref-type="bibr">149</xref></sup>
</td><td rowspan="1" colspan="1">70 CCD patients &#x00026; their 139 relatives, 70 control &#x00026; their 134 relatives, 4 sites; Germany</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">PI</td><td rowspan="1" colspan="1">Significant correlations of cognitive impulsiveness (BIS-11 subscale) were found with PI subscales of aggressive thoughts concerning self/others, aggressive impulses concerning self/ others, checking and symmetry separately. No other subscale of impulsiveness was significantly associated with OCD symptoms.</td></tr><tr><td rowspan="1" colspan="1">Exner et al<sup>10</sup>
</td><td rowspan="1" colspan="1">19 OCD patients, 19 matched controls; Germany</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">PI-R</td><td rowspan="1" colspan="1">Study revealed that episodic and semantic memory performance, but not working memory, reduced significantly in OCD subjects compared to controls. Episodic memory performance in both samples was significantly related to the Padua Rumination and Checking, even after controlled for depression and OC symptom severity. Linear regression revealed that Rumination was most closely related to episodic memory performance in both samples above Checking.</td></tr><tr><td rowspan="1" colspan="1">Filomensky et al<sup><xref rid="ref131" ref-type="bibr">131</xref></sup>
</td><td rowspan="1" colspan="1">35 OCD, 21 BP patients, 24 compulsive buyers; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">PI-WSUR</td><td rowspan="1" colspan="1">OCD patients scored higher on OC symptoms than those with CB and BD; particularly higher on the PI contamination/washing and checking dimensions; however, they did not score higher on any hoarding dimension.</td></tr><tr><td rowspan="1" colspan="1">Fontenelle et al<sup><xref rid="ref133" ref-type="bibr">133</xref></sup>
</td><td rowspan="1" colspan="1">23 OCD patients and 40 obese individuals; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SCL-90</td><td rowspan="1" colspan="1">Patients with OCD had significantly higher obsessive-compulsive scores than obese non-binge and obese binge eaters.</td></tr><tr><td rowspan="1" colspan="1">Fontenelle et al<sup><xref rid="ref137" ref-type="bibr">137</xref></sup>
</td><td rowspan="1" colspan="1">34 OCD, 30 SAD patients; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OCI</td><td rowspan="1" colspan="1">Patients with OCD reported significantly lower rates of exposure to traumatic events. Statistical analyses revealed that the OCI scores better predicted the variance on Dissociative Experience Scale scores in the OCD sample, while the Liebowitz Social Anxiety Scale did so better in the social anxiety group.</td></tr><tr><td rowspan="1" colspan="1">Fontenelle et al<sup><xref rid="ref156" ref-type="bibr">156</xref></sup>
</td><td rowspan="1" colspan="1">53 OCD patients, 53 matched individuals; 3 sites; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OCI-R</td><td rowspan="1" colspan="1">Patients with OCD displayed greater levels of affective sympathy and personal discomfort than controls. Analyses revealed that severity of hoarding symptoms in OCD correlated with empathic concern, fantasy, and personal discomfort.</td></tr><tr><td rowspan="1" colspan="1">Fontenelle et al<sup><xref rid="ref51" ref-type="bibr">51</xref></sup>
</td><td rowspan="1" colspan="1">53 OCD patients, 53 matched controls; 2 sites; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OCI-R</td><td rowspan="1" colspan="1">Washing symptoms explained 31% of the variance of limitation due to physical health problems. Other analyses howeve concluded that depressive, but not obsessive-compulsive symptoms, explained the remaining SF-36 dimensions.</td></tr><tr><td rowspan="1" colspan="1">Fontenelle et al<sup><xref rid="ref32" ref-type="bibr">32</xref></sup>
</td><td rowspan="1" colspan="1">40 OCD patients, 40 healthy controls; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OCI-R</td><td rowspan="1" colspan="1">Patients with OCD displayed higher plasma levels of CCL3. CXCL8, sTNFR1, and sTNFR2 than controls. The levels of sTNFR1 correlated positively with washing symptoms while CCL24 levels correlated negatively with hoarding.</td></tr><tr><td rowspan="1" colspan="1">Fontenelle et al<sup><xref rid="ref168" ref-type="bibr">168</xref></sup>
</td><td rowspan="1" colspan="1">40 OCD patients, 40 healthy controls; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OCI-R</td><td rowspan="1" colspan="1">Patients with OCD displayed lower levels of BDNF and significantly increased levels of NGF as compared to healthy controls. A positive correlation between both NGF and GDNF and severity of washing symptoms was also found.</td></tr><tr><td rowspan="1" colspan="1">Fritzler et al<sup><xref rid="ref179" ref-type="bibr">179</xref></sup>
</td><td rowspan="1" colspan="1">9 OCD patients; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI, Y-BOCS-SR</td><td rowspan="1" colspan="1">Subjects in the Delayed treatment condition following self-directed ERP showed no significant improvements. However, as a combined group with those in the Immediate treatment condition, improvements were observed in outcome measures of Y-BOCS and MOCI.</td></tr><tr><td rowspan="1" colspan="1">Fullana et al<sup><xref rid="ref103" ref-type="bibr">103</xref></sup>
</td><td rowspan="1" colspan="1">56 OCD patients, 40 healthy controls; Spain</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">PI</td><td rowspan="1" colspan="1">OCD patients scored higher in all PI subscales and were also more anxious and depressed than controls. Results showed that patients scored higher on Neuroticism, Sensitivity to Punishment and Psychoticism than normal controls; scored lower on Extraversion. No differences in Sensitivity to Reward found.</td></tr><tr><td rowspan="1" colspan="1">Grabe et al<sup><xref rid="ref155" ref-type="bibr">155</xref></sup>
</td><td rowspan="1" colspan="1">70 OCD patients; Germany</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">HZI/HOCI</td><td rowspan="1" colspan="1">The dimensions 'Checking' and 'Symmetry and Ordering' were significantly related to dissciative symptomatology. A clear-cut lack of association was found in 'Washing and Cleaning', 'Counting and Touching' and 'Aggessive impulses and Fantasies'. HZI dimensions significantly discriminated patients with high from patients with low dissociative symptomatology.</td></tr><tr><td rowspan="1" colspan="1">Grabe et al<sup><xref rid="ref158" ref-type="bibr">158</xref></sup>
</td><td rowspan="1" colspan="1">61 OCD patients; Germany</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">HZI-/HOCI</td><td rowspan="1" colspan="1">In female patients, controlling behavior and obsessions and compulsions associated with counting, touching and talking were associated with bulimia whereas obsessions associated with words, pictures o thought-chains were related to drive for thinness, thus pointing to a differential gender and symptoms-specific relationship between OCD and ED.</td></tr><tr><td rowspan="1" colspan="1">Greist et al<sup><xref rid="ref180" ref-type="bibr">180</xref></sup>
</td><td rowspan="1" colspan="1">325 non-depressive OCD patients; USA</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">Analysis of the MOCI administered at baseline and endpoint revealed significant improvement in pooled sertraline group compared to placebo group.</td></tr><tr><td rowspan="1" colspan="1">Hashimoto et al<sup><xref rid="ref162" ref-type="bibr">162</xref></sup>
</td><td rowspan="1" colspan="1">63 OCD patients, 50 healthy controls; Japan</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">PI</td><td rowspan="1" colspan="1">For the logical memory tasks, a positive association was observed with PI's washing scale but a negative association was observed with PI's precision scale. Positive correlation between interference scores and PI'S precision scale was also observed. Results support the hypothesis that different symptoms may represent distinct and partially overlapping neurocognitive networks in OCD.</td></tr><tr><td rowspan="1" colspan="1">Hermans et al<sup><xref rid="ref120" ref-type="bibr">120</xref></sup>
</td><td rowspan="1" colspan="1">17 OCD patients, 17 non-anxious control; Belgium</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI, PI</td><td rowspan="1" colspan="1">General reality monitoring ability, and selective reality monitoring ability for anxiety relevant actions in was examined. There was no difference observed for patients that reported low or high frequencies of checking behavior.</td></tr><tr><td rowspan="1" colspan="1">Hunter et al<sup><xref rid="ref193" ref-type="bibr">193</xref></sup>
</td><td rowspan="1" colspan="1">198 OCD patients, 1457 adult psychiatric outpatients in all; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SCL-90</td><td rowspan="1" colspan="1">SCL diagnostic scales were shown to differentiate patients positive for each of the eight psychiatric disorders from other psychiatric patients who did not have that disorder.</td></tr><tr><td rowspan="1" colspan="1">Huppert et al<sup><xref rid="ref125" ref-type="bibr">125</xref></sup>
</td><td rowspan="1" colspan="1">128 OCD, 109 PTSD, 63 OAD patients, 40 students; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OCI</td><td rowspan="1" colspan="1">Study revealed presence of relationship between symptoms of OCD and PTSD in all samples, largely accounted for by a combination of symptom overlap and depression.</td></tr><tr><td rowspan="1" colspan="1">Jim&#x000e9;nez-Murcia et al<sup><xref rid="ref132" ref-type="bibr">132</xref></sup>
</td><td rowspan="1" colspan="1">90 female patients (30 OCD, 30 anorexia nervosa, 30 bulimia nervosa); Spain</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">Higher MOCI scores and Eating Disorder Inventory (EDI)-Perfectionism scores predicted higher EDI score Thus, severity of ED symptomatology increases as OC symptomatology increases.</td></tr><tr><td rowspan="1" colspan="1">Jones &#x00026; Menzies.<sup><xref rid="ref110" ref-type="bibr">110</xref></sup>
</td><td rowspan="1" colspan="1">21 OCD patients, 10 controls; Australia</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">MOCI, LOI</td><td rowspan="1" colspan="1">11 patients who received the Danger Ideation Reduction Therapy (DIRT) observed significantly greater improvements from pre-treatment to after-treatment on all measures including MOCI and LOI.</td></tr><tr><td rowspan="1" colspan="1">Julien et al<sup><xref rid="ref153" ref-type="bibr">153</xref></sup>
</td><td rowspan="1" colspan="1">126 OCD patients; Canada</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ, PI-R</td><td rowspan="1" colspan="1">Specificity of belief domains in OCD symptom subtype was investigated. Analyses revealed that participants in the rumination subtype scored higher on Importance/ Control of Thoughts than those in the washing subtype when anxiety was controlled. Responsibility/Threat Estimation predicted rumination scores, Perfectionism/Certainty predicted checking and precision scores, and Importance/Control of Thoughts predicted impulse phobia scores when negative mood states were controlled.</td></tr><tr><td rowspan="1" colspan="1">Karadag et al<sup><xref rid="ref163" ref-type="bibr">163</xref></sup>
</td><td rowspan="1" colspan="1">32 OCD patients and 31 healthy controls; Turkey</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCQ</td><td rowspan="1" colspan="1">MOCQ was used to define checkers from non-checkers using cut-off score of 5 and above. The OCD patients with checking compulsions were no different from the non-checking group for memory of OC relevant material and confidence.</td></tr><tr><td rowspan="1" colspan="1">Kearns et al<sup><xref rid="ref176" ref-type="bibr">176</xref></sup>
</td><td rowspan="1" colspan="1">24 OCD patients; Ireland</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">Significant reduction in clinical symptom ratings on completion of group based CBT for OCD patients was observed in measures including MOCI.</td></tr><tr><td rowspan="1" colspan="1">Keijsers et al<sup><xref rid="ref183" ref-type="bibr">183</xref></sup>
</td><td rowspan="1" colspan="1">40 OCD patients; Netherlands</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">No differential treatment effects between exposure in vivo alone and response prevention alone could be found, although ritualistic behavior was less strongly affected by exposure in vivo following response prevention.</td></tr><tr><td rowspan="1" colspan="1">Kennedy et al<sup><xref rid="ref192" ref-type="bibr">192</xref></sup>
</td><td rowspan="1" colspan="1">280 patients with 6 diagnoses: 33 with OCD, others with major depression, panic disorder, GAD, social phobia and mixed anxiety and depression 31 graduate students as comparison group</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">SCL-90</td><td rowspan="1" colspan="1">Each diagnostic group had a significantly high score on its corresponding subscale. The OCD group had only 2 high subscale scores &#x02014; obsessive-compulsive and phobic anxiety subscale scores. OCD subjects had the lowest general anxiety and depression scores among the 6 diagnostic groups. Those with GAD endorsed many OCD symptoms.</td></tr><tr><td rowspan="1" colspan="1">Kirkby et al<sup><xref rid="ref189" ref-type="bibr">189</xref></sup>
</td><td rowspan="1" colspan="1">13 OCD patients; Australia</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">PI-R</td><td rowspan="1" colspan="1">Across three computer treatment sessions that provided vicarious exposure and response prevention for OCD, all subjects increased their vicarious exposure behaviors that predicted symptom reduction on PI.</td></tr><tr><td rowspan="1" colspan="1">Krochmalik et al<sup><xref rid="ref178" ref-type="bibr">178</xref></sup>
</td><td rowspan="1" colspan="1">5 OCD patients; Australia</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">MOCI, PI</td><td rowspan="1" colspan="1">On the MOCI, 4 of the 5 subjects (unchanged by ERP) met recovery criteria following DIRT. Changes were maintained at follow-up.</td></tr><tr><td rowspan="1" colspan="1">Kyrios &#x00026; lob.<sup><xref rid="ref100" ref-type="bibr">100</xref></sup>
</td><td rowspan="1" colspan="1">15 OCD patients, 15 normal controls; Australia</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">PI</td><td rowspan="1" colspan="1">Significant associations were found between interference scores of OCD-threat words (masked only) with both the depression and anxiety symptom measures, but not with OC symptom severity (measured on PI).</td></tr><tr><td rowspan="1" colspan="1">Li et al<sup><xref rid="ref184" ref-type="bibr">184</xref></sup>
</td><td rowspan="1" colspan="1">16 OCD patients; USA</td><td rowspan="1" colspan="1">Double-blind, placebo-controlled, crossover study</td><td rowspan="1" colspan="1">SCL-90</td><td rowspan="1" colspan="1">Significant reduction in the SCL-90R obsession and anxiety scale was observed with both risperidone and haloperidol compared to placebo augmentation of serotonin reuptake inhibitors in the treatment of OCD patients. On the depression scale, scores of those on risperidone but not haloperidol treatment separated out from placebo.</td></tr><tr><td rowspan="1" colspan="1">L&#x000f3;pez-Sol&#x000e0; et al<sup><xref rid="ref107" ref-type="bibr">107</xref></sup>
</td><td rowspan="1" colspan="1">110 OCD patients, 237 non-clinical sample; Spain</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">DOCS, OBQ</td><td rowspan="1" colspan="1">The association between OC symptom dimensions in DOCS and obsessive beliefs was examined. In OCD patients, Contamination, Responsibility for Harm, and Unacceptable Thoughts were predicted by OBQ-Responsibility. For the Symmetry dimension the OBQ-Perfectionism domain emerged as the only significant predictor.</td></tr><tr><td rowspan="1" colspan="1">Mantovani et al<sup><xref rid="ref187" ref-type="bibr">187</xref></sup>
</td><td rowspan="1" colspan="1">18 OCD subjects through stringent recruitment; USA</td><td rowspan="1" colspan="1">RCT (Sham)</td><td rowspan="1" colspan="1">Y-BOCS-SR</td><td rowspan="1" colspan="1">Correlation between changes in Y-BOCS-SR and cortical excitability measures was examined and results suggested that low-frequency repetitive transcranial magnetic stimulation are supportive of the role of SMA in the modulation of OCD symptoms.</td></tr><tr><td rowspan="1" colspan="1">Mass et al<sup><xref rid="ref136" ref-type="bibr">136</xref></sup>
</td><td rowspan="1" colspan="1">15 OCD, 50 schizophrenia (25 with severe negative symptoms) and 25 alcohol dependence patients; Germany</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">HZI-K/HOCI</td><td rowspan="1" colspan="1">OCD subjects had the highest compulsion scores but the obsessions scores on HZI-K did not differ among the groups.</td></tr><tr><td rowspan="1" colspan="1">Muller et al<sup><xref rid="ref109" ref-type="bibr">109</xref></sup>
</td><td rowspan="1" colspan="1">31 OCD, 18 with TS, 13 with Parkinson's Disease &#x00026; 46 controls; Germany</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI, HZI-K</td><td rowspan="1" colspan="1">On most subscales -Checking, Ordering, and Counting/touching, TS patients scored higher than controls but reported fewer symptoms than OCD patients, particularly on the MOCI subscales 'Checking' and 'Slowness/Repetition' as well as on the MOCI total score and on the HZI subscales 'Cleaning' and 'Obsessive Thoughts'.</td></tr><tr><td rowspan="1" colspan="1">Murayama et al<sup><xref rid="ref112" ref-type="bibr">112</xref></sup>
</td><td rowspan="1" colspan="1">22 OCD, 19 controls; Japan</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">Both checkers and washers were compared with the controls on a symptom provocation task on fMRI. The checkers showed slightly higher activation in the left caudate and left AC which saw a positive correlation between activation and symptom severity. The washers showed higher activation in several bilateral cortico-cerebellar regions which saw a position correlation between symptom severity and the bilateral fronto-temporal gyrus.</td></tr><tr><td rowspan="1" colspan="1">Nakamae et al<sup><xref rid="ref167" ref-type="bibr">167</xref></sup>
</td><td rowspan="1" colspan="1">23 non-medicated OCD patients, 23 healthy controls; Japan</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ</td><td rowspan="1" colspan="1">The relationship between gray matter volume and each dimension of OBQ was explored. Only a significant negative correlation was found between gray matter volume and OBQ-(over-importance and over-control of thoughts) scores in the left amygdala.</td></tr><tr><td rowspan="1" colspan="1">Niemeyer et al<sup><xref rid="ref129" ref-type="bibr">129</xref></sup>
</td><td rowspan="1" colspan="1">34 OCD, 34 healthy controls; Germany</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ, Y-BOCS-SR, OCI-R</td><td rowspan="1" colspan="1">Metacognition (measured on OBQ) contributed significantly but modestly to OC symptoms (measured on the OC scales) after responsibility was controlled for, and conversely responsibility made a significant contribution after controlling for metacognition.</td></tr><tr><td rowspan="1" colspan="1">O'Connor et al<sup><xref rid="ref171" ref-type="bibr">171</xref></sup>
</td><td rowspan="1" colspan="1">44 OCD patients; Canada</td><td rowspan="1" colspan="1">Cross-sequential</td><td rowspan="1" colspan="1">PI, OBQ</td><td rowspan="1" colspan="1">After 20 weeks of treatment s (cognitive appraisal model, exposure and response prevention or inference-based approach), all groups showed a significant reduction in scores including PI. Participants with high levels of obsessional conviction showed greater benefit from IBA than CAM.</td></tr><tr><td rowspan="1" colspan="1">Okada et al<sup><xref rid="ref113" ref-type="bibr">113</xref></sup>
</td><td rowspan="1" colspan="1">12 OCD subjects and 12 matched controls; Japan</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">The study found that oxy-Hb changes in the OCD group during the Stroop color-word task (SCWC) were significantly smaller than those in the control group, especially in the frontopolar cortex. No significant correlations between the SCWC score and age, FIQ, and MOCI score.</td></tr><tr><td rowspan="1" colspan="1">Olantunji et al<sup><xref rid="ref106" ref-type="bibr">106</xref></sup>
</td><td rowspan="1" colspan="1">30 OCD and 30 non-clinical controls; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">DOCS</td><td rowspan="1" colspan="1">DOCS score was found to correlate inversely with the disengagement efficiency score when erotic images served as the distractor, indicating that OCD subjects showed a weakened ability to disengage their attention.</td></tr><tr><td rowspan="1" colspan="1">Overbeek et al<sup><xref rid="ref182" ref-type="bibr">182</xref></sup>
</td><td rowspan="1" colspan="1">120 OCD patients for baseline ratings and 12 for post-treatment ratings; Netherlands</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">Severity of OCD symptoms on the 120 patients following a combined psychopharmacologic and behavioral therapy differed for depressed and nondepressed on the anxiety and depression measures, but not OCD measures. Post-treatment scores on YBOCS and MOCI were also found to be worse for depressed OCD patients despite the lack of difference at baseline.</td></tr><tr><td rowspan="1" colspan="1">Peng et al<sup><xref rid="ref122" ref-type="bibr">122</xref></sup>
</td><td rowspan="1" colspan="1">100 OCD, 38 OCD + other psychosis patients, 101 controls, 47 healthy OCD's relatives; China</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OCI-R</td><td rowspan="1" colspan="1">OCD patients with or without comorbid psychosis scored higher in motor coordination and total neurological soft signs (NSS) than controls, with no significant difference between them in general</td></tr><tr><td rowspan="1" colspan="1">Radomsky et al<sup><xref rid="ref128" ref-type="bibr">128</xref></sup>
</td><td rowspan="1" colspan="1">33 OCD patients, 143 students; Canada</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ, VOCI</td><td rowspan="1" colspan="1">The compulsive checking group reported greater trait anger, but not greater anger expression, than the control group. Beliefs concerning perfectionism and intolerance of uncertainty were positively correlated with anger expression and trait anger among compulsive checkers but not among the control group.</td></tr><tr><td rowspan="1" colspan="1">Rector et al<sup><xref rid="ref142" ref-type="bibr">142</xref></sup>
</td><td rowspan="1" colspan="1">14 OCD probands, their 14 lst degree relatives, 87 normal controls;</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ</td><td rowspan="1" colspan="1">1st degree relatives scored significantly higher than controls on the OBQ domains- inflated responsibility and overestimation of threat. In addition, relatives of early onset OCD probands scored significantly higher than controls on both the inflated responsibility and overestimation of threat domain and the domain tapping perfectionism and intolerance of uncertainty.</td></tr><tr><td rowspan="1" colspan="1">Rubenstein et al<sup><xref rid="ref115" ref-type="bibr">115</xref></sup>
</td><td rowspan="1" colspan="1">50 OCD, 69 normal weight bulimia nervosa patients &#x00026; 28 controls (all females); USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI, SCL-90-R (OC)</td><td rowspan="1" colspan="1">Study confirmed that OCD patients scored higher than both normal volunteers and bulimics, and bulimics scored higher than normal volunteers on the OC subsection of the SCL-90-R and on the MOCI.</td></tr><tr><td rowspan="1" colspan="1">Rufer et al<sup><xref rid="ref154" ref-type="bibr">154</xref></sup>
</td><td rowspan="1" colspan="1">50 OCD patients; Germany</td><td rowspan="1" colspan="1">Cross-sectional study</td><td rowspan="1" colspan="1">HZI/HOCI</td><td rowspan="1" colspan="1">The checking dimension was most strongly related to dissociation, followed by the symmetry/ordering and obsessive thoughts dimensions. Multiple regression analyses revealed that: (1) only the checking dimension showed an independent positive correlation with dissociation, and (2) only higher scores on the DES subscale &#x0201c;amnestic dissociation&#x0201d; were associated with higher scores for checking compulsions.</td></tr><tr><td rowspan="1" colspan="1">Salkovskis et al<sup><xref rid="ref121" ref-type="bibr">121</xref></sup>
</td><td rowspan="1" colspan="1">83 OCD, 48 anxiety &#x00026; 218 non-clinical participants; UK</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI, OCI</td><td rowspan="1" colspan="1">Responsibility Attitude Scale (SAS) &#x00026; Responsibility Interpretations Questionnaire (RIQ) were significantly correlated to both MOCI &#x00026; OCI, indicating that the two responsibility scales are strong predictors of obsessions.</td></tr><tr><td rowspan="1" colspan="1">Scarrabelotti et al<sup><xref rid="ref101" ref-type="bibr">101</xref></sup>
</td><td rowspan="1" colspan="1">20 OCD patients and 151 controls; Australia</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">PI</td><td rowspan="1" colspan="1">After controlling for depression, neuroticism and responsibility were significant predictors of discomfort from obsessions and compulsions (Pl) in both the OCD and normal sample, while extraversion and psychoticism were not important.</td></tr><tr><td rowspan="1" colspan="1">Selvi et al<sup><xref rid="ref181" ref-type="bibr">181</xref></sup>
</td><td rowspan="1" colspan="1">57 OCD patients; Turkey</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">OBQ</td><td rowspan="1" colspan="1">Patients had reduced scores on OBQ-44 following 12 weeks of SSRI treatment. Mean changes in OBQ-44 Importance &#x00026; Control of Intrusive Thoughts subscale of responders were significantly higher than those of SSRI-resistant patients.</td></tr><tr><td rowspan="1" colspan="1">Shin et al<sup><xref rid="ref111" ref-type="bibr">111</xref></sup>
</td><td rowspan="1" colspan="1">30 OCD patients and 30 healthy controls; Korea</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">The MOCI score was found to be negatively correlated with Immediate Presence and Accuracy, Delayed Presence and Accuracy, Immediate Retention, and Organization scores on the ROCF. This study indicates that people with OCD have poor memory function and organizational deficits.</td></tr><tr><td rowspan="1" colspan="1">Simpson et al<sup>196</sup>
</td><td rowspan="1" colspan="1">56 OCD + eating disorder patients; USA</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">Y-BOCS-SR</td><td rowspan="1" colspan="1">Significant decrease in OCD severity, measured by Y-BOCS was observed in patients following a residential treatment program.</td></tr><tr><td rowspan="1" colspan="1">Solem et al<sup><xref rid="ref173" ref-type="bibr">173</xref></sup>
</td><td rowspan="1" colspan="1">83 OCD patients; Norway</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">OBQ</td><td rowspan="1" colspan="1">Y-BOCS &#x00026; OBQ were administered at pre-, post-treatment and follow ups to OCD patients undergoing ERP and results showed significant improvements in symptoms, metacognition score, responsibility and perfectionism.</td></tr><tr><td rowspan="1" colspan="1">Souza et al<sup><xref rid="ref123" ref-type="bibr">123</xref></sup>
</td><td rowspan="1" colspan="1">64 OCD, 33 social phobia, 33 panic disorder, 130 controls; Brazil</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">OCI-R</td><td rowspan="1" colspan="1">OCI's sensitivity to change was evaluated by comparing changes in its total score administered before and after CBGT and by comparing these to changes in Y-BOCS scores. Analyses revealed that OCI-R showed a good ability to assess the effects of treatment in OCD patients.</td></tr><tr><td rowspan="1" colspan="1">Starcevic et al<sup><xref rid="ref22" ref-type="bibr">22</xref></sup>
</td><td rowspan="1" colspan="1">148 OCD participants, of which 70 had OCPD and 78 without; Australia</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">VOCI, SCL-90-R</td><td rowspan="1" colspan="1">Results on VOCI showed that all OCD symptom dimensions except for contamination and checking were significantly more prominent in participants with OCPD. OCPD participants also scored significantly higher on all dimensions of psychopathology based on SCL-90-R.</td></tr><tr><td rowspan="1" colspan="1">Stein et al<sup><xref rid="ref134" ref-type="bibr">134</xref></sup>
</td><td rowspan="1" colspan="1">17 OCD, 12 trichotillomania and 14 borderline personality disorder patients</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">LOI</td><td rowspan="1" colspan="1">Trichotillomania and borderline personality disorder parents had significantly lower scores of obsessive-compulsive symptoms than OCD patients.</td></tr><tr><td rowspan="1" colspan="1">Storch et al<sup><xref rid="ref14" ref-type="bibr">14</xref></sup>
</td><td rowspan="1" colspan="1">87 OCD patients; 2 sites; Minnesota &#x00026; Florida; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OCI-R</td><td rowspan="1" colspan="1">Factors associated with OCD related functional disability were examined. Depressive symptoms and the extent to which a patient attempts to resist and is able to control OCD symptoms predict functional disability strongly.</td></tr><tr><td rowspan="1" colspan="1">Taylor et al<sup><xref rid="ref145" ref-type="bibr">145</xref></sup>
</td><td rowspan="1" colspan="1">248 OCD patients; 12; USA, Canada &#x00026; Australia</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">PI, OBQ</td><td rowspan="1" colspan="1">Given PI subscales and OBQ (inflated responsibility, perfectionism and controlling one's thought), analyses revealed significant main effects. There was no evidence that beliefs interact in their effects on OC symptoms.</td></tr><tr><td rowspan="1" colspan="1">Thiel et al<sup><xref rid="ref188" ref-type="bibr">188</xref></sup>
</td><td rowspan="1" colspan="1">75 female inpatients with anorexia or bulimia nervosa; 29 met criteria for concomitant OCD; Germany</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">HZI/HOCI</td><td rowspan="1" colspan="1">Clinically significant change, as reflected by improvement in scores on the Eating Disorder Inventory, was seen more often in patients without concomitant OCD, but this trend was not statistically significant. The patients whose eating disorders were most improved at follow-up also showed the highest reduction of obsessions and compulsions.</td></tr><tr><td rowspan="1" colspan="1">Tumkaya et al<sup><xref rid="ref114" ref-type="bibr">114</xref></sup>
</td><td rowspan="1" colspan="1">42 OCD patients and 42 healthy controls; Turkey</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">There were significant correlations between situational awareness scores and slowness and doubt scores of MOCI in OCD patients. Results indicated that (l) OCD patients have problems of perception, integration, and comprehension of complex visual perceptions; (II) situation awareness deficits associated with severity and prevalence of obsessions and compulsions.</td></tr><tr><td rowspan="1" colspan="1">Tynes &#x00026; Winstead.<sup><xref rid="ref144" ref-type="bibr">144</xref></sup>
</td><td rowspan="1" colspan="1">41 OCD patients; USA</td><td rowspan="1" colspan="1">Retrospective</td><td rowspan="1" colspan="1">MOCI</td><td rowspan="1" colspan="1">Total BDI score was found to be significantly correlated with total MOCI score in the 41 participants. Checking was correlated with Retarded depression while doubting correlated with both Guilty depression and Retarded depression.</td></tr><tr><td rowspan="1" colspan="1">Tolin et al<sup><xref rid="ref138" ref-type="bibr">138</xref></sup>
</td><td rowspan="1" colspan="1">77 OCD patients, 35 anxious control; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ, OCI-R</td><td rowspan="1" colspan="1">Thought Control Questionnaire- Punishment scale correlated significantly with the OBQ-44 importance/Control of Thoughts scale. Regression revealed that beliefs about the Importance/Control of Thoughts accounted for the relations between OCD and the use of Punishment as a thought control strategy.</td></tr><tr><td rowspan="1" colspan="1">Tolin et al<sup><xref rid="ref150" ref-type="bibr">150</xref></sup>
</td><td rowspan="1" colspan="1">99 OCD patients; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OCI</td><td rowspan="1" colspan="1">Relationship between OCD symptoms and obsessional beliefs was explored. Washing was predicted by responsibility/threat estimation beliefs. Checking/ doubting was not predicted by any obsessional beliefs. Hoarding was predicted by perfectionism/certainty beliefs. Neutralizing was predicted by responsibility/threat estimation beliefs. Obsessing was predicted by importance/control of thoughts and perfectionism/certainty beliefs. Ordering was predicted by perfectionism/certainty beliefs.</td></tr><tr><td rowspan="1" colspan="1">van Balkom et al<sup><xref rid="ref186" ref-type="bibr">186</xref></sup>
</td><td rowspan="1" colspan="1">117 OCD patients; Netherlands</td><td rowspan="1" colspan="1">RCT</td><td rowspan="1" colspan="1">PI-R, SCL-90</td><td rowspan="1" colspan="1">Study aimed to investigate the differential efficacy of cognitive therapy or exposure in vivo with response prevention for OCD versus the sequential combination with fluvoxamine. Results revealed decreases in OC symptom scales (including PI-R and SCL-90) across all 4 treatments, but they did not differ among each other.</td></tr><tr><td rowspan="1" colspan="1">van Noppen et al<sup>175</sup>
</td><td rowspan="1" colspan="1">90 OCD patients; USA</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">Y-BOCS-SR</td><td rowspan="1" colspan="1">A significant decrease was observed in the 90 OCD subjects on the Y-BOCS-SR scores; (mean &#x000b1; SD) 21.8&#x000b1;5.6 at baseline and 16.6 &#x000b1; 6.4 after the 10-week treatment of behavioral group therapy.</td></tr><tr><td rowspan="1" colspan="1">van Oppen et al<sup><xref rid="ref191" ref-type="bibr">191</xref></sup>
</td><td rowspan="1" colspan="1">63 OCD patients; Netherlands</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">PI-R</td><td rowspan="1" colspan="1">PI-R demonstrated not only significant treatment effects, but also large effect sizes, thereby providing evidence of its sensitivity to change. The PI-R and the Y-BOCS were comparable in terms of reliable change and clinical significance.</td></tr><tr><td rowspan="1" colspan="1">Victoria et al<sup><xref rid="ref165" ref-type="bibr">165</xref></sup>
</td><td rowspan="1" colspan="1">48 OCD patients, 24 controls; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OCI-R</td><td rowspan="1" colspan="1">Positive correlations between reaction time to content-specific stimuli and OC symptom severity was found, suggesting that OCD patients experience difficulty in disengaging attention from personally salient stimuli.</td></tr><tr><td rowspan="1" colspan="1">Vulink et al<sup><xref rid="ref143" ref-type="bibr">143</xref></sup>
</td><td rowspan="1" colspan="1">101 female OCD outpatients; Netherlands</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">Y-BOCS-SR</td><td rowspan="1" colspan="1">59 patients reported an exacerbation of OCD symptoms during premenstrual period, 9 during menopause and 17 patients during pregnancy, whereas 11 patients mentioned improvement of OCD symptoms during pregnancy.</td></tr><tr><td rowspan="1" colspan="1">Wahl et al<sup><xref rid="ref130" ref-type="bibr">130</xref></sup>
</td><td rowspan="1" colspan="1">34 OCD, 34 MDD; Brazil</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OCI-R</td><td rowspan="1" colspan="1">OCI-R scores were significantly higher in OCD patients as compared to patients with major depressive disorder.</td></tr><tr><td rowspan="1" colspan="1">Wellen et al<sup><xref rid="ref140" ref-type="bibr">140</xref></sup>
</td><td rowspan="1" colspan="1">92 OCD and 376 non-OCD subjects; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">LOI</td><td rowspan="1" colspan="1">The relationship between the factors, OCD and OCPD was evaluated using logistic regression. Five factors underlying the LOI were identified. Obsessional ruminations and compulsions, organizing activities, and contamination fears may indicate OCD, and ordering and arranging symptoms indicate OCPD.</td></tr><tr><td rowspan="1" colspan="1">Wheaton et al<sup><xref rid="ref152" ref-type="bibr">152</xref></sup>
</td><td rowspan="1" colspan="1">135 OCD patients; 3 sites; USA</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">DOCS, OBQ</td><td rowspan="1" colspan="1">Using DOCS and OBQ, contamination symptoms were predicted by responsibility/threat estimation beliefs, symmetry symptoms were predicted by perfectionism/certainty beliefs, unacceptable thoughts were predicted by Importance/control of thoughts beliefs and symptoms related to being responsible for harm were predicted by responsibility/threat estimation beliefs.</td></tr><tr><td rowspan="1" colspan="1">Woo et al<sup><xref rid="ref124" ref-type="bibr">124</xref></sup>
</td><td rowspan="1" colspan="1">91 OCD patients, 702 students; Korea</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OCI-R, PI-WSUR</td><td rowspan="1" colspan="1">The receiver operating characteristic analyses showed that the OCI-R is an effective screening tool for OCD.</td></tr><tr><td rowspan="1" colspan="1">Wootton et al<sup><xref rid="ref38" ref-type="bibr">38</xref></sup>
</td><td rowspan="1" colspan="1">22 OCD patients; Australia</td><td rowspan="1" colspan="1">Longitudinal</td><td rowspan="1" colspan="1">OCI-R</td><td rowspan="1" colspan="1">Following an 8-week online CBT course, OCD participants improved significantly on outcome measures including OCI-R, hence providing support for the efficacy of Internet administered treatment program.</td></tr><tr><td rowspan="1" colspan="1">Yap et al<sup><xref rid="ref159" ref-type="bibr">159</xref></sup>
</td><td rowspan="1" colspan="1">56 OCD, 46 OCD + depression patients; Australia</td><td rowspan="1" colspan="1">Cross-sectional</td><td rowspan="1" colspan="1">OBQ, Y-BOCS-SR, PI-R</td><td rowspan="1" colspan="1">The study examined differences between depressed and non-depressed OCD cohorts on OCD-related and non-specific factors. The two tested groups did not differ on these variables although depression severity was correlated with obsessional impulses to harm self/others.</td></tr></tbody></table></table-wrap></sec><sec><title>Patient-reported outcomes related to health-related quality of life</title><p>HRQoL is a patient-based concept that focuses on the impact of a perceived health state on the ability to live a fulfilling life.<sup><xref rid="ref42" ref-type="bibr">42</xref></sup> HRQoL is defined as optimum levels of mental, physical, role (eg, work), and social functioning, including relationships, and perceptions of health, fitness, life satisfaction, and well-being.<sup><xref rid="ref43" ref-type="bibr">43</xref></sup> A number of scales have been used in various studies as PROMs pertaining to HRQoL among patients with OCD. These include SF-36, WHOQOL instruments, Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q), <sup><xref rid="ref44" ref-type="bibr">44</xref></sup> Quality of Life Inventory (QOLI),<sup><xref rid="ref45" ref-type="bibr">45</xref></sup> Illness Intrusiveness Rating Scale (IIRS),<sup><xref rid="ref46" ref-type="bibr">46</xref></sup> Quality of Life Scale (QOLS)<sup><xref rid="ref47" ref-type="bibr">47</xref></sup> and The Lancashire Quality of Life Profile (LqoLP, Subjective component),<sup><xref rid="ref48" ref-type="bibr">48</xref></sup>
<italic>Table I.</italic>
</p><p>OCD patients have lower HRQoL compared with community samples or matched controls. <sup><xref rid="ref18" ref-type="bibr">18</xref>,<xref rid="ref23" ref-type="bibr">23</xref>,<xref rid="ref49" ref-type="bibr">49</xref>,<xref rid="ref66" ref-type="bibr">66</xref></sup> Comparisons of HRQoL between patients with OCD and patients with other disorders have shown mixed results; some studies found that OCD patients tend to report higher HRQoL than patients with depression across all or some domains,<sup><xref rid="ref56" ref-type="bibr">56</xref>,<xref rid="ref59" ref-type="bibr">59</xref>,<xref rid="ref67" ref-type="bibr">67</xref>,<xref rid="ref68" ref-type="bibr">68</xref></sup> though others report otherwise.<sup><xref rid="ref50" ref-type="bibr">50</xref>,<xref rid="ref55" ref-type="bibr">55</xref></sup> Similarly, some studies have reported that HRQoL was similar in OCD and schizophrenia patients,<sup><xref rid="ref55" ref-type="bibr">55</xref>,<xref rid="ref69" ref-type="bibr">69</xref></sup> whereas others reported lower scores in OCD patients in the domains of psychological well-being and social relationships<sup><xref rid="ref57" ref-type="bibr">57</xref>,<xref rid="ref68" ref-type="bibr">68</xref>,<xref rid="ref70" ref-type="bibr">70</xref></sup> as well as in overall HRQoL.<sup><xref rid="ref57" ref-type="bibr">57</xref></sup> Patients with OCD have been reported to have lower HRQoL (in the mental health domain) than patients with diabetes<sup><xref rid="ref59" ref-type="bibr">59</xref></sup> as well as end-stage renal failure patients (who were on hemodialysis or kidney transplant recipients).<sup><xref rid="ref55" ref-type="bibr">55</xref></sup>
</p><p>Socio-demographic factors including age,<sup><xref rid="ref51" ref-type="bibr">51</xref>,<xref rid="ref52" ref-type="bibr">52</xref>,<xref rid="ref57" ref-type="bibr">57</xref></sup> gender,<sup><xref rid="ref52" ref-type="bibr">52</xref>,<xref rid="ref71" ref-type="bibr">71</xref></sup> marital status,<sup><xref rid="ref49" ref-type="bibr">49</xref></sup> employment,<sup><xref rid="ref51" ref-type="bibr">51</xref>,<xref rid="ref53" ref-type="bibr">53</xref>,<xref rid="ref57" ref-type="bibr">57</xref></sup> education,<sup><xref rid="ref52" ref-type="bibr">52</xref></sup> low social status,<sup><xref rid="ref65" ref-type="bibr">65</xref></sup> and perceived lack of social support<sup><xref rid="ref65" ref-type="bibr">65</xref></sup> are associated with self-reported HRQoL in OCD patients.</p><p>Illness-specific severity has been shown to impair HRQoL. While some studies have shown that Y-BOCS scores predicted or were correlated with HRQoL in some or all domains,<sup><xref rid="ref23" ref-type="bibr">23</xref>,<xref rid="ref24" ref-type="bibr">24</xref>,<xref rid="ref49" ref-type="bibr">49</xref>,<xref rid="ref50" ref-type="bibr">50</xref>,<xref rid="ref52" ref-type="bibr">52</xref>,<xref rid="ref54" ref-type="bibr">54</xref>,<xref rid="ref60" ref-type="bibr">60</xref>,<xref rid="ref63" ref-type="bibr">63</xref>,<xref rid="ref64" ref-type="bibr">64</xref>,<xref rid="ref67" ref-type="bibr">67</xref>,<xref rid="ref68" ref-type="bibr">68</xref></sup> others found that obsessive symptoms<sup><xref rid="ref49" ref-type="bibr">49</xref>,<xref rid="ref65" ref-type="bibr">65</xref>,<xref rid="ref72" ref-type="bibr">72</xref>,<xref rid="ref73" ref-type="bibr">73</xref></sup> or compulsions alone<sup><xref rid="ref74" ref-type="bibr">74</xref></sup> specifically contributed to lowered HRQoL in patients with OCD. Presence of hoarding,<sup><xref rid="ref51" ref-type="bibr">51</xref></sup> checking<sup><xref rid="ref54" ref-type="bibr">54</xref></sup> and washing symptoms<sup><xref rid="ref51" ref-type="bibr">51</xref>,<xref rid="ref54" ref-type="bibr">54</xref></sup> as well as the scores on the contamination/washing dimension of YBOCS have been reported to affect HRQoL.<sup><xref rid="ref52" ref-type="bibr">52</xref></sup> In addition, HRQoL scores were impacted by the degree of symptom interference and resistance against symptoms,<sup><xref rid="ref68" ref-type="bibr">68</xref></sup> and correlated negatively with cognitive appraisals of thought control and inflated personal responsibility.<sup><xref rid="ref58" ref-type="bibr">58</xref></sup> Adverse effects of medications have also been shown to be associated with poorer HRQoL.<sup><xref rid="ref65" ref-type="bibr">65</xref></sup>
</p><p>Studies have consistently shown that comorbid depression or depressive symptoms predict decreased HRQoL among those with OCD, with associations across multiple domains of HRQoL.<sup><xref rid="ref23" ref-type="bibr">23</xref>,<xref rid="ref49" ref-type="bibr">49</xref>,<xref rid="ref54" ref-type="bibr">54</xref>,<xref rid="ref65" ref-type="bibr">65</xref>,<xref rid="ref67" ref-type="bibr">67</xref>,<xref rid="ref68" ref-type="bibr">68</xref>,<xref rid="ref72" ref-type="bibr">72</xref>,<xref rid="ref74" ref-type="bibr">74</xref>,<xref rid="ref75" ref-type="bibr">75</xref></sup> Comorbidity with other medical and mental illnesses also results in further decline in HRQoL.<sup><xref rid="ref53" ref-type="bibr">53</xref>,<xref rid="ref76" ref-type="bibr">76</xref></sup>
</p><p>A lower HRQoL in the psychological health and level of independence domain was found to predict help-seeking behavior.<sup><xref rid="ref77" ref-type="bibr">77</xref></sup> Besiroglu et al<sup><xref rid="ref77" ref-type="bibr">77</xref></sup> also found that Y-BOCS scores were significantly correlated with social relationships and level of independence domain in the help-seeking group. The authors postulated that individuals whose HRQoL is minimally impaired by OCD are less likely to seek help than significantly affected patients.</p><p>HRQoL has also been used as an outcome measure in clinical trials. Statistically significant improvements have been reported in patients in the active treatment arm in pharmaco therapeutic trials.<sup><xref rid="ref24" ref-type="bibr">24</xref>,<xref rid="ref78" ref-type="bibr">78</xref></sup> Hollander et al<sup><xref rid="ref24" ref-type="bibr">24</xref></sup> reported that compared with nonresponders, responded had a higher baseline HRQoL. Although baseline HRQoL did not predict future relapse, HRQoL continued to be correlated with symptom severity at end point. HRQoL was thus sensitive to both symptom improvement (treatment response) and symptom deterioration (relapse). However, Tenney et al<sup><xref rid="ref78" ref-type="bibr">78</xref></sup> reported that improvements in HRQoL seemed to occur independently of symptoms and responders and nonresponders did not differ in their improvement in HRQoL. Patients on clinical treatment, followed up longitudinally, have similarly shown improvements in HRQoL,<sup><xref rid="ref56" ref-type="bibr">56</xref>,<xref rid="ref64" ref-type="bibr">64</xref></sup>'<sup><xref rid="ref66" ref-type="bibr">66</xref>,<xref rid="ref79" ref-type="bibr">79</xref></sup> with only a few studies failing to find any significant difference between pre- and post-treatment HRQoL.<sup><xref rid="ref80" ref-type="bibr">80</xref></sup> CBT as well as cognitive-behavioral group therapy (CBGT) were shown to improve HRQoL significantly among responders in clinical samples,<sup><xref rid="ref54" ref-type="bibr">54</xref>,<xref rid="ref62" ref-type="bibr">62</xref>,<xref rid="ref81" ref-type="bibr">81</xref></sup> though Internetbased CBT (ICBT) with therapist support was not shown to improve HRQoL.<sup><xref rid="ref82" ref-type="bibr">82</xref></sup> A randomized controlled trial (RCT) examining the effects of augmenting serotonin reuptake inhibitors (SRIs) with exposure and ritual prevention (ERP) versus stress management training did not find any significant difference in the rate of change in quality of life between the two groups, posthoc analyses however revealed modest but significantly superior quality of life at study completion (post-test).<sup><xref rid="ref83" ref-type="bibr">83</xref></sup> A few studies have reported improvements in HRQoL among patients undergoing other forms of health behaviours and treatments. Patients showed improvement following acceptance and commitment therapy (ACT)<sup><xref rid="ref84" ref-type="bibr">84</xref>,<xref rid="ref85" ref-type="bibr">85</xref></sup> and progressive relaxation techniques (PRT).<sup><xref rid="ref84" ref-type="bibr">84</xref></sup> A preliminary study examining the impact of aerobic exercise as an adjunctive intervention to CBT and pharmacological treatment of OCD reported a significant improvement in overall sense of well-being after intervention.<sup><xref rid="ref86" ref-type="bibr">86</xref></sup> Ooms et al<sup><xref rid="ref61" ref-type="bibr">61</xref></sup> observed significant improvement in HRQoL in their study exploring the long-term effects of deep brain stimulation in patients with therapy-resistant OCD.</p></sec><sec><title>Patient-reported outcomes related to OCD-specific symptoms</title><p>OCD is a heterogeneous condition and patients often present with multiple symptoms comprising both obsessional concerns and compulsive behaviors. There have been many attempts to subtype OCD based on symptoms. While early symptom subtyping approaches characterized OCD patients by their principal compulsive behavior, these were later extended to factor analysis of symptom measures.<sup><xref rid="ref87" ref-type="bibr">87</xref></sup> Patients differ not only in the type of symptoms experienced but also in terms of the severity of the symptoms and the distress and interference caused by them. A number of scales have been used to report different aspects of symptoms in OCD such as symptom dimensions, severity, and distress caused by them. These include Clark-Beck Obsessive Compulsive Inventory (CBOCI),<sup><xref rid="ref88" ref-type="bibr">88</xref></sup> Dimensional Obsessive-Compulsive Scale (DOCS),<sup><xref rid="ref89" ref-type="bibr">89</xref></sup> Hamburg Obsessive-Compulsive Inventory (HZI/HOCI),<sup><xref rid="ref90" ref-type="bibr">90</xref></sup> Leyton Obsessional Inventory (LOI),<sup><xref rid="ref91" ref-type="bibr">91</xref></sup> Maudsley Obsessive-Compulsive Inventory (MOCI),<sup><xref rid="ref92" ref-type="bibr">92</xref></sup> Obsessional Beliefs Questionnaire-44 (OBQ-44),<sup><xref rid="ref93" ref-type="bibr">93</xref></sup> Obsessive Compulsive Inventory Revised (OCI-R),<sup><xref rid="ref12" ref-type="bibr">12</xref></sup> Padua Inventory Revised (PI-R),<sup><xref rid="ref94" ref-type="bibr">94</xref></sup> Structured Clinical Interview for Obsessive-Compulsive Spectrum Self-Report - Lifetime (SCI-OBS-SR),<sup><xref rid="ref95" ref-type="bibr">95</xref></sup> Symptom Checklist-90-Revised (SCL-90-R),<sup><xref rid="ref96" ref-type="bibr">96</xref></sup> Vancouver Obsessional-Compulsive Inventory (VOCI)<sup><xref rid="ref97" ref-type="bibr">97</xref></sup> and Yale-Brown Obsessive-Compulsive Scale, Self-Report Version (Y-BOCS-SR),<sup><xref rid="ref98" ref-type="bibr">98</xref></sup>
<italic>Table I.</italic> These have been used in studies to report the differences between patient and control groups, to investigate neuropsychological features across symptombased OCD subtypes, association with imaging parameters and as treatment outcomes.</p><p>A number of studies have reported that patients with OCD score higher on symptom and/or dysfunctional belief measures as compared with controls.<sup><xref rid="ref51" ref-type="bibr">51</xref>,<xref rid="ref99" ref-type="bibr">99</xref>,<xref rid="ref129" ref-type="bibr">129</xref></sup> Studies comparing OCD with other psychiatric disorders found that symptom severity was similar among OCD and generalized anxiety disorder patients.<sup><xref rid="ref102" ref-type="bibr">102</xref></sup> One study reported similar scores in OCD and depressive patients<sup><xref rid="ref108" ref-type="bibr">108</xref></sup> while others reported higher severity scores in OCD patients.<sup><xref rid="ref116" ref-type="bibr">116</xref>,<xref rid="ref130" ref-type="bibr">130</xref></sup> Symptom scores and/or scores on dysfunctional beliefs of OCD patients were higher than those among patients with compulsive buying,<sup><xref rid="ref131" ref-type="bibr">131</xref></sup> Tourette's syndrome,<sup><xref rid="ref109" ref-type="bibr">109</xref>,<xref rid="ref126" ref-type="bibr">126</xref></sup> anorexia nervosa,<sup><xref rid="ref108" ref-type="bibr">108</xref>,<xref rid="ref132" ref-type="bibr">132</xref></sup> bulimia nervosa,<sup><xref rid="ref115" ref-type="bibr">115</xref>,<xref rid="ref132" ref-type="bibr">132</xref></sup> binge eating disorder,<sup><xref rid="ref133" ref-type="bibr">133</xref></sup> trichotillomania,<sup><xref rid="ref134" ref-type="bibr">134</xref></sup> clozapine-treated schizophrenia,<sup><xref rid="ref135" ref-type="bibr">135</xref></sup> schizophrenia,<sup><xref rid="ref136" ref-type="bibr">136</xref></sup> bipolar disorder-I,<sup><xref rid="ref131" ref-type="bibr">131</xref></sup> other anxiety disorders<sup><xref rid="ref104" ref-type="bibr">104</xref>,<xref rid="ref108" ref-type="bibr">108</xref>,<xref rid="ref116" ref-type="bibr">116</xref>,<xref rid="ref119" ref-type="bibr">119</xref>,<xref rid="ref121" ref-type="bibr">121</xref>,<xref rid="ref123" ref-type="bibr">123</xref>,<xref rid="ref125" ref-type="bibr">125</xref>,<xref rid="ref126" ref-type="bibr">126</xref>,<xref rid="ref138" ref-type="bibr">138</xref>,<xref rid="ref139" ref-type="bibr">139</xref></sup> alcohol dependence,<sup><xref rid="ref136" ref-type="bibr">136</xref></sup> and borderline personality disorder.<sup><xref rid="ref134" ref-type="bibr">134</xref></sup> Individuals with OCD and obsessive-compulsive personality disorder (OCPD) reported higher severity scores as compared with patients with OCD alone<sup><xref rid="ref22" ref-type="bibr">22</xref></sup> and symptom dimensions were also differentially related to OCD and OCDP.<sup><xref rid="ref140" ref-type="bibr">140</xref></sup> Patients with OCD reported higher symptom severity than pathological gamblers but dysfunctional belief scores were found to be similar in the two groups.<sup><xref rid="ref139" ref-type="bibr">139</xref></sup> Those with chronic medical conditions scored higher on dysfunctional beliefs than those with OCD;<sup><xref rid="ref141" ref-type="bibr">141</xref></sup> non-affected first-degree relatives scored higher on dysfunctional beliefs than controls but scored lower than OCD patients.<sup><xref rid="ref142" ref-type="bibr">142</xref></sup>
</p><p>Vulink et al<sup><xref rid="ref143" ref-type="bibr">143</xref></sup> reported an exacerbation of OCD symptoms among female outpatients during the premenstrual period with a significant difference between the premenstrual and midmenstrual phase. Depression was positively correlated with symptom severity<sup><xref rid="ref101" ref-type="bibr">101</xref>,<xref rid="ref144" ref-type="bibr">144</xref></sup> as was neuroticism,<sup><xref rid="ref101" ref-type="bibr">101</xref></sup>responsibility,<sup><xref rid="ref101" ref-type="bibr">101</xref>,<xref rid="ref145" ref-type="bibr">145</xref></sup> perfectionism and intolerance of uncertainty,<sup><xref rid="ref145" ref-type="bibr">145</xref></sup> worry,<sup><xref rid="ref102" ref-type="bibr">102</xref></sup> alexithymia,<sup><xref rid="ref146" ref-type="bibr">146</xref></sup> magical ideation,<sup><xref rid="ref147" ref-type="bibr">147</xref></sup> dissociation,<sup><xref rid="ref137" ref-type="bibr">137</xref></sup> pessimistic attitudes,<sup><xref rid="ref129" ref-type="bibr">129</xref></sup> and poor insight.<sup><xref rid="ref146" ref-type="bibr">146</xref></sup>
</p><p>Factor analyses of PROMs of symptoms have yielded symptom dimensions that are largely consistent with clinical observations.<sup><xref rid="ref148" ref-type="bibr">148</xref></sup> Associations with OCD symptom dimensions include that of cognitive attention al impulsiveness with aggressive obsessions and checking but not washing;<sup><xref rid="ref149" ref-type="bibr">149</xref></sup> responsibility with checking and rumination<sup><xref rid="ref104" ref-type="bibr">104</xref></sup> and obsessions<sup><xref rid="ref121" ref-type="bibr">121</xref></sup>; perfectionism/certainty with ordering,<sup><xref rid="ref33" ref-type="bibr">33</xref>,<xref rid="ref117" ref-type="bibr">117</xref>,<xref rid="ref150" ref-type="bibr">150</xref></sup> symmetry symptoms<sup><xref rid="ref151" ref-type="bibr">151</xref>,<xref rid="ref152" ref-type="bibr">152</xref></sup> and checking and precision;<sup><xref rid="ref153" ref-type="bibr">153</xref></sup> responsibility/threat estimation with obsessing,<sup><xref rid="ref117" ref-type="bibr">117</xref></sup> checking,<sup><xref rid="ref33" ref-type="bibr">33</xref>,<xref rid="ref117" ref-type="bibr">117</xref></sup> contamination,<sup><xref rid="ref152" ref-type="bibr">152</xref></sup> rumination,<sup><xref rid="ref153" ref-type="bibr">153</xref></sup> and washing and mental neutralizing;<sup><xref rid="ref150" ref-type="bibr">150</xref></sup> importance/control of thoughts with obsessions,<sup><xref rid="ref150" ref-type="bibr">150</xref>,<xref rid="ref151" ref-type="bibr">151</xref></sup> unacceptable/taboo thoughts,<sup><xref rid="ref33" ref-type="bibr">33</xref>,<xref rid="ref152" ref-type="bibr">152</xref></sup> punishment,<sup><xref rid="ref138" ref-type="bibr">138</xref></sup> and impulse phobia<sup><xref rid="ref153" ref-type="bibr">153</xref></sup>; amnestic dissociation with checking<sup><xref rid="ref154" ref-type="bibr">154</xref></sup> and dissociative symptomatology with checking and symmetry and ordering,<sup><xref rid="ref155" ref-type="bibr">155</xref></sup> magical ideation with washing,<sup><xref rid="ref119" ref-type="bibr">119</xref></sup> fantasy with hoarding,<sup><xref rid="ref156" ref-type="bibr">156</xref></sup> and fear of contamination with low beliefs subgroup<sup><xref rid="ref151" ref-type="bibr">151</xref></sup> and being sexually nonsensual.<sup><xref rid="ref157" ref-type="bibr">157</xref></sup> Perfectionism and intolerance of uncertainty were related to trait anger and anger expression in the checker group,<sup><xref rid="ref128" ref-type="bibr">128</xref></sup> and obsessions with higher rates of antipsychotic use.<sup><xref rid="ref33" ref-type="bibr">33</xref></sup> OCD dimensions of controlling behavior and specific obsessions in females were associated with core symptoms of eating disorders like bulimia and drive for thinness,<sup><xref rid="ref158" ref-type="bibr">158</xref></sup> while obsessional impulses to harm self/others was predictive of depression severity.<sup><xref rid="ref159" ref-type="bibr">159</xref></sup> Childhood experiences of sociotropy and perception of threat were found to be closely related to belief domains in OCD,<sup><xref rid="ref160" ref-type="bibr">160</xref></sup> and it has also been suggested that the relationship between obsessive beliefs and obsessive-compulsive symptoms are accounted for by inferential confusion.<sup><xref rid="ref161" ref-type="bibr">161</xref></sup>
</p><p>Investigations of the association between symptom dimensions and neuropsychological profiles have been characterized by inconsistent findings. While some have found associations between symptom dimensions and deficits in memory<sup><xref rid="ref105" ref-type="bibr">105</xref>,<xref rid="ref111" ref-type="bibr">111</xref></sup> others could only demonstrate a trend<sup><xref rid="ref162" ref-type="bibr">162</xref></sup> and some did not show any association.<sup><xref rid="ref163" ref-type="bibr">163</xref></sup> Kyrios and lob<sup><xref rid="ref100" ref-type="bibr">100</xref></sup> failed to demonstrate any association of symptom dimensions with Stroop interference test, while Okada et al<sup><xref rid="ref113" ref-type="bibr">113</xref></sup> showed a negative correlation between Stroop color-word task correct scores and symptom severity in OCD patients. Rectification of preattentive inhibition was far less evident in checkers as compared with noncheckers<sup><xref rid="ref164" ref-type="bibr">164</xref></sup> and attentional bias to personally salient stimuli was correlated with symptom severity.<sup><xref rid="ref165" ref-type="bibr">165</xref></sup> Tumkaya et al<sup><xref rid="ref114" ref-type="bibr">114</xref></sup> found significant correlations between situation awareness scores and symptom severity as well as slowness and doubt dimensions of OCD patients.</p><p>No association was established between severity scores and gray matter volumes among OCD patients,<sup><xref rid="ref166" ref-type="bibr">166</xref></sup> although dysfunctional belief (over importance and thought control) was negatively correlated with gray matter volume<sup><xref rid="ref167" ref-type="bibr">167</xref></sup> and a significant correlation was found between OC-related dysfunctional beliefs and morphometric variability in the anterior temporal lobe.<sup><xref rid="ref127" ref-type="bibr">127</xref></sup> While a study found that washing symptoms were positively related to tumor necrosis factor receptor 1 (TNFR1) and chemokine (C-C motif) ligand 24 (CCL-24)<sup><xref rid="ref168" ref-type="bibr">168</xref></sup> another reported that plasma levels of nerve growth factor (NGF) and glial cell-derived neurotrophic factor (GNDF) correlated significantly with severity of washing symptoms.<sup><xref rid="ref32" ref-type="bibr">32</xref></sup> Significant interaction effects of catechol-O-methyltransferase and brain derived neurotrophic factor (BDNF) genotype were found with dysfunctional beliefs&#x02014;responsibility and overestimation of threat and over importance/need to control thoughts.<sup><xref rid="ref169" ref-type="bibr">169</xref></sup>
</p><p>Studies have reported significant improvement in symptom severity and/or dysfunctional beliefs in OCD patients treated with behavioral therapy,<sup><xref rid="ref118" ref-type="bibr">118</xref>,<xref rid="ref170" ref-type="bibr">170</xref>,<xref rid="ref174" ref-type="bibr">174</xref></sup> group behavioral treatment,<sup><xref rid="ref123" ref-type="bibr">123</xref>,<xref rid="ref173" ref-type="bibr">173</xref>,<xref rid="ref177" ref-type="bibr">177</xref></sup> ICBT,<sup><xref rid="ref38" ref-type="bibr">38</xref>,<xref rid="ref82" ref-type="bibr">82</xref></sup> danger ideation reduction therapy,<sup><xref rid="ref109" ref-type="bibr">109</xref>,<xref rid="ref178" ref-type="bibr">178</xref></sup> ACT,<sup><xref rid="ref85" ref-type="bibr">85</xref></sup> self-directed treatment,<sup><xref rid="ref179" ref-type="bibr">179</xref></sup> SSRIs,<sup><xref rid="ref180" ref-type="bibr">180</xref>,<xref rid="ref181" ref-type="bibr">181</xref></sup> and combination of SSRIs and behavioral therapy.<sup><xref rid="ref182" ref-type="bibr">182</xref></sup> No evidence was found to suggest that response prevention alone or gradual exposure in vivo alone had a differential effect on OCD symptoms although the patients showed significant overall improvement following treatment; ritualistic behavior was significantly more affected by response prevention than by exposure alone.<sup><xref rid="ref183" ref-type="bibr">183</xref></sup> Antipsychotics (risperidone and haloperidol) were both found to be effective in reducing severity of obsessions in patients with treatment resistant OCD.<sup><xref rid="ref184" ref-type="bibr">184</xref></sup> However, no improvement in symptom severity was found after an open-label trial of flutamidc for OCD.<sup><xref rid="ref183" ref-type="bibr">183</xref></sup>
</p><p>A study comparing differential efficacy of CBT and exposure and response prevention (ERP) versus their sequential combination with fluvoxamine found a significant decrease in symptom measures in patients randomized to all four arms but the four treatments did not differ among each other.<sup><xref rid="ref186" ref-type="bibr">186</xref></sup> Low-frequency repetitive transcranial magnetic stimulation (rTMS) for 4 weeks was associated with significant decrease in symptom severity and furthermore, cortical excitatory measures correlated with effective treatment response.<sup><xref rid="ref187" ref-type="bibr">187</xref></sup> A residential program using a multimodal approach for patients with OCD and coexisting eating disorder resulted in significant decreases in OCD severity<sup><xref rid="ref83" ref-type="bibr">83</xref></sup> however another study found that concomitant OCD did not indicate a significantly poorer prognosis for patients with anorexia or bulimia nervosa.<sup><xref rid="ref188" ref-type="bibr">188</xref></sup> Patients also reported improvement after a computer-based treatment program that provided vicarious ERP for OCD.<sup><xref rid="ref189" ref-type="bibr">189</xref></sup>
</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>The objective of this review was to present an overview of PROs and their related measures in the context of OCD. A total of 155 publications fulfilled our inclusion criteria. The most common PROM used in OCD patients was the PI. The PI was used in 27 of the 155 included studies. Other commonly used instruments included MOCI, and OBQ. While a number of measures have been used in OCD patients to examine functioning, HRQoL and OCD-specific symptoms from the patient's perspective, the term &#x0201c;patient-reported outcome&#x0201d; is rarely used. These measures are instead referred to as &#x0201c;self-reported measure&#x0201d; and other than symptom measures, these are generic self-report instruments that capture functioning and HRQoL. Patient input into the construction of the measures which are currently being used is lacking. It is evident that OCD affects specific domains and these effects may vary across cultures. Thus, it is imperative that patients' input be included in the development of PROMs. In addition, the validity and responsiveness of these measures must be established using stringent study designs.</p><p>A number of studies have compared PROs to those of clinician-reported measures, and findings suggest that overall there is significant correlation between the two.<sup><xref rid="ref19" ref-type="bibr">19</xref>,<xref rid="ref25" ref-type="bibr">25</xref>,<xref rid="ref26" ref-type="bibr">26</xref>,<xref rid="ref36" ref-type="bibr">36</xref>,<xref rid="ref49" ref-type="bibr">49</xref>,<xref rid="ref123" ref-type="bibr">123</xref></sup> However, some studies have found that clinician-based assessments do not correlate well with patient reports,<sup><xref rid="ref14" ref-type="bibr">14</xref>,<xref rid="ref118" ref-type="bibr">118</xref>,<xref rid="ref127" ref-type="bibr">127</xref></sup> with others discovering significant differences between clinician and patient reported outcomes. Eisen et al<sup><xref rid="ref49" ref-type="bibr">49</xref></sup> reported that HRQoL became significantly more impaired after a certain cut-off point for symptom severity, suggesting that functioning and HRQoL may be preserved in individuals with OCD until a particular threshold of severity is crossed. However, the finding was not replicated with the clinician-administered Social and Occupational Functioning Assessment Scale (SOFAS), suggesting that the self-reported measure Q-LES-Q may be a more specific measure or that a self-report measure may be more sensitive than a rater-administered scale in detecting changes in HRQoL relative to OCD.<sup><xref rid="ref49" ref-type="bibr">49</xref></sup> Stengler Wenzke et al<sup><xref rid="ref57" ref-type="bibr">57</xref></sup> reported that HRQoL in patients with OCD was unexpectedly lower in the domains of 'psychological well-being' and 'social relationships' compared with patients with schizophrenia&#x02014;a finding that re-emphasises the point that patients' perception of their HRQoL tends to be different from that assessed by clinicians. Other studies have reported low correlations between the PI-R and Y-BOCS severity scale.<sup><xref rid="ref190" ref-type="bibr">190</xref>,<xref rid="ref191" ref-type="bibr">191</xref></sup> However, the authors felt that the two scales measured relatively unrelated features of OCD and suggested that research should focus on patients for whom there is a high discrepancy between measures to clarify understanding of differences in the &#x0201c;measurement between measures.&#x0201d;</p><p>PROMs can serve as screening instruments to identify the presence or absence of an OCD diagnosis as well as help focus attention on comorbidities which might otherwise be overlooked during busy clinical consultations.<sup><xref rid="ref192" ref-type="bibr">192</xref>,<xref rid="ref193" ref-type="bibr">193</xref></sup> While these measures are not diagnostic in nature they can help highlight important areas of follow up during the clinical interview. PROMs have been shown to be as good as, and at times even better than, clinician-reported measures at predicting outcome. While Mantovani et al<sup><xref rid="ref187" ref-type="bibr">187</xref></sup> reported correlations between neurophysiological measures of outcome and both patient- and clinician-administered scales, another study reported that there was no significant difference in the clinician-administered Y-BOCS score between responders and nonresponders, though responders reported less severe psychopathology at baseline on self-reported scales.<sup><xref rid="ref194" ref-type="bibr">194</xref></sup>
</p><p>Of particular importance are studies that have established a correlation between self-reported measures and putative biological markers.<sup><xref rid="ref167" ref-type="bibr">167</xref>,<xref rid="ref168" ref-type="bibr">168</xref>,<xref rid="ref169" ref-type="bibr">169</xref></sup> These studies lend further credibility to the use of self-report measures as patient-reported functioning and symptoms have been linked to plausible pathways and neural mechanisms, which may in turn affect treatment response,<sup><xref rid="ref32" ref-type="bibr">32</xref>,<xref rid="ref168" ref-type="bibr">168</xref></sup> leading to the differences observed in outcome trials.</p><p>Overall, our review suggests that multiple measures must be used in the assessment of OCD, given the heterogeneity of the disorder. It would be ideal to have a single multidimensional patient-reported instrument that not only assesses the different domains affected in OCD but also serves other purposes, such as diagnosis and outcome monitoring. Unfortunately, no such instrument currently exists. Future research must focus on the development of such a multidimensional instrument while ensuring that patients are involved in all the stages of its development.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foa</surname><given-names>EB.</given-names></name><name><surname>Kozak</surname><given-names>MJ.</given-names></name><name><surname>Goodman</surname><given-names>WK.</given-names></name><name><surname>Hollander</surname><given-names>E.</given-names></name><name><surname>Jenike</surname><given-names>MA.</given-names></name><name><surname>Rasmussen</surname><given-names>SA.</given-names></name></person-group><article-title>DSM-IV field trial: obsessive-compulsive disorder.</article-title><source><italic>Am J Psychiatry.</italic></source><year>1995</year><volume>152</volume><fpage>90</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">7802127</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><article-title>American Psychiatric Association.</article-title><source><italic>Diagnostic and Statistical Manual of Mental Disorders.</italic> 5th ed. Arlington, VA: American Psychiatric Publishing.</source><year>2013</year></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruscio</surname><given-names>AM.</given-names></name><name><surname>Stein</surname><given-names>DJ.</given-names></name><name><surname>Chiu</surname><given-names>WT.</given-names></name><name><surname>Kessler</surname><given-names>RC.</given-names></name></person-group><article-title>The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication.</article-title><source><italic>Mol Psychiatry.</italic></source><year>2010</year><volume>15</volume><fpage>53</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">18725912</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McEvoy</surname><given-names>PM.</given-names></name><name><surname>Grove</surname><given-names>R.</given-names></name><name><surname>Slade</surname><given-names>T.</given-names></name></person-group><article-title>Epidemiology of anxiety disorders in the Australian general population: findings of the 2007 Australian National Survey of Mental Health and Wellbeing.</article-title><source><italic>Aust N Z J Psychiatry.</italic></source><year>2011</year><volume>45</volume><fpage>957</fpage><lpage>967</lpage><pub-id pub-id-type="pmid">22044173</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramaniam</surname><given-names>M.</given-names></name><name><surname>Abdin</surname><given-names>E.</given-names></name><name><surname>Vaingankar</surname><given-names>JA.</given-names></name><name><surname>Chong</surname><given-names>SA.</given-names></name></person-group><article-title>Obsessivecompulsive disorder: prevalence, correlates, help-seeking and quality of life in a multiracial Asian population.</article-title><source><italic>Soc Psychiatry Psychiatr Epidemiol.</italic></source><year>2012</year><volume>47</volume><fpage>2035</fpage><lpage>2043</lpage><pub-id pub-id-type="pmid">22526825</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohn</surname><given-names>R.</given-names></name><name><surname>Saxena</surname><given-names>S.</given-names></name><name><surname>Levav</surname><given-names>I.</given-names></name><name><surname>Saraceno</surname><given-names>B.</given-names></name></person-group><article-title>The treatment gap in mental health care.</article-title><source><italic>Bull World Health Organ.</italic></source><year>2004</year><volume>82</volume><fpage>858</fpage><lpage>866</lpage><pub-id pub-id-type="pmid">15640922</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vos</surname><given-names>T.</given-names></name><name><surname>Flaxman</surname><given-names>AD.</given-names></name><name><surname>Naghavi</surname><given-names>M.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.</article-title><source><italic>Lancet.</italic></source><year>2012</year><volume>380</volume><fpage>2163</fpage><lpage>2196</lpage><pub-id pub-id-type="pmid">23245607</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ustun</surname><given-names>TB.</given-names></name><name><surname>Ayuso-Mateos</surname><given-names>JL.</given-names></name><name><surname>Chatterji</surname><given-names>S.</given-names></name></person-group><article-title>Global burden of depressive disorders in the year 2000.</article-title><source><italic>Br J Psychiatry.</italic></source><year>2004</year><volume>184</volume><fpage>386</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">15123501</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><article-title>U.S Food and Drug Administration. Guidance for Industry. Patientreported outcome measures: Use in medical product development to support labelling claims.</article-title><source><italic>Federal Register.</italic></source><year>2009</year><volume>74</volume><fpage>65132</fpage><lpage>65133</lpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ware</surname><given-names>JE.</given-names></name><name><surname>Sherbourne</surname><given-names>CD.</given-names></name></person-group><article-title>The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection.</article-title><source><italic>Med Care.</italic></source><year>1992</year><volume>30</volume><fpage>473</fpage><lpage>483</lpage><pub-id pub-id-type="pmid">1593914</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><article-title>The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties.</article-title><source><italic>SocSciMed.</italic></source><year>1998</year><volume>46</volume><fpage>1569</fpage><lpage>1585</lpage></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foa</surname><given-names>EB.</given-names></name><name><surname>Huppert</surname><given-names>JD.</given-names></name><name><surname>Leiberg</surname><given-names>S.</given-names></name><name><surname>et al</surname></name></person-group><article-title>The Obsessive-Compulsive Inventory: development and validation of a short version.</article-title><source><italic>Psychol Assess.</italic></source><year>2002</year><volume>14</volume><fpage>485</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">12501574</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><article-title>The Cochrane Collaboration Patient reported outcomes. In: Higgins JPT, Green S.</article-title><source><italic>Cochrane Handbook for Systematic Reviews of Interventions.</italic> Version 5.1.0. Chichester, UK: Wiley.</source><year>2011</year></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storch</surname><given-names>EA.</given-names></name><name><surname>Abramowitz</surname><given-names>JS.</given-names></name><name><surname>Keeley</surname><given-names>M.</given-names></name></person-group><article-title>Correlates and mediators of functional disability in obsessive-compulsive disorder.</article-title><source><italic>Depress Anxiety.</italic></source><year>2009</year><volume>26</volume><fpage>806</fpage><lpage>813</lpage><pub-id pub-id-type="pmid">19170106</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>DV.</given-names></name><name><surname>Harnett-Sheehan</surname><given-names>K.</given-names></name><name><surname>Raj</surname><given-names>BA.</given-names></name></person-group><article-title>The measurement of disability,</article-title><source><italic>int Clin Psychopharmacol.</italic></source><year>1996</year><volume>(suppl 3)</volume><fpage>89</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">8923116</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weissman</surname><given-names>MM.</given-names></name><name><surname>Bothwell</surname><given-names>S.</given-names></name></person-group><article-title>Assessment of social adjustment by patient self-report.</article-title><source><italic>Arch Gen Psychiatry.</italic></source><year>1976</year><volume>33</volume><fpage>1111</fpage><lpage>1115</lpage><pub-id pub-id-type="pmid">962494</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marks</surname><given-names>I.</given-names></name></person-group><article-title/><source><italic>Behavioural Psychotherapy.</italic> Bristol, UK: John Wright; London, UK: Institute of Psychiatry</source><year>1986</year></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Didie</surname><given-names>ER.</given-names></name><name><surname>Walters</surname><given-names>MM.</given-names></name><name><surname>Pinto</surname><given-names>A.</given-names></name><name><surname>Menard</surname><given-names>W.</given-names></name><name><surname>Eisen</surname><given-names>JL.</given-names></name><name><surname>Mancebo</surname><given-names>M.</given-names></name><name><surname>Rasmussen</surname><given-names>SA.</given-names></name><name><surname>Phillips</surname><given-names>KA.</given-names></name></person-group><article-title>A comparison of quality of life and psychosocial functioning in obsessive-compulsive disorder and body dysmorphic disorder.</article-title><source><italic>Ann Clin Psychiatry.</italic></source><year>2007</year><volume>19</volume><fpage>181</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">17729020</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosa</surname><given-names>AC.</given-names></name><name><surname>Diniz</surname><given-names>JB.</given-names></name><name><surname>Fossaluza</surname><given-names>V.</given-names></name><name><surname>Torres</surname><given-names>AR.</given-names></name><name><surname>Fontenelle</surname><given-names>LF.</given-names></name><name><surname>De Mathis</surname><given-names>AS.</given-names></name><name><surname>da Conceic&#x000e4;o Rosario</surname><given-names>M.</given-names></name><name><surname>Miguel</surname><given-names>EC.</given-names></name><name><surname>Shavitt</surname><given-names>RG.</given-names></name></person-group><article-title>Clinical correlates of social adjustment in patients with obsessive-compulsive disorder.</article-title><source><italic>J Psychiatr Res.</italic></source><year>2012</year><volume>46</volume><fpage>1286</fpage><lpage>1292</lpage><pub-id pub-id-type="pmid">22800713</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>BL.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Schwab</surname><given-names>JJ.</given-names></name></person-group><article-title>Work, social, and family disabilities of subjects with anxiety and depression.</article-title><source><italic>South Med J.</italic></source><year>2002</year><volume>95</volume><fpage>1424</fpage><lpage>1427</lpage><pub-id pub-id-type="pmid">12597311</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lochner</surname><given-names>C.</given-names></name><name><surname>Mogotsi</surname><given-names>M.</given-names></name><name><surname>du Toit</surname><given-names>PL.</given-names></name><name><surname>Kaminer</surname><given-names>D.</given-names></name><name><surname>Niehaus</surname><given-names>DJ.</given-names></name><name><surname>Stein</surname><given-names>DJ.</given-names></name></person-group><article-title>Quality of life in anxiety disorders: a comparison of obsessive-compulsive disorder, social anxiety disorder, and panic disorder.</article-title><source><italic>Psychopathology.</italic></source><year>2003</year><volume>36</volume><fpage>255</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">14571055</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starcevic</surname><given-names>V.</given-names></name><name><surname>Berle</surname><given-names>D.</given-names></name><name><surname>Brakoulias</surname><given-names>V.</given-names></name><name><surname>Sammut</surname><given-names>P.</given-names></name><name><surname>Moses</surname><given-names>K.</given-names></name><name><surname>Milicevic</surname><given-names>D.</given-names></name><name><surname>Hannan</surname><given-names>A.</given-names></name></person-group><article-title>Obsessive-compulsive personality disorder co-occurring with obsessive-compulsive disorder: Conceptual and clinical implications.</article-title><source><italic>Aust N Z J Psychiatry.</italic></source><year>2013</year><volume>47</volume><fpage>65</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">22689335</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huppert</surname><given-names>JD.</given-names></name><name><surname>Simpson</surname><given-names>HB.</given-names></name><name><surname>Nissenson</surname><given-names>KJ.</given-names></name><name><surname>Liebowitz</surname><given-names>MR.</given-names></name><name><surname>Foa</surname><given-names>EB.</given-names></name></person-group><article-title>Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls.</article-title><source><italic>Depress Anxiety.</italic></source><year>2009</year><volume>26</volume><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">18800368</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollander</surname><given-names>E.</given-names></name><name><surname>Stein</surname><given-names>DJ.</given-names></name><name><surname>Fineberg</surname><given-names>NA.</given-names></name><name><surname>Marteau</surname><given-names>F.</given-names></name><name><surname>Legault</surname><given-names>M.</given-names></name></person-group><article-title>Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.</article-title><source><italic>J Clin Psychiatry.</italic></source><year>2010</year><volume>71</volume><fpage>784</fpage><lpage>792</lpage><pub-id pub-id-type="pmid">20492845</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diefenbach</surname><given-names>GJ.</given-names></name><name><surname>Abramowitz</surname><given-names>JS.</given-names></name><name><surname>Norberg</surname><given-names>MM.</given-names></name><name><surname>Tolin</surname><given-names>DF.</given-names></name></person-group><article-title>Changes in quality of life following cognitive-behavioral therapy for obsessive-compulsive disorder.</article-title><source><italic>Behav Res Ther.</italic></source><year>2007</year><volume>45</volume><fpage>3060</fpage><lpage>3068</lpage><pub-id pub-id-type="pmid">17559803</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>T&#x000fc;kel</surname><given-names>R.</given-names></name><name><surname>Bozkurt</surname><given-names>O.</given-names></name><name><surname>Polat</surname><given-names>A.</given-names></name><name><surname>Gen&#x000e7;</surname><given-names>A.</given-names></name><name><surname>Atli</surname><given-names>H.</given-names></name></person-group><article-title>Clinical predictors of response to pharmacotherapy with selective serotonin reuptake inhibitors in obsessive-compulsive disorder.</article-title><source><italic>Psychiatry Clin Neurosci.</italic></source><year>2006</year><volume>60</volume><fpage>404</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">16884439</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farris</surname><given-names>SG.</given-names></name><name><surname>McLean</surname><given-names>CP.</given-names></name><name><surname>Van Meter</surname><given-names>PE.</given-names></name><name><surname>Simpson</surname><given-names>HB.</given-names></name><name><surname>Foa</surname><given-names>EB.</given-names></name></person-group><article-title>Treatment response, symptom remission, and wellness in obsessive-compulsive disorder.</article-title><source><italic>J Clin Psychiatry.</italic></source><year>2013</year><volume>74</volume><fpage>685</fpage><lpage>690</lpage><pub-id pub-id-type="pmid">23945445</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontenelle</surname><given-names>JM.</given-names></name><name><surname>Harrison</surname><given-names>BJ.</given-names></name><name><surname>Santana</surname><given-names>L.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Correlates of insight into different symptom dimensions in obsessive-compulsive disorder.</article-title><source><italic>Ann Clin Psychiatry.</italic></source><year>2013</year><volume>25</volume><fpage>11</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">23376865</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>JM.</given-names></name><name><surname>Storch</surname><given-names>EA.</given-names></name><name><surname>Murphy</surname><given-names>TK.</given-names></name></person-group><article-title>Clinical correlates and treatment response of the Yale-Brown Obsessive Compulsive Scale auxiliary items.</article-title><source><italic>Cogn Ther Res.</italic></source><year>2011</year><volume>35</volume><fpage>404</fpage><lpage>413</lpage></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancebo</surname><given-names>MC.</given-names></name><name><surname>Greenberg</surname><given-names>B.</given-names></name><name><surname>Grant</surname><given-names>JE.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Correlates of occupational disability in a clinical sample of obsessive-compulsive disorder.</article-title><source><italic>Compr Psychiatry.</italic></source><year>2008</year><volume>49</volume><fpage>43</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">18063040</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambless</surname><given-names>DL.</given-names></name><name><surname>Steketee</surname><given-names>G.</given-names></name></person-group><article-title>Expressed emotion and behavior therapy outcome: a prospective study with obsessive-compulsive and agoraphobic outpatients.</article-title><source><italic>J Consult Clin Psychol.</italic></source><year>1999</year><volume>67</volume><fpage>658</fpage><lpage>665</lpage><pub-id pub-id-type="pmid">10535232</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontenelle</surname><given-names>LF.</given-names></name><name><surname>Barbosa</surname><given-names>IG.</given-names></name><name><surname>Luna</surname><given-names>JV.</given-names></name><name><surname>Rocha</surname><given-names>NP.</given-names></name><name><surname>Silva Miranda</surname><given-names>A.</given-names></name><name><surname>Teixeira</surname><given-names>AL.</given-names></name></person-group><article-title>Neurotrophic factors in obsessive-compulsive disorder.</article-title><source><italic>Psychiatry Res.</italic></source><year>2012</year><volume>199</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">22494702</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brakoulias</surname><given-names>V.</given-names></name><name><surname>Starcevic</surname><given-names>V.</given-names></name><name><surname>Berle</surname><given-names>D.</given-names></name><name><surname>et al</surname></name></person-group><article-title>The use of psychotropic agents for the symptoms of obsessive-compulsive disorder.</article-title><source><italic>Australas Psychiatry.</italic></source><year>2013</year><volume>21</volume><fpage>117</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">23426097</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santana</surname><given-names>L.</given-names></name><name><surname>Fontenelle</surname><given-names>JM.</given-names></name><name><surname>Y&#x000fc;cel</surname><given-names>M.</given-names></name><name><surname>Fontenelle</surname><given-names>LF.</given-names></name></person-group><article-title>Rates and correlates of nonadherence to treatment in obsessive-compulsive disorder.</article-title><source><italic>J Psychiatr Pract.</italic></source><year>2013</year><volume>19</volume><fpage>42</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">23334678</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montgomery</surname><given-names>SA.</given-names></name><name><surname>Kasper</surname><given-names>S.</given-names></name><name><surname>Stein</surname><given-names>DJ.</given-names></name><name><surname>Bang Hedegaard</surname><given-names>K.</given-names></name><name><surname>Lemming</surname><given-names>OM.</given-names></name></person-group><article-title>Citalopram 20 rng, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder,</article-title><source><italic>Int Clin Psychopharmacol.</italic></source><year>2001</year><volume>16</volume><fpage>75</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">11236072</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerard</surname><given-names>A.</given-names></name><name><surname>Liard</surname><given-names>F.</given-names></name><name><surname>Crochard</surname><given-names>A.</given-names></name><name><surname>Goni</surname><given-names>S.</given-names></name><name><surname>Millet</surname><given-names>B.</given-names></name></person-group><article-title>Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment.</article-title><source><italic>Neuropsychiatr Dis Treat.</italic></source><year>2012</year><volume>8</volume><fpage>605</fpage><lpage>614</lpage><pub-id pub-id-type="pmid">23271910</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Noppen</surname><given-names>B.</given-names></name><name><surname>Steketee</surname><given-names>G.</given-names></name><name><surname>McCorkle</surname><given-names>BH.</given-names></name><name><surname>Pato</surname><given-names>M.</given-names></name></person-group><article-title>Group and multifamily behavioral treatment for obsessive compulsive disorder: a pilot study.</article-title><source><italic>J Anxiety Disord.</italic></source><year>1997</year><volume>11</volume><fpage>431</fpage><lpage>446</lpage><pub-id pub-id-type="pmid">9276786</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wootton</surname><given-names>BM.</given-names></name><name><surname>Titov</surname><given-names>N.</given-names></name><name><surname>Dear</surname><given-names>BF.</given-names></name><name><surname>et al</surname></name></person-group><article-title>An Internet administered treatment program for obsessive-compulsive disorder: a feasibility study.</article-title><source><italic>J Anxiety Disord.</italic></source><year>2011</year><volume>25</volume><fpage>1102</fpage><lpage>1107</lpage><pub-id pub-id-type="pmid">21899983</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greist</surname><given-names>JH.</given-names></name><name><surname>Marks</surname><given-names>IM.</given-names></name><name><surname>Baer</surname><given-names>L.</given-names></name><name><surname>Kobak</surname><given-names>KA.</given-names></name><name><surname>Wenzel</surname><given-names>KW.</given-names></name><name><surname>Hirsch</surname><given-names>MJ.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control.</article-title><source><italic>J Clin Psychiatry.</italic></source><year>2002</year><volume>63</volume><fpage>138</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">11874215</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenwright</surname><given-names>M.</given-names></name><name><surname>Marks</surname><given-names>I.</given-names></name><name><surname>Graham</surname><given-names>C.</given-names></name><name><surname>Franses</surname><given-names>A.</given-names></name><name><surname>Mataix-Cols</surname><given-names>D.</given-names></name></person-group><article-title>Brief scheduled phone support from a clinician to enhance computer-aided self-help for obsessive-compulsive disorder: randomized controlled trial.</article-title><source><italic>J Clin Psychol.</italic></source><year>2005</year><volume>61</volume><fpage>1499</fpage><lpage>1508</lpage><pub-id pub-id-type="pmid">16173084</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>SE.</given-names></name><name><surname>Yen</surname><given-names>CH.</given-names></name><name><surname>Stack</surname><given-names>DE.</given-names></name><name><surname>Jenike</surname><given-names>MA.</given-names></name></person-group><article-title>Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment.</article-title><source><italic>J Psychiatr Res.</italic></source><year>2006</year><volume>40</volume><fpage>511</fpage><lpage>519</lpage><pub-id pub-id-type="pmid">16229857</pub-id></element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bullinger</surname><given-names>M.</given-names></name><name><surname>Andersson</surname><given-names>R.</given-names></name><name><surname>Cella</surname><given-names>D.</given-names></name><name><surname>Aaronsson</surname><given-names>N.</given-names></name></person-group><article-title>Developing and evaluating cross-cultural instruments from minimum requirements to optimal models.</article-title><source><italic>Qual Life Res.</italic></source><year>1993</year><volume>2</volume><fpage>451</fpage><lpage>459</lpage><pub-id pub-id-type="pmid">8161979</pub-id></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowling</surname><given-names>A.</given-names></name></person-group><article-title>Health-related quality of life: A discussion of the concept, its use and measurement background: The'Quality of Life' Presented to the Adapting to Change Core Course, September 1999. Available at: http://info.worldbank.org/etools/docs/library/48475/m2s5bowling.pdf last accessed on 16th Dec 2013.</article-title></element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endicott</surname><given-names>J.</given-names></name><name><surname>Knee</surname><given-names>J.</given-names></name><name><surname>Harrison</surname><given-names>W.</given-names></name><name><surname>Blumenthal</surname><given-names>R.</given-names></name></person-group><article-title>Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.</article-title><source><italic>Psychopharmacol Bull.</italic></source><year>1993</year><volume>29</volume><fpage>321</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">8290681</pub-id></element-citation></ref><ref id="ref45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frisch</surname><given-names>M.</given-names></name><name><surname>Cornell</surname><given-names>J.</given-names></name><name><surname>Villanueva</surname><given-names>M.</given-names></name><name><surname>Retzlaff</surname><given-names>PJ.</given-names></name></person-group><article-title>Clinical validation of the Quality of Life Inventory. A measure of life satisfaction for use in treatment planning and outcome assessment.</article-title><source><italic>Psychol Assess.</italic></source><year>1992</year><volume>4</volume><fpage>92</fpage><lpage>101</lpage></element-citation></ref><ref id="ref46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devins</surname><given-names>GM.</given-names></name><name><surname>Binik</surname><given-names>YM.</given-names></name><name><surname>Hutchinson</surname><given-names>TA.</given-names></name><name><surname>Hollomby</surname><given-names>DJ.</given-names></name><name><surname>Barre</surname><given-names>PE.</given-names></name><name><surname>Guttmann</surname><given-names>RD.</given-names></name></person-group><article-title>The emotional impact of end-stage renal disease: Importance of patients' perceptions of intrusiveness and control.</article-title><source><italic>Int J Psychiatry Med.</italic></source><year>1983</year><volume>13</volume><fpage>327</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">6671863</pub-id></element-citation></ref><ref id="ref47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flanagan</surname><given-names>JC.</given-names></name></person-group><article-title>A research approach to improving our quality of life. Am</article-title><source><italic>Psychologist.</italic></source><year>1978</year><volume>33</volume><fpage>138</fpage><lpage>147</lpage></element-citation></ref><ref id="ref48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>JPJ.</given-names></name></person-group><article-title>The Social Care Directive: development of a quality of life profile for use in community services for the mentally ill.</article-title><source><italic>Soc Work Soc Sci Rev.</italic></source><year>1991</year><volume>3</volume><fpage>5</fpage><lpage>45</lpage></element-citation></ref><ref id="ref49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisen</surname><given-names>JL.</given-names></name><name><surname>Mancebo</surname><given-names>MA.</given-names></name><name><surname>Pinto</surname><given-names>A.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Impact of obsessive compulsive disorder on quality of life.</article-title><source><italic>Compr Psychiatry.</italic></source><year>2006</year><volume>47</volume><fpage>270</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">16769301</pub-id></element-citation></ref><ref id="ref50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapaport</surname><given-names>MH.</given-names></name><name><surname>Clary</surname><given-names>C.</given-names></name><name><surname>Fayyad</surname><given-names>R.</given-names></name><name><surname>Endicott</surname><given-names>J.</given-names></name></person-group><article-title>Quality-of-life impairment in depressive and anxiety disorders.</article-title><source><italic>Am J Psychiatry.</italic></source><year>2005</year><volume>162</volume><fpage>1171</fpage><lpage>1178</lpage><pub-id pub-id-type="pmid">15930066</pub-id></element-citation></ref><ref id="ref51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontenelle</surname><given-names>IS.</given-names></name><name><surname>Fontenelle</surname><given-names>LF.</given-names></name><name><surname>Borges</surname><given-names>MC.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Quality of life and symptom dimensions of patients with obsessive-compulsive disorder.</article-title><source><italic>Psychiatry Res.</italic></source><year>2010</year><volume>179</volume><fpage>198</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">20483484</pub-id></element-citation></ref><ref id="ref52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>U.</given-names></name><name><surname>Maina</surname><given-names>G.</given-names></name><name><surname>Bogetto</surname><given-names>F.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Clinical predictors of health related quality of life in obsessive-compulsive disorder.</article-title><source><italic>Compr Psychiatry.</italic></source><year>2010</year><volume>51</volume><fpage>193</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">20152302</pub-id></element-citation></ref><ref id="ref53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Salgado</surname><given-names>B.</given-names></name><name><surname>Dolengevich-Segal</surname><given-names>H.</given-names></name><name><surname>Arrojo-Romero</surname><given-names>M.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Perceived quality of life in obsessive-compulsive disorder: related factors.</article-title><source><italic>BMC Psychiatry.</italic></source><year>2006</year><volume>6</volume><fpage>20</fpage><pub-id pub-id-type="pmid">16684346</pub-id></element-citation></ref><ref id="ref54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moritz</surname><given-names>S.</given-names></name><name><surname>Rufer</surname><given-names>M.</given-names></name><name><surname>Fricke</surname><given-names>S.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Quality of life in obsessive-compulsive disorder before and after treatment.</article-title><source><italic>Compr Psychiatry.</italic></source><year>2005</year><volume>46</volume><fpage>453</fpage><lpage>459</lpage><pub-id pub-id-type="pmid">16275213</pub-id></element-citation></ref><ref id="ref55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bobes</surname><given-names>J.</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>MP.</given-names></name><name><surname>Bascara'n</surname><given-names>MT.</given-names></name><name><surname>Arango</surname><given-names>C.</given-names></name><name><surname>S&#x000e1;iz</surname><given-names>PA.</given-names></name><name><surname>Bouso&#x000f1;o</surname><given-names>M.</given-names></name></person-group><article-title>Quality of life and disability in patients with obsessive-compulsive disorder.</article-title><source><italic>Eur Psychiatry.</italic></source><year>2001</year><volume>16</volume><fpage>239</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">11418275</pub-id></element-citation></ref><ref id="ref56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>S.</given-names></name><name><surname>Bhatia</surname><given-names>MS.</given-names></name><name><surname>Thawani</surname><given-names>R.</given-names></name><name><surname>Jhanjee</surname><given-names>A.</given-names></name></person-group><article-title>Quality of life in patients with obsessive compulsive disorder: a longitudinal study from India.</article-title><source><italic>Asian J Psychiatr.</italic></source><year>2011</year><volume>4</volume><fpage>178</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">23051114</pub-id></element-citation></ref><ref id="ref57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stengler-Wenzke</surname><given-names>K.</given-names></name><name><surname>Kroll</surname><given-names>M.</given-names></name><name><surname>Matschinger</surname><given-names>H.</given-names></name><name><surname>Angermeyer</surname><given-names>MC.</given-names></name></person-group><article-title>Subjective quality of life of patients with obsessive-compulsive disorder.</article-title><source><italic>Soc Psychiatry Psychiatr Epidemiol.</italic></source><year>2006</year><volume>41</volume><fpage>662</fpage><lpage>668</lpage><pub-id pub-id-type="pmid">16721502</pub-id></element-citation></ref><ref id="ref58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Sharma</surname><given-names>MP.</given-names></name><name><surname>Kandavel</surname><given-names>T.</given-names></name><name><surname>Janardhan Reddy</surname><given-names>YC.</given-names></name></person-group><article-title>Cognitive appraisals and quality of life in patients with obsessive compulsive disorder.</article-title><source><italic>J Obsessive Compuls Relat Disord.</italic></source><year>2012</year><volume>1</volume><fpage>301</fpage><lpage>305</lpage></element-citation></ref><ref id="ref59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koran</surname><given-names>LM.</given-names></name><name><surname>Thienemann</surname><given-names>ML.</given-names></name><name><surname>Davenport</surname><given-names>R.</given-names></name></person-group><article-title>Quality of life for patients with obsessive-compulsive disorder.</article-title><source><italic>Am J Psychiatry.</italic></source><year>1996</year><volume>153</volume><fpage>783</fpage><lpage>788</lpage><pub-id pub-id-type="pmid">8633690</pub-id></element-citation></ref><ref id="ref60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akdede</surname><given-names>BBK.</given-names></name><name><surname>Alptekin</surname><given-names>K.</given-names></name><name><surname>Akvardar</surname><given-names>Y.</given-names></name><name><surname>Kitis</surname><given-names>A.</given-names></name></person-group><article-title>Quality of life in patients with obsessive-compulsive disorder: relations with cognitive functions and clinical symptoms.</article-title><source><italic>Turk J Psychiatry.</italic></source><year>2005</year><volume>16</volume><fpage>13</fpage><lpage>19</lpage></element-citation></ref><ref id="ref61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ooms</surname><given-names>P.</given-names></name><name><surname>Mantione</surname><given-names>M.</given-names></name><name><surname>Figee</surname><given-names>M.</given-names></name><name><surname>Schuurman</surname><given-names>PR.</given-names></name><name><surname>van den Munckhof</surname><given-names>P.</given-names></name><name><surname>Denys</surname><given-names>D.</given-names></name></person-group><article-title>Deep brain stimulation for obsessive-compulsive disorders: longterm analysis of quality of life.</article-title><source><italic>J Neurol Neurosurg Psychiatry.</italic></source><year>2014</year><volume>85</volume><fpage>153</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">23715912</pub-id></element-citation></ref><ref id="ref62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norberg</surname><given-names>MM.</given-names></name><name><surname>Calamari</surname><given-names>JE.</given-names></name><name><surname>Cohen</surname><given-names>RJ.</given-names></name><name><surname>Riemann</surname><given-names>BC.</given-names></name></person-group><article-title>Quality of life in obsessive-compulsive disorder: an evaluation of impairment and a preliminary analysis of the ameliorating effects of treatment.</article-title><source><italic>Depress Anxiety.</italic></source><year>2008</year><volume>25</volume><fpage>248</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">17352377</pub-id></element-citation></ref><ref id="ref63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gezgin&#x000e7;</surname><given-names>K.</given-names></name><name><surname>Uguz</surname><given-names>F.</given-names></name><name><surname>Karatayli</surname><given-names>S.</given-names></name><name><surname>et al</surname></name></person-group><article-title>The impact of obsessive-compulsive disorder in pregnancy on quality of life.</article-title><source><italic>Int J Psychiatry Clin Pract.</italic></source><year>2008</year><volume>12</volume><fpage>134</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">24916624</pub-id></element-citation></ref><ref id="ref64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koran</surname><given-names>LM.</given-names></name><name><surname>Bromberg</surname><given-names>D.</given-names></name><name><surname>Hornfeldt</surname><given-names>CS.</given-names></name><name><surname>Shepski</surname><given-names>JC.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Hollander</surname><given-names>E.</given-names></name></person-group><article-title>Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder.</article-title><source><italic>Compr Psychiatry.</italic></source><year>2010</year><volume>51</volume><fpage>373</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">20579510</pub-id></element-citation></ref><ref id="ref65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>SY.</given-names></name><name><surname>Yen</surname><given-names>CF.</given-names></name><name><surname>Huang</surname><given-names>MF.</given-names></name><name><surname>Wang</surname><given-names>PW.</given-names></name><name><surname>Yeh</surname><given-names>YC.</given-names></name></person-group><article-title>Quality of life and its correlates in patients with obsessive-compulsive disorder.</article-title><source><italic>Kaohsiung J Med Sci.</italic></source><year>2010</year><volume>26</volume><fpage>397</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">20705250</pub-id></element-citation></ref><ref id="ref66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hertenstein</surname><given-names>E.</given-names></name><name><surname>Thiel</surname><given-names>N.</given-names></name><name><surname>Herbst</surname><given-names>N.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Quality of life changes following inpatient and outpatient treatment in obsessive-compulsive disorder: a study with 12 months follow-up. Ann</article-title><source><italic>Gen Psychiatry.</italic></source><year>2013</year><volume>12</volume><fpage>4</fpage></element-citation></ref><ref id="ref67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vikas</surname><given-names>A.</given-names></name><name><surname>Avasthi</surname><given-names>A.</given-names></name><name><surname>Sharan</surname><given-names>P.</given-names></name></person-group><article-title>Psychological impact of obsessive compulsive disorder on patients and their caregivers: a comparative study with depressive disorder.</article-title><source><italic>Int J Soc Psychiatry.</italic></source><year>2011</year><volume>57</volume><fpage>45</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">21252355</pub-id></element-citation></ref><ref id="ref68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kugler</surname><given-names>BB.</given-names></name><name><surname>Lewin</surname><given-names>AB.</given-names></name><name><surname>Phares</surname><given-names>V.</given-names></name><name><surname>Geffken</surname><given-names>GR.</given-names></name><name><surname>Murphy</surname><given-names>TK.</given-names></name><name><surname>Storch</surname><given-names>EA.</given-names></name></person-group><article-title>Quality of life in obsessive-compulsive disorder: the role of mediating variables.</article-title><source><italic>Psychiatry Res.</italic></source><year>2013</year><volume>206</volume><fpage>43</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">23122558</pub-id></element-citation></ref><ref id="ref69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solanki</surname><given-names>RK.</given-names></name><name><surname>Singh</surname><given-names>P.</given-names></name><name><surname>Midha</surname><given-names>A.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Disability and quality of life in schizophrenia and obsessive compulsive disorder: a cross-sectional comparative study.</article-title><source><italic>East Asian Arch Psychiatry.</italic></source><year>2010</year><volume>20</volume><fpage>7</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">22351805</pub-id></element-citation></ref><ref id="ref70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gururaj</surname><given-names>GP.</given-names></name><name><surname>Math</surname><given-names>SB.</given-names></name><name><surname>Reddy</surname><given-names>J.</given-names></name><name><surname>Chandrashekar</surname><given-names>CR.</given-names></name></person-group><article-title>Family burden, quality of life and disability in obsessive compulsive disorder: an Indian perspective.</article-title><source><italic>J Postgrad Med.</italic></source><year>2008</year><volume>54</volume><fpage>91</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">18480523</pub-id></element-citation></ref><ref id="ref71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farooqi</surname><given-names>YN.</given-names></name><name><surname>Rasul</surname><given-names>F.</given-names></name></person-group><article-title>Gender differences in perceived quality of life of patients suffering from obsessive-compulsive disorder.</article-title><source><italic>Pak J Psychol Res.</italic></source><year>2011</year><volume>26</volume></element-citation></ref><ref id="ref72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassin</surname><given-names>SE.</given-names></name><name><surname>Richter</surname><given-names>MA.</given-names></name><name><surname>Zhang</surname><given-names>KA.</given-names></name><name><surname>Rector</surname><given-names>NA.</given-names></name></person-group><article-title>Quality of life in treatment-seeking patients with obsessive-compulsive disorder with and without major depressive disorder.</article-title><source><italic>Can J Psychiatry.</italic></source><year>2009</year><volume>54</volume><fpage>460</fpage><lpage>467</lpage><pub-id pub-id-type="pmid">19660168</pub-id></element-citation></ref><ref id="ref73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masellis</surname><given-names>M.</given-names></name><name><surname>Rector</surname><given-names>NA.</given-names></name><name><surname>Richter</surname><given-names>MA.</given-names></name></person-group><article-title>Quality of life in OCD: differential impact of obsessions, compulsions, and depression comorbidity.</article-title><source><italic>Can J Psychiatry.</italic></source><year>2003</year><volume>48</volume><fpage>72</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">12655903</pub-id></element-citation></ref><ref id="ref74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stengler-Wenzke</surname><given-names>K.</given-names></name><name><surname>Kroll</surname><given-names>M.</given-names></name><name><surname>Riedel-Heller</surname><given-names>S.</given-names></name><name><surname>Matschinger</surname><given-names>H.</given-names></name><name><surname>Angermeyer</surname><given-names>MC.</given-names></name></person-group><article-title>Quality of life in obsessive-compulsive disorder: the different impact of obsessions and compulsions.</article-title><source><italic>Psychopathology.</italic></source><year>2007</year><volume>40</volume><fpage>282</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">17622707</pub-id></element-citation></ref><ref id="ref75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besiroglu</surname><given-names>L.</given-names></name><name><surname>Uguz</surname><given-names>F.</given-names></name><name><surname>Saglam</surname><given-names>M.</given-names></name><name><surname>Agargun</surname><given-names>MY.</given-names></name><name><surname>Cilli</surname><given-names>AS.</given-names></name></person-group><article-title>Factors associated with major depressive disorder occurring after the onset of obsessivecompulsive disorder.</article-title><source><italic>J Affect Disord.</italic></source><year>2007</year><volume>102</volume><fpage>73</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">17222458</pub-id></element-citation></ref><ref id="ref76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>JE.</given-names></name><name><surname>Mancebo</surname><given-names>MC.</given-names></name><name><surname>Pinto</surname><given-names>A.</given-names></name><name><surname>Eisen</surname><given-names>JL.</given-names></name><name><surname>Rasmussen</surname><given-names>SA.</given-names></name></person-group><article-title>Impulse control disorders in adults with obsessive compulsive disorder.</article-title><source><italic>J Psychiatr Res.</italic></source><year>2006</year><volume>40</volume><fpage>494</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">16430922</pub-id></element-citation></ref><ref id="ref77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Be&#x0015f;iro&#x0011f;lu</surname><given-names>L.</given-names></name><name><surname>Cllli</surname><given-names>AS.</given-names></name><name><surname>A&#x0015f;kin</surname><given-names>R.</given-names></name></person-group><article-title>The predictors of health care seeking behavior in obsessive-compulsive disorder.</article-title><source><italic>Compr Psychiatry.</italic></source><year>2004</year><volume>45</volume><fpage>99</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">14999660</pub-id></element-citation></ref><ref id="ref78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tenney</surname><given-names>NH.</given-names></name><name><surname>Denys</surname><given-names>DA.</given-names></name><name><surname>van Megen</surname><given-names>HJ.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder.</article-title><source><italic>Int Clin Psychopharmacol.</italic></source><year>2003</year><volume>18</volume><fpage>29</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">12490772</pub-id></element-citation></ref><ref id="ref79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougherty</surname><given-names>DD.</given-names></name><name><surname>Jameson</surname><given-names>M.</given-names></name><name><surname>Deckersbach</surname><given-names>T.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder.</article-title><source><italic>Int Clin Psychopharmacol.</italic></source><year>2009</year><volume>24</volume><fpage>306</fpage><lpage>311</lpage><pub-id pub-id-type="pmid">19730388</pub-id></element-citation></ref><ref id="ref80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Be&#x0015f;iro&#x0011f;lu</surname><given-names>L.</given-names></name><name><surname>U&#x0011f;uz</surname><given-names>F.</given-names></name><name><surname>Yilmaz</surname><given-names>E.</given-names></name><name><surname>A&#x0011f;arg&#x000fc;n</surname><given-names>MY.</given-names></name><name><surname>A&#x0015f;kin</surname><given-names>R.</given-names></name><name><surname>Aydin</surname><given-names>A.</given-names></name></person-group><article-title>Psychopharmacological treatment and quality of life in obsessive compulsive disorder.</article-title><source><italic>Turk Psikiyatri Derg .</italic></source><year>2008</year><volume>19</volume><fpage>38</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">18330742</pub-id></element-citation></ref><ref id="ref81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordioli</surname><given-names>AV.</given-names></name><name><surname>Heldt</surname><given-names>E.</given-names></name><name><surname>Bochi</surname><given-names>DB.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Cognitive-behavioral group therapy in obsessive-compulsive disorder: a randomized clinical trial.</article-title><source><italic>PsychotherPsychosom.</italic></source><year>2003</year><volume>72</volume><fpage>211</fpage><lpage>216</lpage></element-citation></ref><ref id="ref82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>E.</given-names></name><name><surname>Ljo'tsson</surname><given-names>B.</given-names></name><name><surname>Hedman</surname><given-names>E.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Internet-based cognitive behavior therapy for obsessive compulsive disorder: a pilot study.</article-title><source><italic>BMC Psychiatry.</italic></source><year>2011</year><volume>11</volume><fpage>125</fpage><pub-id pub-id-type="pmid">21812991</pub-id></element-citation></ref><ref id="ref83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>HB.</given-names></name><name><surname>Foa</surname><given-names>EB.</given-names></name><name><surname>Liebowitz</surname><given-names>MR.</given-names></name><name><surname>et al</surname></name></person-group><article-title>A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.</article-title><source><italic>Am J Psychiatry.</italic></source><year>2008</year><volume>165</volume><fpage>621</fpage><lpage>630</lpage><pub-id pub-id-type="pmid">18316422</pub-id></element-citation></ref><ref id="ref84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Twohig</surname><given-names>MP.</given-names></name><name><surname>Hayes</surname><given-names>SC.</given-names></name><name><surname>et al</surname></name></person-group><article-title>A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder.</article-title><source><italic>J Consult Clin Psychol.</italic></source><year>2010</year><volume>78</volume><fpage>705</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">20873905</pub-id></element-citation></ref><ref id="ref85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehlin</surname><given-names>JP.</given-names></name><name><surname>Morrison</surname><given-names>KL.</given-names></name><name><surname>Twohig</surname><given-names>MP.</given-names></name></person-group><article-title>Acceptance and commitment therapy as a treatment for scrupulosity in obsessive compulsive disorder.</article-title><source><italic>BehavModif.</italic></source><year>2013</year><volume>37</volume><fpage>409</fpage><lpage>430</lpage></element-citation></ref><ref id="ref86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>RA.</given-names></name><name><surname>Abrantes</surname><given-names>AM.</given-names></name><name><surname>Strong</surname><given-names>DR.</given-names></name><name><surname>et al</surname></name></person-group><article-title>A pilot study of moderateintensity aerobic exercise for obsessive compulsive disorder.</article-title><source><italic>J Nerv Ment Dis.</italic></source><year>2007</year><volume>195</volume><fpage>514</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">17568300</pub-id></element-citation></ref><ref id="ref87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKay</surname><given-names>D.</given-names></name><name><surname>Abramowitz</surname><given-names>JS.</given-names></name><name><surname>Calamari</surname><given-names>JE.</given-names></name><name><surname>et al</surname></name></person-group><article-title>A critical evaluation of obsessive-compulsive disorder subtypes: symptoms versus mechanisms.</article-title><source><italic>Clin Psychol Rev.</italic></source><year>2004</year><volume>24</volume><fpage>283</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">15245833</pub-id></element-citation></ref><ref id="ref88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>DA.</given-names></name><name><surname>Beck</surname><given-names>AT.</given-names></name></person-group><source><italic>Manual for the Clark-Beck Obsessive Compulsive Inventory.</italic> San Antonio, TX: The Psychological Corporation.</source><year>2002</year></element-citation></ref><ref id="ref89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramowitz</surname><given-names>JS.</given-names></name><name><surname>Deacon</surname><given-names>B.</given-names></name><name><surname>Olatunji</surname><given-names>B.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Assessment of obsessivecompulsive symptom dimensions: Development and evaluation of the dimensional obsessive-compulsive scale.</article-title><source><italic>Psychol Assess.</italic></source><year>2010</year><volume>22</volume><fpage>180</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">20230164</pub-id></element-citation></ref><ref id="ref90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klepsch</surname><given-names>R.</given-names></name><name><surname>Zaworka</surname><given-names>W.</given-names></name><name><surname>Hand</surname><given-names>I.</given-names></name><name><surname>Lunenschloss</surname><given-names>K.</given-names></name><name><surname>Jauernig</surname><given-names>G.</given-names></name></person-group><article-title>Derivation and validation of the Hamburg Obsession/ Compulsion Inventory-Short Form (HOCI-S): first results.</article-title><source><italic>Psychol Assess.</italic></source><year>1991</year><volume>3</volume><fpage>196</fpage><lpage>201</lpage></element-citation></ref><ref id="ref91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>J.</given-names></name></person-group><article-title>The Leyton Obsessional Inventory.</article-title><source><italic>Psychol Med.</italic></source><year>1970</year><volume>1</volume><fpage>48</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">5526113</pub-id></element-citation></ref><ref id="ref92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodgson</surname><given-names>RJ.</given-names></name><name><surname>Rachman</surname><given-names>S.</given-names></name></person-group><article-title>Obsessional-compulsive complaints.</article-title><source><italic>Behav Res Ther.</italic></source><year>1997</year><volume>15</volume><fpage>389</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">612339</pub-id></element-citation></ref><ref id="ref93"><label>93</label><element-citation publication-type="journal"><article-title>Obsessive Compulsive Cognitions Working Group. Psychometric validation of the obsessive belief questionnaire and interpretation of intrusions inventory-Part 2: Factor analyses and testing of a brief version.</article-title><source><italic>Behav Res Ther.</italic></source><year>2005</year><volume>43</volume><fpage>1527</fpage><lpage>1542</lpage><pub-id pub-id-type="pmid">16299894</pub-id></element-citation></ref><ref id="ref94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Oppen</surname><given-names>P.</given-names></name><name><surname>Hoekstra</surname><given-names>RJ.</given-names></name><name><surname>Emmelkamp</surname><given-names>PM.</given-names></name></person-group><article-title>The structure of obsessive-compulsive symptoms.</article-title><source><italic>Behav Res Ther.</italic></source><year>1995</year><volume>33</volume><fpage>15</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">7872933</pub-id></element-citation></ref><ref id="ref95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dell'Osso</surname><given-names>L.</given-names></name><name><surname>Rucci</surname><given-names>P.</given-names></name><name><surname>Cassano</surname><given-names>GB.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Measuring social anxiety and obsessive-compulsive spectra: comparison of interviews and self-report instruments.</article-title><source><italic>Compr Psychiatry.</italic></source><year>2002</year><volume>43</volume><fpage>81</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">11893984</pub-id></element-citation></ref><ref id="ref96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derogatis</surname><given-names>L.</given-names></name></person-group><source><italic>SCL-90-R: Administration, Scoring and Procedures Manual-1 for the Revised Version.</italic> Baltimore, MD: Johns Hopkins University Press.</source><year>1977</year></element-citation></ref><ref id="ref97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thordarson</surname><given-names>DS.</given-names></name><name><surname>Radomsky</surname><given-names>AS.</given-names></name><name><surname>Rachman</surname><given-names>S.</given-names></name><name><surname>Shafran</surname><given-names>R.</given-names></name><name><surname>Sawchuk</surname><given-names>N.</given-names></name><name><surname>Hakstian</surname><given-names>AR.</given-names></name></person-group><article-title>The Vancouver Obsessional Compulsive Inventory (VOCI).</article-title><source><italic>Behav Res Ther.</italic></source><year>2004</year><volume>42</volume><fpage>1289</fpage><lpage>1314</lpage><pub-id pub-id-type="pmid">15381439</pub-id></element-citation></ref><ref id="ref98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baer</surname><given-names>L.</given-names></name></person-group><article-title>Getting</article-title><source><italic>Control. Overcoming Your Obsessions and Compulsions.</italic> New York, NY: Penguin Books.</source><year>1991</year></element-citation></ref><ref id="ref99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chik</surname><given-names>HM.</given-names></name><name><surname>Calamari</surname><given-names>JE.</given-names></name><name><surname>Rector</surname><given-names>NA.</given-names></name><name><surname>Riemann</surname><given-names>BC.</given-names></name></person-group><article-title>What do low-dysfunctional beliefs obsessive-compulsive disorder subgroups believe?</article-title><source><italic>J Anxiety Disord.</italic></source><year>2010</year><volume>24</volume><fpage>837</fpage><lpage>846</lpage><pub-id pub-id-type="pmid">20621440</pub-id></element-citation></ref><ref id="ref100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyrios</surname><given-names>M.</given-names></name><name><surname>lob</surname><given-names>MA.</given-names></name></person-group><article-title>Automatic and strategic processing in obsessivecompulsive disorder: Attentional bias, cognitive avoidance or more complex phenomena?</article-title><source><italic>J Anxiety Disord.</italic></source><year>1998</year><volume>12</volume><fpage>271</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">9699114</pub-id></element-citation></ref><ref id="ref101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scarrabelotti</surname><given-names>MB.</given-names></name><name><surname>Duck</surname><given-names>JM.</given-names></name><name><surname>Dickerson</surname><given-names>MM.</given-names></name></person-group><article-title>Individual differences in obsessive-compulsive behavior: The role of the eysenckian dimensions and appraisals of responsibility.</article-title><source><italic>Pers Individ Dif.</italic></source><year>1995</year><volume>18</volume><fpage>413</fpage><lpage>421</lpage></element-citation></ref><ref id="ref102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dastgiri</surname><given-names>SS.</given-names></name><name><surname>Nateghian</surname><given-names>S.</given-names></name></person-group><article-title>Investigating the overlap of Padua inventory and worry among patients with obsessive-compulsive disorder, generalized anxiety disorder and normal people.</article-title><source><italic>Iran J Psychiatry.</italic></source><year>2008</year><fpage>110</fpage><lpage>113</lpage></element-citation></ref><ref id="ref103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fullana</surname><given-names>MA.</given-names></name><name><surname>Mataix-Cols</surname><given-names>D.</given-names></name><name><surname>Trujillo</surname><given-names>JL.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Personality characteristics in obsessive-compulsive disorder and individuals with subclinical obsessive-compulsive problems.</article-title><source><italic>Br J Clin Psychol.</italic></source><year>2004</year><volume>43(Pt 4)</volume><fpage>387</fpage><lpage>398</lpage><pub-id pub-id-type="pmid">15530209</pub-id></element-citation></ref><ref id="ref104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amtz</surname><given-names>A.</given-names></name><name><surname>Voncken</surname><given-names>M.</given-names></name><name><surname>Goosen</surname><given-names>ACA.</given-names></name></person-group><article-title>Responsibility and obsessive-compulsive disorder: An experimental test.</article-title><source><italic>Behav Res Ther.</italic></source><year>2007</year><volume>45</volume><fpage>425</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">16697349</pub-id></element-citation></ref><ref id="ref105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Exner</surname><given-names>C.</given-names></name><name><surname>Martin</surname><given-names>V.</given-names></name><name><surname>Rief</surname><given-names>W.</given-names></name></person-group><article-title>Self- focused ruminations and memory deficits in obsessive-compulsive disorder.</article-title><source><italic>Cogn Ther Res.</italic></source><year>2009</year><volume>33</volume><fpage>163</fpage><lpage>174</lpage></element-citation></ref><ref id="ref106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olantunji</surname><given-names>BO.</given-names></name><name><surname>Ciesielski</surname><given-names>BG.</given-names></name><name><surname>Zaid</surname><given-names>DH.</given-names></name></person-group><article-title>A selective impairment in attentional disengagement from erotica in obsessive-compulsive disorder.</article-title><source><italic>Prog Neuropsychopharmacol Biol Psychiatry.</italic></source><year>2011</year><volume>35</volume><fpage>1977</fpage><lpage>1982</lpage><pub-id pub-id-type="pmid">21801779</pub-id></element-citation></ref><ref id="ref107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Sol&#x000e0;</surname><given-names>C.</given-names></name><name><surname>Guti&#x000e9;rrez</surname><given-names>F.</given-names></name><name><surname>Alonso</surname><given-names>P.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Spanish version of the Dimensional Obsessive-Compulsive Scale (DOCS): Psychometric properties and relation to obsessive beliefs.</article-title><source><italic>Compr Psychiatry.</italic></source><year>2014</year><volume>55</volume><fpage>206</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">24209609</pub-id></element-citation></ref><ref id="ref108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emmelkamp</surname><given-names>PMG.</given-names></name><name><surname>Kraaijkamp</surname><given-names>HJM.</given-names></name><name><surname>van Den Hout</surname><given-names>MA.</given-names></name></person-group><article-title>Assessment of obsessive-compulsive disorder.</article-title><source><italic>BehavModif.</italic></source><year>1999</year><volume>23</volume><fpage>269</fpage><lpage>279</lpage></element-citation></ref><ref id="ref109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>N.</given-names></name><name><surname>Putz</surname><given-names>A.</given-names></name><name><surname>Kathmann</surname><given-names>N.</given-names></name><name><surname>Lehle</surname><given-names>R.</given-names></name><name><surname>G&#x000fc;nther</surname><given-names>W.</given-names></name><name><surname>Straube</surname><given-names>A.</given-names></name></person-group><article-title>Characteristics of obsessive-compulsive symptoms in Tourette's syndrome, obsessive-compulsive disorder, and Parkinson's disease.</article-title><source><italic>Psychiatry Res.</italic></source><year>1975</year><volume>70</volume><fpage>105</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">9194204</pub-id></element-citation></ref><ref id="ref110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>MK.</given-names></name><name><surname>Menzies</surname><given-names>RG.</given-names></name></person-group><article-title>Danger ideation reduction therapy (DIRT) for obsessive-compulsive washers. A controlled trial.</article-title><source><italic>Behav Res Ther.</italic></source><year>1998</year><volume>36</volume><fpage>959</fpage><lpage>970</lpage><pub-id pub-id-type="pmid">9714946</pub-id></element-citation></ref><ref id="ref111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>MS.</given-names></name><name><surname>Kim</surname><given-names>MS.</given-names></name><name><surname>Ha</surname><given-names>TH.</given-names></name><name><surname>Kwon</surname><given-names>JS.</given-names></name></person-group><article-title>Deficits of organizational strategy and visual memory in obsessive-compulsive disorder.</article-title><source><italic>Neuropsychology.</italic></source><year>2004</year><volume>18</volume><fpage>665</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">15506834</pub-id></element-citation></ref><ref id="ref112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murayama</surname><given-names>K.</given-names></name><name><surname>Nakao</surname><given-names>T.</given-names></name><name><surname>Sanematsu</surname><given-names>H.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Differential neural network of checking versus washing symptoms in obsessive-compulsive disorder.</article-title><source><italic>Prog Neuropsychopharmacol Biol Psychiatry.</italic></source><year>2013</year><volume>40</volume><fpage>160</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">22996045</pub-id></element-citation></ref><ref id="ref113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname><given-names>K.</given-names></name><name><surname>Ota</surname><given-names>T.</given-names></name><name><surname>Lida</surname><given-names>J.</given-names></name><name><surname>Kishimoto</surname><given-names>N.</given-names></name><name><surname>Kishimoto</surname><given-names>T.</given-names></name></person-group><article-title>Lower prefrontal activity in adults with obsessive-compulsive disorder as measured by near-infrared spectroscopy. Prog Neuropsychopharmacol</article-title><source><italic>Biol Psychiatry.</italic></source><year>2013</year><volume>43</volume><fpage>7</fpage><lpage>13</lpage></element-citation></ref><ref id="ref114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tumkaya</surname><given-names>S.</given-names></name><name><surname>Karadag</surname><given-names>F.</given-names></name><name><surname>Mueller</surname><given-names>ST.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Situation awareness in obsessive-compulsive disorder.</article-title><source><italic>Psychiatry Res.</italic></source><year>2013</year><volume>209</volume><fpage>579</fpage><lpage>588</lpage><pub-id pub-id-type="pmid">23537845</pub-id></element-citation></ref><ref id="ref115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>CS.</given-names></name></person-group><article-title>Symptom overlap between OCD and bulimia nervosa.</article-title><source><italic>J Anxiety Disord.</italic></source><year>1995</year><volume>9</volume><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="ref116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>DA.</given-names></name><name><surname>Antony</surname><given-names>MM.</given-names></name><name><surname>Beck</surname><given-names>AT.</given-names></name><name><surname>Swinson</surname><given-names>RP.</given-names></name><name><surname>Steer</surname><given-names>RA.</given-names></name></person-group><article-title>Screening for obsessive and compulsive symptoms: validation of the Clark-Beck Obsessive-Compulsive Inventory.</article-title><source><italic>Psychol Assess.</italic></source><year>2005</year><volume>17</volume><fpage>132</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">16029101</pub-id></element-citation></ref><ref id="ref117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moritz</surname><given-names>S.</given-names></name><name><surname>Kempke</surname><given-names>S.</given-names></name><name><surname>Luyten</surname><given-names>P.</given-names></name><name><surname>Randjbar</surname><given-names>S.</given-names></name><name><surname>Jelinek</surname><given-names>L.</given-names></name></person-group><article-title>Was Freud partly right on obsessive-compulsive disorder (OCD)? Investigation of latent aggression in OCD.</article-title><source><italic>Psychiatry Res.</italic></source><year>2011</year><volume>187</volume><fpage>180</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">20950865</pub-id></element-citation></ref><ref id="ref118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belloch</surname><given-names>A.</given-names></name><name><surname>Roncero</surname><given-names>M.</given-names></name><name><surname>Garcia-Soriano</surname><given-names>M.</given-names></name><name><surname>Carrio</surname><given-names>C.</given-names></name><name><surname>Cabedo</surname><given-names>E.</given-names></name><name><surname>Fernandez-Alvarez</surname><given-names>H.</given-names></name></person-group><article-title>The Spanish version of the obsessive-compulsive inventory-revised (OCI-R): reliability, validity, diagnostic accuracy and sensitivity to treatment effects in clinical samples.</article-title><source><italic>J Obsessive Compuls Relat Disord.</italic></source><year>2013</year><volume>2</volume><fpage>249</fpage><lpage>256</lpage></element-citation></ref><ref id="ref119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Einstein</surname><given-names>DA.</given-names></name><name><surname>Menzies</surname><given-names>RG.</given-names></name></person-group><article-title>Magical thinking in obsessive-compulsive disorder, panic disorder and the general community.</article-title><source><italic>Behav Cogn Psychother.</italic></source><year>2006</year><fpage>351</fpage><lpage>357</lpage></element-citation></ref><ref id="ref120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermans</surname><given-names>D.</given-names></name><name><surname>Martens</surname><given-names>K.</given-names></name><name><surname>De Cort</surname><given-names>K.</given-names></name><name><surname>Pieters</surname><given-names>G.</given-names></name><name><surname>Eelen</surname><given-names>P.</given-names></name></person-group><article-title>Reality monitoring and metacognitive beliefs related to cognitive confidence in obsessive-compulsive disorder.</article-title><source><italic>Behav Res Ther.</italic></source><year>2003</year><volume>41</volume><fpage>383</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">12643963</pub-id></element-citation></ref><ref id="ref121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salkovskis</surname><given-names>PM.</given-names></name><name><surname>Wroe</surname><given-names>AL.</given-names></name><name><surname>Geldhill</surname><given-names>A.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Responsibility attitudes and interpretations are characteristic of obsessive compulsive disorder.</article-title><source><italic>Behav Res Ther.</italic></source><year>2000</year><volume>38</volume><fpage>347</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">10761280</pub-id></element-citation></ref><ref id="ref122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>ZW.</given-names></name><name><surname>Xu</surname><given-names>T.</given-names></name><name><surname>Miao</surname><given-names>GD.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Neurological soft signs in obsessivecompulsive disorder: the effect of co-morbid psychosis and evidence for familiality.</article-title><source><italic>Prog Neuropsychopharmacol Biol Psychiatry.</italic></source><year>2012</year><volume>39</volume><fpage>200</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">22735396</pub-id></element-citation></ref><ref id="ref123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>FP.</given-names></name><name><surname>Foa</surname><given-names>EB.</given-names></name><name><surname>Meyer</surname><given-names>E.</given-names></name><name><surname>Niederauer</surname><given-names>KG.</given-names></name><name><surname>Cordioli</surname><given-names>AV.</given-names></name></person-group><article-title>Psychometric properties of the Brazilian Portuguese version of the Obsessive-Compulsive Inventory - Revised (OCI-R).</article-title><source><italic>Rev Bras Psiquiatr.</italic></source><year>2011</year><volume>33</volume><fpage>137</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">21829906</pub-id></element-citation></ref><ref id="ref124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>CW.</given-names></name><name><surname>Kwon</surname><given-names>SM.</given-names></name><name><surname>Lim</surname><given-names>YJ.</given-names></name><name><surname>Shin</surname><given-names>MS.</given-names></name></person-group><article-title>The Obsessive-Compulsive Inventory-Revised (OCI-R): psychometric properties of the Korean version and the order, gender, and cultural effects.</article-title><source><italic>J Behav Ther Exp Psychiatry.</italic></source><year>2010</year><volume>41</volume><fpage>220</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">20163784</pub-id></element-citation></ref><ref id="ref125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huppert</surname><given-names>JD.</given-names></name><name><surname>Moser</surname><given-names>JS.</given-names></name><name><surname>Gershuny</surname><given-names>BS.</given-names></name><name><surname>et al</surname></name></person-group><article-title>The relationship between obsessive-compulsive and posttraumatic stress symptoms in clinical and non-clinical samples.</article-title><source><italic>J Anxiety Disord.</italic></source><year>2005</year><volume>19</volume><fpage>127</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">15488372</pub-id></element-citation></ref><ref id="ref126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anholt</surname><given-names>GE.</given-names></name><name><surname>Cath</surname><given-names>DC.</given-names></name><name><surname>Emmelkamp</surname><given-names>PM.</given-names></name><name><surname>van Oppen</surname><given-names>P.</given-names></name><name><surname>Smit</surname><given-names>JH.</given-names></name><name><surname>van Balkom</surname><given-names>AJ.</given-names></name></person-group><article-title>Do obsessional beliefs discriminate OCD without tic patients from OCD with tic and Tourette's syndrome patients?</article-title><source><italic>Behav Res Ther.</italic></source><year>2006</year><volume>44</volume><fpage>1537</fpage><lpage>1543</lpage><pub-id pub-id-type="pmid">16480944</pub-id></element-citation></ref><ref id="ref127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>P.</given-names></name><name><surname>Orbegozo</surname><given-names>A.</given-names></name><name><surname>Pujol</surname><given-names>J.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Neural correlates of obsessivecompulsive related dysfunctional beliefs.</article-title><source><italic>Prog Neuropsychopharmacol Biol Psychiatry.</italic></source><year>2013</year><volume>47</volume><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">23911440</pub-id></element-citation></ref><ref id="ref128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radomsky</surname><given-names>AS.</given-names></name><name><surname>Ashbaugh</surname><given-names>AR.</given-names></name><name><surname>Gelfand</surname><given-names>LA.</given-names></name></person-group><article-title>Relationships between anger, symptoms, and cognitive factors in OCD checkers.</article-title><source><italic>Behav Res Ther.</italic></source><year>2007</year><volume>45</volume><fpage>2712</fpage><lpage>2725</lpage><pub-id pub-id-type="pmid">17723225</pub-id></element-citation></ref><ref id="ref129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niemeyer</surname><given-names>H.</given-names></name><name><surname>Moritz</surname><given-names>S.</given-names></name><name><surname>Pietrowsky</surname><given-names>R.</given-names></name></person-group><article-title>Responsibility, in eta cog nit ion and unrealistic pessimism in obsessive-compulsive disorder.</article-title><source><italic>J Obsessive Compuls Relat Disord.</italic></source><year>2013</year><volume>2</volume><fpage>119</fpage><lpage>129</lpage></element-citation></ref><ref id="ref130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahl</surname><given-names>K.</given-names></name><name><surname>Sch&#x000f6;nfeld</surname><given-names>S.</given-names></name><name><surname>Hissbach</surname><given-names>J.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Differences and similarities between obsessive and ruminative thoughts in obsessive-compulsive and depressed patients: a comparative study.</article-title><source><italic>J Behav Ther Exp Psychiatry.</italic></source><year>2011</year><volume>42</volume><fpage>454</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">21596010</pub-id></element-citation></ref><ref id="ref131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filomensky</surname><given-names>TZ.</given-names></name><name><surname>Almeida</surname><given-names>KM.</given-names></name><name><surname>Castro Nogueira</surname><given-names>MC.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Neither bipolar nor obsessive-compulsive disorder: compulsive buyers are impulsive acquirers.</article-title><source><italic>Compr Psychiatry.</italic></source><year>2012</year><volume>53</volume><fpage>554</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">22099581</pub-id></element-citation></ref><ref id="ref132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jimenez-Murcia</surname><given-names>S.</given-names></name><name><surname>Fern&#x000e1;ndez-Aranda</surname><given-names>F.</given-names></name><name><surname>Raich</surname><given-names>RM.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Obsessivecompulsive and eating disorders: comparison of clinical and personality features.</article-title><source><italic>Psychiatry Clin Neurosci.</italic></source><year>2007</year><volume>61</volume><fpage>385</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">17610663</pub-id></element-citation></ref><ref id="ref133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontenelle</surname><given-names>LF.</given-names></name><name><surname>Mendlowicz</surname><given-names>MV.</given-names></name><name><surname>de Menezes</surname><given-names>GB.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Comparison of symptom profiles of obese binge eaters, obese non-binge eaters, and patients with obsessive-compulsive disorder.</article-title><source><italic>J Nerv Ment Dis.</italic></source><year>2002</year><volume>190</volume><fpage>643</fpage><lpage>646</lpage><pub-id pub-id-type="pmid">12357101</pub-id></element-citation></ref><ref id="ref134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>DJ.</given-names></name><name><surname>Mullen</surname><given-names>L.</given-names></name><name><surname>Islam</surname><given-names>MN.</given-names></name><name><surname>Cohen</surname><given-names>L.</given-names></name><name><surname>DeCaria</surname><given-names>CM.</given-names></name><name><surname>Hollander</surname><given-names>E.</given-names></name></person-group><article-title>Compulsive and impulsive symptomatology in trichotillomania.</article-title><source><italic>Psychopathology.</italic></source><year>1995</year><volume>28</volume><fpage>208</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">7480576</pub-id></element-citation></ref><ref id="ref135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname><given-names>M.</given-names></name><name><surname>Chorcorain</surname><given-names>AN.</given-names></name><name><surname>Griffith</surname><given-names>E.</given-names></name><name><surname>Trimble</surname><given-names>T.</given-names></name><name><surname>O'Callaghan</surname><given-names>E.</given-names></name></person-group><article-title>Obsessive compulsive symptoms in patients with schizophrenia on clozapine and with obsessive compulsive disorder: a comparison study.</article-title><source><italic>Compr Psychiatry.</italic></source><year>2014</year><volume>55</volume><fpage>130</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">24209980</pub-id></element-citation></ref><ref id="ref136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mass</surname><given-names>R.</given-names></name><name><surname>Weigel</surname><given-names>S.</given-names></name><name><surname>Schneider</surname><given-names>S.</given-names></name><name><surname>Klepsch</surname><given-names>R.</given-names></name></person-group><article-title>Schizophrenia-specific basic symptoms. A successful replication.</article-title><source><italic>Psychopathology.</italic></source><year>1998</year><volume>31</volume><fpage>113</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">9636940</pub-id></element-citation></ref><ref id="ref137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontenelle</surname><given-names>LF.</given-names></name><name><surname>Domingues</surname><given-names>AM.</given-names></name><name><surname>Souza</surname><given-names>WF.</given-names></name><name><surname>et al</surname></name></person-group><article-title>History of trauma and dissociative symptoms among patients with obsessive-compulsive disorder and social anxiety disorder.</article-title><source><italic>Psychiatr Q.</italic></source><year>2007</year><volume>78</volume><fpage>241</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">17453345</pub-id></element-citation></ref><ref id="ref138"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tolin</surname><given-names>DF.</given-names></name><name><surname>Worhunsky</surname><given-names>P.</given-names></name><name><surname>Brady</surname><given-names>RE.</given-names></name><name><surname>Maltby</surname><given-names>N.</given-names></name></person-group><article-title>The relationship between obsessive beliefs and thought-control strategies in a clinical sample.</article-title><source><italic>Cogn Ther Res.</italic></source><year>2007</year><volume>31</volume><fpage>307</fpage><lpage>318</lpage></element-citation></ref><ref id="ref139"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anholt</surname><given-names>GE.</given-names></name><name><surname>Emmelkamp</surname><given-names>PM.</given-names></name><name><surname>Cath</surname><given-names>DC.</given-names></name><name><surname>van Oppen</surname><given-names>P.</given-names></name><name><surname>Nelissen</surname><given-names>H.</given-names></name><name><surname>Smit</surname><given-names>JH.</given-names></name></person-group><article-title>Do patients with OCD and pathological gambling have similar dysfunctional cognitions?</article-title><source><italic>Behav Res Ther.</italic></source><year>2004</year><volume>42</volume><fpage>529</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">15033499</pub-id></element-citation></ref><ref id="ref140"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wellen</surname><given-names>D.</given-names></name><name><surname>Samuels</surname><given-names>J.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Utility of the Leyton Obsessional Inventory to distinguish OCD and OCPD.</article-title><source><italic>Depress Anxiety.</italic></source><year>2007</year><volume>24</volume><fpage>301</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">17099877</pub-id></element-citation></ref><ref id="ref141"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baptista</surname><given-names>MN.</given-names></name><name><surname>Magna</surname><given-names>LA.</given-names></name><name><surname>McKay</surname><given-names>D.</given-names></name><name><surname>Del-Porto</surname><given-names>JA.</given-names></name></person-group><article-title>Assessment of obsessive beliefs: comparing individuals with obsessive-compulsive disorder to a medical sample.</article-title><source><italic>J Behav Ther Exp Psychiatry.</italic></source><year>2011</year><volume>42</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">21073999</pub-id></element-citation></ref><ref id="ref142"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rector</surname><given-names>NA.</given-names></name><name><surname>Cassin</surname><given-names>SE.</given-names></name><name><surname>Richter</surname><given-names>MA.</given-names></name><name><surname>Burroughs</surname><given-names>E.</given-names></name></person-group><article-title>Obsessive beliefs in first-degree relatives of patients with OCD: a test of the cognitive vulnerability model.</article-title><source><italic>J Anxiety Disord.</italic></source><year>2009</year><volume>23</volume><fpage>145</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">18619770</pub-id></element-citation></ref><ref id="ref143"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vulink</surname><given-names>NCC.</given-names></name><name><surname>Denys</surname><given-names>D.</given-names></name><name><surname>Bus</surname><given-names>L.</given-names></name><name><surname>Westenberg</surname><given-names>HGM.</given-names></name></person-group><article-title>Female hormones affect symptom severity in obsessive-compulsive disorder.</article-title><source><italic>Int Clin Psychopharmacol.</italic></source><year>2006</year><volume>21</volume><fpage>171</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">16528139</pub-id></element-citation></ref><ref id="ref144"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tynes</surname><given-names>LL.</given-names></name><name><surname>Winstead</surname><given-names>DK.</given-names></name></person-group><article-title>Subtyping obsessive compulsive patients by depressive symptoms: a retrospective pilot study.</article-title><source><italic>Psychiatr Q.</italic></source><year>1999</year><volume>70</volume><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">9924732</pub-id></element-citation></ref><ref id="ref145"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>S.</given-names></name><name><surname>Abramowitz</surname><given-names>JS.</given-names></name><name><surname>KcKay</surname><given-names>D.</given-names></name></person-group><article-title>Are there interactions among dysfunctional beliefs in obsessive compulsive disorder.</article-title><source><italic>Cogn Behav Ther.</italic></source><year>2005</year><volume>34</volume><fpage>89</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">15986785</pub-id></element-citation></ref><ref id="ref146"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeBerardis</surname><given-names>D.</given-names></name><name><surname>Campanella</surname><given-names>D.</given-names></name><name><surname>Gambi</surname><given-names>F.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Insight and alexithymia in adult outpatients with obsessive-compulsive disorder.</article-title><source><italic>Eur Arch Psychiatry Clin Neurosci.</italic></source><year>2005</year><volume>255</volume><fpage>350</fpage><lpage>358</lpage><pub-id pub-id-type="pmid">15711867</pub-id></element-citation></ref><ref id="ref147"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Einstein</surname><given-names>DA.</given-names></name><name><surname>Menzies</surname><given-names>RG.</given-names></name></person-group><article-title>The presence of magical thinking in obsessive compulsive disorder.</article-title><source><italic>Behav Res Ther.</italic></source><year>2004</year><volume>42</volume><fpage>539</fpage><lpage>549</lpage><pub-id pub-id-type="pmid">15033500</pub-id></element-citation></ref><ref id="ref148"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brakoulias</surname><given-names>V.</given-names></name><name><surname>Starcevic</surname><given-names>V.</given-names></name><name><surname>Berle</surname><given-names>D.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Further support for five dimensions of obsessive-compulsive symptoms.</article-title><source><italic>J Nerv Ment Dis.</italic></source><year>2013</year><volume>201</volume><fpage>452</fpage><lpage>429</lpage><pub-id pub-id-type="pmid">23686154</pub-id></element-citation></ref><ref id="ref149"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ettelt</surname><given-names>S.</given-names></name><name><surname>Ruhrmann</surname><given-names>S.</given-names></name><name><surname>Barnow</surname><given-names>S.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Impulsiveness in obsessivecompulsive disorder: results from a family study.</article-title><source><italic>Acta Psychiatr Scand.</italic></source><year>2007</year><volume>115</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">17201865</pub-id></element-citation></ref><ref id="ref150"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tolin</surname><given-names>DF.</given-names></name><name><surname>Brady</surname><given-names>RE.</given-names></name><name><surname>Hannan</surname><given-names>S.</given-names></name></person-group><article-title>Obsessional beliefs and symptoms of obsessive-compulsive disorder in a clinical sample.</article-title><source><italic>J Psychopathol Behav Assess.</italic></source><year>2008</year><volume>30</volume><fpage>31</fpage><lpage>42</lpage></element-citation></ref><ref id="ref151"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calamari</surname><given-names>JE.</given-names></name><name><surname>Cohen</surname><given-names>RJ.</given-names></name><name><surname>Rector</surname><given-names>NA.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Dysfunctional belief-based obsessive-compulsive disorder subgroups.</article-title><source><italic>Behav Res Ther.</italic></source><year>2006</year><volume>44</volume><fpage>1347</fpage><lpage>1360</lpage><pub-id pub-id-type="pmid">16337605</pub-id></element-citation></ref><ref id="ref152"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheaton</surname><given-names>MG.</given-names></name><name><surname>Abramowitz</surname><given-names>JS.</given-names></name><name><surname>Berrnan</surname><given-names>NC.</given-names></name><name><surname>Riemann</surname><given-names>BC.</given-names></name><name><surname>Hale</surname><given-names>LR.</given-names></name></person-group><article-title>The relationship between obsessive beliefs and symptom dimensions in obsessive-compulsive disorder.</article-title><source><italic>Behav Res Ther.</italic></source><year>2010</year><volume>48</volume><fpage>949</fpage><lpage>954</lpage><pub-id pub-id-type="pmid">20800750</pub-id></element-citation></ref><ref id="ref153"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julien</surname><given-names>D.</given-names></name><name><surname>O'Connor</surname><given-names>KP.</given-names></name><name><surname>Aardema</surname><given-names>F.</given-names></name><name><surname>Todorov</surname><given-names>C.</given-names></name></person-group><article-title>The specificity of belief domains in obsessive-compulsive symptom subtypes.</article-title><source><italic>Personal Individual Diff.</italic></source><year>2006</year><volume>41</volume><fpage>1205</fpage><lpage>1216</lpage></element-citation></ref><ref id="ref154"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rufer</surname><given-names>M.</given-names></name><name><surname>Fricke</surname><given-names>S.</given-names></name><name><surname>Held</surname><given-names>D.</given-names></name><name><surname>Cremer</surname><given-names>J.</given-names></name><name><surname>Hand</surname><given-names>I.</given-names></name></person-group><article-title>Dissociation and symptom dimensions of obsessive-compulsive disorder. A replication study.</article-title><source><italic>Eur Arch Psychiatry Clin Neurosci.</italic></source><year>2006</year><volume>256</volume><fpage>146</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">16267636</pub-id></element-citation></ref><ref id="ref155"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabe</surname><given-names>HJ.</given-names></name><name><surname>Goldschmidt</surname><given-names>F.</given-names></name><name><surname>Lehmkuhl</surname><given-names>L.</given-names></name><name><surname>G&#x000e4;nsicke</surname><given-names>M.</given-names></name><name><surname>Spitzer</surname><given-names>C.</given-names></name><name><surname>Freyberger</surname><given-names>HJ.</given-names></name></person-group><article-title>Dissociative symptoms in obsessive-compulsive dimensions.</article-title><source><italic>Psychopathology.</italic></source><year>1999</year><volume>32</volume><fpage>319</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">10575330</pub-id></element-citation></ref><ref id="ref156"><label>156</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontenelle</surname><given-names>LF.</given-names></name><name><surname>Soares</surname><given-names>ID.</given-names></name><name><surname>Miele</surname><given-names>F.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Empathy and symptoms dimensions of patients with obsessive-compulsive disorder.</article-title><source><italic>J Psychiatr Res.</italic></source><year>2009</year><volume>43</volume><fpage>455</fpage><lpage>463</lpage><pub-id pub-id-type="pmid">18614180</pub-id></element-citation></ref><ref id="ref157"><label>157</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aksaray</surname><given-names>G.</given-names></name><name><surname>Yelken</surname><given-names>B.</given-names></name><name><surname>Kaptano&#x0011f;lu</surname><given-names>C.</given-names></name><name><surname>Oflu</surname><given-names>S.</given-names></name><name><surname>Ozaltin</surname><given-names>M.</given-names></name></person-group><article-title>Sexuality in women with obsessive compulsive disorder.</article-title><source><italic>J Sex Marital Ther.</italic></source><year>2001</year><volume>27</volume><fpage>273</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">11354932</pub-id></element-citation></ref><ref id="ref158"><label>158</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabe</surname><given-names>HJ.</given-names></name><name><surname>Thiel</surname><given-names>A.</given-names></name><name><surname>Freyberger</surname><given-names>HJ.</given-names></name></person-group><article-title>Symptoms of eating disorders in obsessive-compulsive disorder.</article-title><source><italic>Acta Psychiatr Scand.</italic></source><year>2000</year><volume>102</volume><fpage>449</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">11142435</pub-id></element-citation></ref><ref id="ref159"><label>159</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname><given-names>K.</given-names></name><name><surname>Mogan</surname><given-names>C.</given-names></name><name><surname>Kyrios</surname><given-names>M.</given-names></name></person-group><article-title>Obsessive-compulsive disorder and comorbid depression: the role of OCD-related and non-specific factors.</article-title><source><italic>J Anxiety Disord.</italic></source><year>2012</year><volume>26</volume><fpage>565</fpage><lpage>573</lpage><pub-id pub-id-type="pmid">22495108</pub-id></element-citation></ref><ref id="ref160"><label>160</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Careau</surname><given-names>Y.</given-names></name><name><surname>O'Connor</surname><given-names>KP.</given-names></name><name><surname>Turgeon</surname><given-names>L.</given-names></name><name><surname>Freeston</surname><given-names>MH.</given-names></name></person-group><article-title>Childhood experiences and adult beliefs in obsessive-compulsive disorder: evaluating a specific etiological model.</article-title><source><italic>J Cogn Psychother.</italic></source><year>2012</year><volume>26</volume><fpage>236</fpage><lpage>256</lpage></element-citation></ref><ref id="ref161"><label>161</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aardema</surname><given-names>F.</given-names></name><name><surname>O'Connor</surname><given-names>KP.</given-names></name><name><surname>Emmelkamp</surname><given-names>PM.</given-names></name></person-group><article-title>Inferential confusion and obsessive beliefs in obsessive-compulsive disorder.</article-title><source><italic>Cogn Behav Ther.</italic></source><year>2006</year><volume>35</volume><fpage>138</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">16952897</pub-id></element-citation></ref><ref id="ref162"><label>162</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>N.</given-names></name><name><surname>Nakaaki</surname><given-names>S.</given-names></name><name><surname>Omori</surname><given-names>IM.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Distinct neuropsychological profiles of three major symptom dimensions in obsessive-compulsive disorder.</article-title><source><italic>Psychiatry Res.</italic></source><year>2011</year><volume>187</volume><fpage>166</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">20817310</pub-id></element-citation></ref><ref id="ref163"><label>163</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karadag</surname><given-names>F.</given-names></name><name><surname>Oguzhanoglu</surname><given-names>N.</given-names></name><name><surname>Ozdel</surname><given-names>O.</given-names></name><name><surname>Atesci</surname><given-names>FC.</given-names></name><name><surname>Amuk</surname><given-names>T.</given-names></name></person-group><article-title>Memory function in patients with obsessive compulsive disorder and the problem of confidence in their memories: a clinical study.</article-title><source><italic>Croat Med J.</italic></source><year>2005</year><volume>46</volume><fpage>282</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">15849851</pub-id></element-citation></ref><ref id="ref164"><label>164</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enright</surname><given-names>SJ.</given-names></name><name><surname>Beech</surname><given-names>AR.</given-names></name><name><surname>Claridge</surname><given-names>GS.</given-names></name></person-group><article-title>A further investigation of cognitive inhibition in obsessive-compulsive disorder and other anxiety disorders.</article-title><source><italic>Person Individ Diff.</italic></source><year>1995</year><volume>19</volume><fpage>535</fpage><lpage>542</lpage></element-citation></ref><ref id="ref165"><label>165</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sizino da Victoria</surname><given-names>M.</given-names></name><name><surname>Nascimento</surname><given-names>AL.</given-names></name><name><surname>Fontenelle</surname><given-names>LF.</given-names></name></person-group><article-title>Symptom-specific attentional bias to threatening stimuli in obsessive-compulsive disorder.</article-title><source><italic>Compr Psychiatry.</italic></source><year>2012</year><volume>53</volume><fpage>783</fpage><lpage>788</lpage><pub-id pub-id-type="pmid">22300902</pub-id></element-citation></ref><ref id="ref166"><label>166</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>JS.</given-names></name><name><surname>Kim</surname><given-names>HS.</given-names></name><name><surname>Yoo</surname><given-names>SY.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Morphometric alterations of anterior superior temporal cortex in obsessive-compulsive disorder.</article-title><source><italic>Depress Anxiety.</italic></source><year>2006</year><volume>23</volume><fpage>290</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">16688740</pub-id></element-citation></ref><ref id="ref167"><label>167</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamae</surname><given-names>T.</given-names></name><name><surname>Narumoto</surname><given-names>J.</given-names></name><name><surname>Sakai</surname><given-names>Y.</given-names></name><name><surname>Nishida</surname><given-names>S.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Fukui</surname><given-names>K.</given-names></name></person-group><article-title>The neural basis of dysfunctional beliefs in non-medicated patients with obsessive-compulsive disorder.</article-title><source><italic>Prog Neuropsychopharmacol Biol Psychiatry.</italic></source><year>2012</year><volume>37</volume><fpage>22</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">22172533</pub-id></element-citation></ref><ref id="ref168"><label>168</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontenelle</surname><given-names>LF.</given-names></name><name><surname>Barbosa</surname><given-names>IG.</given-names></name><name><surname>Luna</surname><given-names>JV.</given-names></name><name><surname>de Sousa</surname><given-names>LP.</given-names></name><name><surname>Abreu</surname><given-names>MN.</given-names></name><name><surname>Teixeira</surname><given-names>AL.</given-names></name></person-group><article-title>A cytokine study of adult patients with obsessive-compulsive disorder.</article-title><source><italic>Compr Psychiatry.</italic></source><year>2012</year><volume>53</volume><fpage>797</fpage><lpage>804</lpage><pub-id pub-id-type="pmid">22300901</pub-id></element-citation></ref><ref id="ref169"><label>169</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>P.</given-names></name><name><surname>L&#x000f3;pez-Sol&#x000e0;</surname><given-names>C.</given-names></name><name><surname>Gratac&#x000f3;s</surname><given-names>M.</given-names></name><name><surname>et al</surname></name></person-group><article-title>The interaction between COMT and BDNF variants influences obsessive-compulsive-related dysfunctional beliefs.</article-title><source><italic>J Anxiety Disord.</italic></source><year>2013</year><volume>27</volume><fpage>321</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">23602946</pub-id></element-citation></ref><ref id="ref170"><label>170</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Einsten</surname><given-names>DA.</given-names></name><name><surname>Menzies</surname><given-names>RG.</given-names></name></person-group><article-title>Does magical thinking improve across treatment for obsessive-compulsive disorder?</article-title><source><italic>Behav Change.</italic></source><year>2008</year><volume>25</volume><fpage>149</fpage><lpage>155</lpage></element-citation></ref><ref id="ref171"><label>171</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Connor</surname><given-names>KP.</given-names></name><name><surname>Aardema</surname><given-names>F.</given-names></name><name><surname>Bouthillier</surname><given-names>D.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Evaluation of an inference-based approach to treating obsessive-compulsive disorder.</article-title><source><italic>Cogn Behav Ther.</italic></source><year>2005</year><volume>34</volume><fpage>148</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">16195054</pub-id></element-citation></ref><ref id="ref172"><label>172</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramowitz</surname><given-names>JS.</given-names></name><name><surname>Tolin</surname><given-names>DF.</given-names></name><name><surname>Diefenbach</surname><given-names>GJ.</given-names></name></person-group><article-title>Measuring change in OCD: sensitivity of the obsessive-compulsive inventory-revised.</article-title><source><italic>J Psychopathology Behav Assess.</italic></source><year>2005</year><volume>27</volume><fpage>317</fpage><lpage>324</lpage></element-citation></ref><ref id="ref173"><label>173</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solem</surname><given-names>S.</given-names></name><name><surname>H&#x00103;land</surname><given-names>AT.</given-names></name><name><surname>Vogel</surname><given-names>PA.</given-names></name><name><surname>Hansen</surname><given-names>B.</given-names></name><name><surname>Wells</surname><given-names>A.</given-names></name></person-group><article-title>Change in metacognitions predicts outcome in obsessive-compulsive disorder patients undergoing treatment with exposure and response prevention.</article-title><source><italic>Behav Res Ther.</italic></source><year>2009</year><volume>47</volume><fpage>301</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">19203749</pub-id></element-citation></ref><ref id="ref174"><label>174</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anholt</surname><given-names>GA.</given-names></name><name><surname>van Oppen</surname><given-names>P.</given-names></name><name><surname>Cath</surname><given-names>DC.</given-names></name><name><surname>Emmelkamp</surname><given-names>PM.</given-names></name><name><surname>Smit</surname><given-names>JH.</given-names></name><name><surname>van Balkom</surname><given-names>AJ.</given-names></name></person-group><article-title>Sensitivity to change of the Obsessive Beliefs Questionnaire.</article-title><source><italic>Clin Psychol Psychother.</italic></source><year>2010</year><volume>17</volume><fpage>154</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">19658124</pub-id></element-citation></ref><ref id="ref175"><label>175</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Noppen</surname><given-names>BL.</given-names></name><name><surname>Pato</surname><given-names>MT.</given-names></name><name><surname>Marsland</surname><given-names>R.</given-names></name><name><surname>Rasmussen</surname><given-names>SA.</given-names></name></person-group><article-title>A time limited behavioral group for treatment of obsessive-compulsive disorder.</article-title><source><italic>J Psychother Pract Res.</italic></source><year>1998</year><volume>7</volume><fpage>272</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">9752638</pub-id></element-citation></ref><ref id="ref176"><label>176</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearns</surname><given-names>C.</given-names></name><name><surname>Tone</surname><given-names>Y.</given-names></name><name><surname>Rush</surname><given-names>G.</given-names></name><name><surname>Lucey</surname><given-names>JV.</given-names></name></person-group><article-title>Effectiveness of group-based cognitive-behavioural therapy in patients with obsessive-compulsive disorder.</article-title><source><italic>The Psychiatrist Online.</italic></source><year>2010</year><volume>34</volume><fpage>6</fpage><lpage>9</lpage></element-citation></ref><ref id="ref177"><label>177</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bortoncello</surname><given-names>CF.</given-names></name><name><surname>Braga</surname><given-names>DT.</given-names></name><name><surname>Gomes</surname><given-names>JB.</given-names></name><name><surname>Souza</surname><given-names>FP.</given-names></name><name><surname>Cordioli</surname><given-names>AV.</given-names></name></person-group><article-title>Psychometric properties of the Brazilian version of the Obsessive Beliefs Questionnaire (OBQ-44).</article-title><source><italic>J Anxiety Disord.</italic></source><year>2012</year><volume>26</volume><fpage>430</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">22306130</pub-id></element-citation></ref><ref id="ref178"><label>178</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krochmalik</surname><given-names>A.</given-names></name><name><surname>Jones</surname><given-names>MK.</given-names></name><name><surname>Menzies</surname><given-names>RG.</given-names></name></person-group><article-title>Danger Ideation Reduction Therapy (DIRT) for treatment-resistant compulsive washing.</article-title><source><italic>Behav Res Ther.</italic></source><year>2001</year><volume>39</volume><fpage>897</fpage><lpage>912</lpage><pub-id pub-id-type="pmid">11480831</pub-id></element-citation></ref><ref id="ref179"><label>179</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritzler</surname><given-names>BK.</given-names></name><name><surname>Hecker</surname><given-names>JE.</given-names></name><name><surname>Losee</surname><given-names>MC.</given-names></name></person-group><article-title>Self-directed treatment with minimal therapist contact: preliminary findings for obsessive-compulsive disorder.</article-title><source><italic>Behav Res Ther.</italic></source><year>1997</year><volume>35</volume><fpage>627</fpage><lpage>631</lpage><pub-id pub-id-type="pmid">9193126</pub-id></element-citation></ref><ref id="ref180"><label>180</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greist</surname><given-names>JH.</given-names></name><name><surname>Jefferson</surname><given-names>JW.</given-names></name><name><surname>Kobak</surname><given-names>KA.</given-names></name><name><surname>et al</surname></name></person-group><article-title>A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessivecompulsive disorder.</article-title><source><italic>Int Clin Psychopharmacol.</italic></source><year>1995</year><volume>10</volume><fpage>57</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">7673657</pub-id></element-citation></ref><ref id="ref181"><label>181</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvi</surname><given-names>Y.</given-names></name><name><surname>Atli</surname><given-names>A.</given-names></name><name><surname>Be&#x0015f;iro&#x0011f;lu</surname><given-names>L.</given-names></name><name><surname>Aydin</surname><given-names>A.</given-names></name><name><surname>Gulec</surname><given-names>M.</given-names></name></person-group><article-title>The impact of obsessive beliefs on pharmacological treatment response in patients with obsessivecompulsive disorder.</article-title><source><italic>Int J Psychiatry Clin Pract.</italic></source><year>2011</year><volume>15</volume><fpage>209</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">22121931</pub-id></element-citation></ref><ref id="ref182"><label>182</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Overbeek</surname><given-names>T.</given-names></name><name><surname>Schruers</surname><given-names>K.</given-names></name><name><surname>Vermetten</surname><given-names>E.</given-names></name><name><surname>Griez</surname><given-names>E.</given-names></name></person-group><article-title>Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect.</article-title><source><italic>J Clin Psychiatry.</italic></source><year>2002</year><volume>63</volume><fpage>1106</fpage><lpage>1112</lpage><pub-id pub-id-type="pmid">12523869</pub-id></element-citation></ref><ref id="ref183"><label>183</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keijsers</surname><given-names>GPJ.</given-names></name><name><surname>Hoogduin</surname><given-names>CAL.</given-names></name><name><surname>Schaap</surname><given-names>CPDR.</given-names></name><name><surname>de Jong</surname><given-names>T.</given-names></name><name><surname>de Koning</surname></name></person-group><article-title>The immediate effects of exposure versus response prevention in the treatment of obsessive-compulsive disorder.</article-title><source><italic>Behav Cogn Psychother.</italic></source><year>1995</year><volume>23</volume><fpage>35</fpage><lpage>44</lpage></element-citation></ref><ref id="ref184"><label>184</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>May</surname><given-names>RS.</given-names></name><name><surname>Tolbert</surname><given-names>LC.</given-names></name><name><surname>Jackson</surname><given-names>WT.</given-names></name><name><surname>Flournoy</surname><given-names>JM.</given-names></name><name><surname>Baxter</surname><given-names>LR.</given-names></name></person-group><article-title>Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study.</article-title><source><italic>J Clin Psychiatry.</italic></source><year>2005</year><volume>66</volume><fpage>736</fpage><lpage>743</lpage><pub-id pub-id-type="pmid">15960567</pub-id></element-citation></ref><ref id="ref185"><label>185</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altemus</surname><given-names>M.</given-names></name><name><surname>Greenberg</surname><given-names>BD.</given-names></name><name><surname>Keuler</surname><given-names>D.</given-names></name><name><surname>Jacobson</surname><given-names>KR.</given-names></name><name><surname>Murphy</surname><given-names>DL.</given-names></name></person-group><article-title>Open trial of flutamide for treatment of obsessive-compulsive disorder.</article-title><source><italic>J Clin Psychiatry.</italic></source><year>1999</year><volume>60</volume><fpage>442</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">10453797</pub-id></element-citation></ref><ref id="ref186"><label>186</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Balkom</surname><given-names>AJ.</given-names></name><name><surname>de Haan</surname><given-names>E.</given-names></name><name><surname>van Oppen</surname><given-names>P.</given-names></name><name><surname>Spinhoven</surname><given-names>P.</given-names></name><name><surname>Hoogduin</surname><given-names>KA.</given-names></name><name><surname>van Dyck</surname><given-names>R.</given-names></name></person-group><article-title>Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder.</article-title><source><italic>J Nerv Ment Dis.</italic></source><year>1998</year><volume>186</volume><fpage>492</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">9717867</pub-id></element-citation></ref><ref id="ref187"><label>187</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantovani</surname><given-names>A.</given-names></name><name><surname>Rossi</surname><given-names>S.</given-names></name><name><surname>Bassi</surname><given-names>BD.</given-names></name><name><surname>Simpson</surname><given-names>HB.</given-names></name><name><surname>Fallon</surname><given-names>BA.</given-names></name><name><surname>Lisanby</surname><given-names>SH.</given-names></name></person-group><article-title>Modulation of motor cortex excitability in obsessive-compulsive disorder: An exploratory study on the relations of neurophysiology measures with clinical outcome.</article-title><source><italic>Psychiatry Res.</italic></source><year>2013</year><volume>210</volume><fpage>1026</fpage><lpage>1032</lpage><pub-id pub-id-type="pmid">24064461</pub-id></element-citation></ref><ref id="ref188"><label>188</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiel</surname><given-names>A.</given-names></name><name><surname>Zuger</surname><given-names>M.</given-names></name><name><surname>Jacoby</surname><given-names>GE.</given-names></name><name><surname>Schussler</surname><given-names>G.</given-names></name></person-group><article-title>Thirty-month outcome in patients with anorexia or bulimia nervosa and concomitant obsessive-compulsive disorder.</article-title><source><italic>Am J Psychiatry.</italic></source><year>1998</year><volume>155</volume><fpage>244</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">9464205</pub-id></element-citation></ref><ref id="ref189"><label>189</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkby</surname><given-names>KC.</given-names></name><name><surname>Berrios</surname><given-names>GE.</given-names></name><name><surname>Daniels</surname><given-names>BA.</given-names></name><name><surname>Menzies</surname><given-names>RG.</given-names></name><name><surname>Clark</surname><given-names>A.</given-names></name><name><surname>Romano</surname><given-names>A.</given-names></name></person-group><article-title>Process-outcome analysis in computer-aided treatment of obsessive-compulsive disorder.</article-title><source><italic>Compr Psychiatry.</italic></source><year>2000</year><volume>41</volume><fpage>259</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">10929793</pub-id></element-citation></ref><ref id="ref190"><label>190</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anholt</surname><given-names>GE.</given-names></name><name><surname>van Oppen</surname><given-names>P.</given-names></name><name><surname>Emmelkamp</surname><given-names>PM.</given-names></name><name><surname>et al</surname></name></person-group><article-title>Measuring obsessivecompulsive symptoms: Padua Inventory-Revised vs. Yale-Brown Obsessive Compulsive Scale.</article-title><source><italic>J Anxiety Disord.</italic></source><year>2009</year><volume>23</volume><fpage>830</fpage><lpage>835</lpage><pub-id pub-id-type="pmid">19443176</pub-id></element-citation></ref><ref id="ref191"><label>191</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Oppen</surname><given-names>P.</given-names></name><name><surname>Emmelkamp</surname><given-names>PMG.</given-names></name><name><surname>van Balkom</surname><given-names>AJLM.</given-names></name></person-group><article-title>The sensitivity to change of measures for obsessive-compulsive disorder.</article-title><source><italic>J Anxiety Disord.</italic></source><year>1995</year><volume>9</volume><fpage>241</fpage><lpage>248</lpage></element-citation></ref><ref id="ref192"><label>192</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>BL.</given-names></name><name><surname>Morris</surname><given-names>RL.</given-names></name><name><surname>Pedley</surname><given-names>LL.</given-names></name><name><surname>Schwab</surname><given-names>JJ.</given-names></name></person-group><article-title>The ability of the Symptom Checklist SCL-90 to differentiate various anxiety and depressive disorders.</article-title><source><italic>Psychiatr Q.</italic></source><year>2001</year><volume>72</volume><fpage>277</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">11467161</pub-id></element-citation></ref><ref id="ref193"><label>193</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>EE.</given-names></name><name><surname>Penick</surname><given-names>EC.</given-names></name><name><surname>Powell</surname><given-names>BJ.</given-names></name><name><surname>Othmer</surname><given-names>E.</given-names></name><name><surname>Nickel</surname><given-names>EJ.</given-names></name><name><surname>Desouza</surname><given-names>C.</given-names></name></person-group><article-title>Development of scales to screen for eight common psychiatric disorders.</article-title><source><italic>J Nerv Ment Dis.</italic></source><year>2005</year><volume>193</volume><fpage>131</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">15684916</pub-id></element-citation></ref><ref id="ref194"><label>194</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>DW.</given-names></name><name><surname>Monahan</surname><given-names>P.</given-names></name><name><surname>Gable</surname><given-names>J.</given-names></name><name><surname>Blum</surname><given-names>N.</given-names></name><name><surname>Clancy</surname><given-names>G.</given-names></name><name><surname>Baker</surname><given-names>P.</given-names></name></person-group><article-title>Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder.</article-title><source><italic>J Clin Psychiatry.</italic></source><year>1998</year><volume>59</volume><fpage>420</fpage><lpage>425</lpage><pub-id pub-id-type="pmid">9721822</pub-id></element-citation></ref></ref-list><glossary><title>List of Abbreviations used in Table IIa</title><def-list id="DL1"><def-item><term>BDD</term><def><p>Body dysmorphic disorder</p></def></def-item><def-item><term>BDNF</term><def><p>Brain-derived neurotrophic factor</p></def></def-item><def-item><term>GAD</term><def><p>Generalized anxiety disorder</p></def></def-item><def-item><term>GBT</term><def><p>Group behavior therapy</p></def></def-item><def-item><term>HC</term><def><p>Healthy control</p></def></def-item><def-item><term>IRT</term><def><p>Intensive residential treatment</p></def></def-item><def-item><term>MDD</term><def><p>Major depressive disorder</p></def></def-item><def-item><term>MFBT</term><def><p>Multi-family behavior therapy</p></def></def-item><def-item><term>OC</term><def><p>Obsessive-compulsive</p></def></def-item><def-item><term>OCD</term><def><p>Obsessive-compulsive disorder</p></def></def-item><def-item><term>OCPD</term><def><p>Obsessive-compulsive personality disorder</p></def></def-item><def-item><term>PD</term><def><p>Panic disorder</p></def></def-item><def-item><term>PDA</term><def><p>Panic disorder with agoraphobia</p></def></def-item><def-item><term>PTSD</term><def><p>Post-traumatic stress disorder</p></def></def-item><def-item><term>RCT</term><def><p>Randomised controlled trial</p></def></def-item><def-item><term>SAD</term><def><p>Social anxiety disorder</p></def></def-item><def-item><term>SAS-SR</term><def><p>Social Adjustment Scale-Self Report</p></def></def-item><def-item><term>SDS</term><def><p>Sheehan Disability Scale</p></def></def-item><def-item><term>SSRI</term><def><p>Selective serotonin reuptake inhibitor</p></def></def-item><def-item><term>WSAS</term><def><p>Work and Social Adjustment Scale</p></def></def-item><def-item><term>Y-BOCS</term><def><p>Yale-Brown Obsessive-Compulsive Scale</p></def></def-item></def-list></glossary><glossary><title>List of Abbreviations used in Table IIb</title><def-list id="DL2"><def-item><term>ACT</term><def><p>Acceptance and Commitment Therapy</p></def></def-item><def-item><term>BDD</term><def><p>Body dysmorphic disorder</p></def></def-item><def-item><term>ERP</term><def><p>Exposure and Response Prevention</p></def></def-item><def-item><term>IIRS</term><def><p>Illness Intrusiveness Rating Scale</p></def></def-item><def-item><term>MDD</term><def><p>Major Depressive Disorder</p></def></def-item><def-item><term>MOS-36</term><def><p>Medical Outcomes Study SF-36 Health Survey</p></def></def-item><def-item><term>OCD</term><def><p>Obsessive-compulsive disorder</p></def></def-item><def-item><term>PD</term><def><p>Panic Disorder</p></def></def-item><def-item><term>PTSD</term><def><p>Post-traumatic stress disorder</p></def></def-item><def-item><term>Q-LES-Q</term><def><p>Quality of Life Enjoyment and Satisfaction Questionnaire</p></def></def-item><def-item><term>QOL</term><def><p>Quality of life</p></def></def-item><def-item><term>QOLI</term><def><p>Quality of Life Inventory</p></def></def-item><def-item><term>QOLS</term><def><p> Quality of Life Scale</p></def></def-item><def-item><term>RCT</term><def><p>Randomised controlled trial</p></def></def-item><def-item><term>SF-36</term><def><p>Short Form (36) Health Survey</p></def></def-item><def-item><term>SP</term><def><p>Social phobia</p></def></def-item><def-item><term>SRIs</term><def><p>Serotonin reuptake inhibitors</p></def></def-item><def-item><term>WHOQOL-BREF</term><def><p>The World Health Organization Quality of Life-BREF</p></def></def-item><def-item><term>WHOQOL-BREF-TR</term><def><p>WHO Quality of Life-BREF-Turkish Version</p></def></def-item></def-list></glossary><glossary><title>List of Abbreviations used in Table IIc</title><def-list id="DL3"><def-item><term>BD</term><def><p>Bipolar disorder</p></def></def-item><def-item><term>BDNF</term><def><p>Brain derived neurotropic factor</p></def></def-item><def-item><term>CAM</term><def><p>Cognitive Appraisal Model</p></def></def-item><def-item><term>BIS</term><def><p>Barratt Impulsiveness Scale</p></def></def-item><def-item><term>CB</term><def><p>Compulsive buyers</p></def></def-item><def-item><term>CBGT</term><def><p>Cognitive behavioral group therapy</p></def></def-item><def-item><term>CBT</term><def><p>Cognitive behavioral therapy</p></def></def-item><def-item><term>COMT</term><def><p>Catechol-O-methyltransferase</p></def></def-item><def-item><term>DAS</term><def><p>Dysfunctional attitude scale</p></def></def-item><def-item><term>DIRT</term><def><p>Danger Ideation Reduction Therapy</p></def></def-item><def-item><term>DOCS</term><def><p>Dimensional Obsessive Compulsive Scale</p></def></def-item><def-item><term>ED</term><def><p>Eating disorder</p></def></def-item><def-item><term>ERP</term><def><p>Exposure and Response Prevention</p></def></def-item><def-item><term>fMRI</term><def><p>Functional magnetic resonance imaging</p></def></def-item><def-item><term>GAD</term><def><p>Generalised anxiety disorder</p></def></def-item><def-item><term>GDNF</term><def><p>Glial cell-derived neurotrophic factor</p></def></def-item><def-item><term>HZI/HOCI</term><def><p>Hamburg Obsessive Compulsive Disorder</p></def></def-item><def-item><term>IBA</term><def><p>Interference-Based Approach</p></def></def-item><def-item><term>LOI</term><def><p>Leyton Obsessional Inventory</p></def></def-item><def-item><term>MADRAS</term><def><p>Montgomery &#x000c5;sberg Depression Rating Scale</p></def></def-item><def-item><term>MDD</term><def><p>Major Depressive Disorder</p></def></def-item><def-item><term>MI</term><def><p>Magical ideation</p></def></def-item><def-item><term>MOCI</term><def><p>Maudsley Obsessive Compulsive Inventory</p></def></def-item><def-item><term>MOCQ</term><def><p>Maudsley Obsessive Compulsive Questionnaire</p></def></def-item><def-item><term>NGF</term><def><p>Nerve growth factor</p></def></def-item><def-item><term>OAD</term><def><p>Other anxiety disorder</p></def></def-item><def-item><term>OBQ</term><def><p>Obsessional Beliefs Questionnaire</p></def></def-item><def-item><term>OCD</term><def><p>Obsessive-compulsive disorder</p></def></def-item><def-item><term>OCPD</term><def><p>Obsessive compulsive personality disorder</p></def></def-item><def-item><term>OCI-R</term><def><p>Obsessive Compulsive Inventory-Revised</p></def></def-item><def-item><term>OCI-SV</term><def><p>Obsessive Compulsive Inventory-Short Version</p></def></def-item><def-item><term>PI-R</term><def><p>Padua Inventory-Revised</p></def></def-item><def-item><term>PI-WSUR</term><def><p>Pi-Washington State University revised form)</p></def></def-item><def-item><term>PG</term><def><p>Pathological gambling</p></def></def-item><def-item><term>PTSD</term><def><p>Post-traumatic stress disorder</p></def></def-item><def-item><term>RAS</term><def><p>Responsibility Attitude Scale</p></def></def-item><def-item><term>RIQ</term><def><p>Responsibility Interpretations Questionnaire</p></def></def-item><def-item><term>ROCF</term><def><p>Rey-Osterrieth Complex Figure</p></def></def-item><def-item><term>SAD</term><def><p>Social anxiety disorder</p></def></def-item><def-item><term>SCL-90-R</term><def><p>Symptom Checklist-90-Revised</p></def></def-item><def-item><term>SCWC</term><def><p>Stroop Color Word Task</p></def></def-item></def-list></glossary></back></article>